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ABSTRACT 
Harmful shifts within the microbiota, termed dysbiosis, are associated with 
an array of diseases that plague modern society. Dysbiosis may include loss of 
diversity, expansion of pathobionts, and reductions of beneficial microbes that 
are required for symbiosis with the host. While one or more of these alterations 
are identified in correlation to many disorders, the impetus for these dysfunctional 
communities has remained largely uncharacterized.  One pathway that has likely 
evolved to maintain healthy microbiota populations is secretory immunoglobulin 
A (IgA), which shapes commensal communities and maintains tolerant host-
microbe responses. Intestinal IgA is produced at high levels as a result of T 
follicular helper cell (TFH) and B cell interactions in germinal centers along the gut, 
however, the molecular cues that govern T cell dependent IgA are largely 
unknown. This dissertation has uncovered a mechanism by which T cells use 
innate signaling through Toll-like receptors (TLRs) and Myeloid differentiation 
primary response gene 88 (MyD88) in order to detect shifts within the microbiota 
and direct IgA secretion. Loss of this pathway diminishes high-affinity IgA 
targeting of the microbiota and fails to constrain bacterial communities, leading to 
dysbiosis.  Animals lacking MyD88 signaling within T cells are more prone to 
developing increased colitis severity and metabolic syndrome, both of which can 
be treated by rescuing the dysbiotic microbiota to a healthy state. These findings 
iv 
identify that T cells converge innate and adaptive immune signals to coordinate 
IgA against the microbiota. This maintenance of healthy microbiota communities 
has widespread impacts on immune development and metabolism, highlighting 
the wide variety of physiological pathways that have evolved to depend on 
symbiotic host-microbiota interactions in order to promote health and prevent 
diseases. 
Dedicated to my three M’s Petersen. 
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The origin of the adaptive immune system coincided with a dramatic 
increase in both the diversity and abundance of the microbiome, expanding the 
metabolic and genetic capacity of commensal communities (1). Despite 
traditional views that our immune system was designed to battle pathogens and 
maintain sterility, it has been hypothesized that the adaptive arm instead evolved 
to foster this increased symbiotic complexity while limiting infectious risks. Due to 
this relationship, a flexible dialogue has emerged between the host and resident 
microbes that shapes both immune development and the microbiota architecture. 
This communication is required to mold and maintain beneficial commensal 
communities while inducing tolerant immune responses to the microbiota.  
Seminal studies have provided evidence for the deleterious impact of 
failures within host-microbial communications that lead to perturbations to the 
microbiota, termed dysbiosis (2, 3). Indeed, dysbiosis has been implicated in 
allergic, autoimmune, and metabolic diseases, making involvement of the 
microbiota in disease development and persistence an ideal target for 
preventative and therapeutic treatments (4-6). While recent investigations have 
uncovered some elements of host-microbe interactions that initiate some of these 
disorders, the extent of the cross-talk between our immune system and 
microbiota is complex, and therefore largely unexplored.  
In order to ensure beneficial microbiota composition, the adaptive immune 
system has evolved a highly specific form of selection through the production of 
Immunoglobulin A (IgA). Secretory IgA (sIgA) is the most abundant antibody 
found within mucosal sites and performs a variety of valuable functions, including 
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barrier formation by sterically hindering microbe attachment to host cells, 
entrapment and elimination of pathogenic microbes, and modulation of antigenic 
expression within commensals (7, 8). All of these responses result in little 
activation of the host immune system, and are therefore thought to shape the 
microbiota while maintaining tolerance to it. Production of sIgA occurs via two 
mechanisms that differ by their dependence on T cells (9). Given the proper cues, 
B cells trafficking throughout the gut enact class switch recombination (CSR) to 
produce IgA capable of targeting a broad range of microbial antigens with 
moderate to low affinity. However, when T cells interact with B cells to direct 
antibody production, CSR within B cells is accompanied by rapid activation and 
cell death that results in a phenomenon called somatic hyper mutation (SHM). 
The end product of these reactions is a highly antigen specific sIgA that is 
capable of binding its targets with high affinity.   
T cells are multifaceted effector cells of the adaptive immune system that 
have the ability to modulate their responses to external cues. Notably, T cell 
development is dependent on the microbiota (10-12). While classically studied for 
their dependence on antigen presenting cells (APCs) for activation, the 
identification that T cells express Toll like receptors (TLRs), which recognize 
conserved microbial patterns, suggests that direct sensing of microbial products 
could provide a mechanism to influence T cell responses (13). This would be 
particularly relevant within the gut where an abundant source of commensal 
ligands exists. Previous studies support this idea through the discovery that a 
single commensal species, Bacteroides fragilis, utilizes TLR2 signaling to 
4	
promote its own colonization while enhancing T cell induced tolerance to the 
microbiota (14).  
Most TLRs signal through a common, downstream adaptor protein called 
Myeloid differentiation primary response gene 88 (MyD88) (15). Therefore, in 
order to interrogate the impact of direct recognition of microbial ligands on T cell 
function within the gut, we created a mouse that contains a specific deletion of 
MyD88 within T cells. We hypothesized that direct recognition of microbial 
products directs T cell development within the gut in order to shape the 
microbiota architecture and induce tolerant immune responses towards 
commensals.  Indeed, we have discovered that mice lacking T cell specific 
MyD88 have a defective T cell-dependent IgA response and reduced ability to 
shape healthy microbiota communities (16). The resulting dysbiosis that occurs 
within these animals leads to a greater susceptibility to both colitis and the onset 
of obesity and insulin resistance. Providing these animals with a fecal microbial 
transplant (FMT) or recolonization with beneficial microbial communities is 
capable of rescuing disease. Thus, this dissertation demonstrates that direct 
recognition of microbial ligands on T cells is vital to proper IgA targeting within 
the gut to maintain beneficial microbiota structure and promote health.  
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Defining dysbiosis and its influence on host immunity
and disease
Charisse Petersen and June L. Round*
Department of Pathology, Division of Microbiology and
Immunology, University of Utah School of Medicine, Salt
Lake City, UT 84112, USA
Summary
Mammalian immune system development depends
on instruction from resident commensal micro-
organisms. Diseases associated with abnormal
immune responses towards environmental and
self antigens have been rapidly increasing over the
last 50 years. These diseases include inflammatory
bowel disease (IBD), multiple sclerosis (MS), type I
diabetes (T1D), allergies and asthma. The observa-
tion that people with immune mediated diseases
house a different microbial community when com-
pared to healthy individuals suggests that patho-
genesis arises from improper training of the
immune system by the microbiota. However, with
hundreds of different microorganisms on our
bodies it is hard to know which of these contribute
to health and more importantly how? Microbiolo-
gists studying pathogenic organisms have long
adhered to Koch’s postulates to directly relate a
certain disease to a specific microbe, raising the
question of whether this might be true of
commensal–host relationships as well. Emerging
evidence supports that rather than one or two
dominant organisms inducing host health, the
composition of the entire community of microbial
residents influences a balanced immune response.
Thus, perturbations to the structure of complex
commensal communities (referred to as dysbiosis)
can lead to deficient education of the host immune
system and subsequent development of immune
mediated diseases. Here we will overview the lit-
erature that describes the causes of dysbiosis and
the mechanisms evolved by the host to prevent
these changes to community structure. Building
off these studies, we will categorize the different
types of dysbiosis and define how collections of
microorganisms can influence the host response.
This research has broad implications for future
therapies that go beyond the introduction of a
single organism to induce health. We propose that
identifying mechanisms to re-establish a healthy
complex microbiota after dysbiosis has occurred,
a process we will refer to as rebiosis, will be fun-
damental to treating complex immune diseases.
What is dysbiosis?
Our current knowledge of the architecture of a healthy
microbiota comes from multiple studies in individuals with
no overt signs of disease (Huttenhower et al., 2012). This
structure includes Bacteroidetes and Firmicutes as the
dominant bacterial phyla present in stool samples and
Proteobacteria and Actinobacteria being a small but
consistent presence in most people. Broadly defined,
dysbiosis is any change to the composition of resident
commensal communities relative to the community found
in healthy individuals. In the last decade, a number of
studies have documented significant changes in the struc-
ture of microbial communities in patients and mouse
models of inflammatory bowel diseases (IBD) such as
Crohn’s and ulcerative colitis (UC) (Frank et al., 2007),
diabetes (Karlsson et al., 2013), asthma (Abrahamsson
et al., 2013), allergies and even autism (Parracho et al.,
2005). Given the emerging importance of the microbiota
to host development, it is speculated that these observed
changes in microbial composition are contributing factors
to the initiation and/or persistence of many of these
diseases.
There are multiple ways that the structure of the micro-
bial community can be influenced. This includes the
genetics of the host, diet, infection, or medical inter-
ventions (such as antibiotics). The hygiene hypothesis
originally proposed that antibiotic usage and lifestyle
alterations that limit microbial exposure were predispos-
ing populations of people in developed countries to
Received 21 March, 2014; revised 29 April, 2014; accepted 30 April,
2014. *For correspondence. E-mail june.round@path.utah.edu; Tel.
(+1) 801 213 4164 (office) or (+1) 801587 5684 (lab).
Cellular Microbiology (2014) 16(7), 1024–1033 doi:10.1111/cmi.12308
First published online 2 June 2014
© 2014 The Authors. Cellular Microbiology published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
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autoimmune disease (Strachan, 2000). Therefore it was
suggested that, due to the inability to differentiate
between pathogen and commensal, antibiotics disturb
microbiota structure and, subsequently, the co-
evolutionary relationship between our immune system
and the symbionts we host. Since then a significant
amount of research has gone into exploring the functional
importance of the microbiota and the influence antibiotic
treatment has on its architecture (Ubeda et al., 2010;
Buffie et al., 2012; Cho and Blaser, 2012). Interestingly,
antibiotics commonly used in the clinic have significant
impacts on our microbial residents (Table 1). Importantly,
many antibiotics have long lasting effects on the
microbiota, leading to the permanent loss of some organ-
isms, while others outgrow and persist. While these
studies have documented dysbiosis in the context of
disease or antibiotic use, recent investigations have
begun to identify causality between dysbiosis and disease
progression. Collectively, these studies now allow us to
better understand what dysbiosis is and begin to catego-
rize it into three types that will be discussed in depth here.
These include (i) loss of beneficial microbial organisms,
(ii) expansion of pathobionts or potentially harmful micro-
organisms and (iii) loss of overall microbial diversity
(Fig. 1). These three types of dysbiosis are not mutually
exclusively and may all occur concurrently. This review is
intended to help synthesize the current data to allow a
more defined understanding of what dysbiosis is and how
it influences health, immune system development and
disease.
Loss of beneficial microbial organisms
It has become well established that the microbiota
is important for the maturation and development of
appropriate intestinal immune responses (Round and
Mazmanian, 2009; Cho and Blaser, 2012; Hooper et al.,
2012). Recent studies have begun to identify the organ-
isms and their mechanisms responsible for eliciting
immune development within the host. The immune
response must be carefully balanced between the
inflammation required for pathogen eradication and
tolerant reactions that prevent unwanted immune
responses towards self tissue and commensals. Tolerant
mechanisms evolved by the host include production of
mucus and antimicrobial peptides to create a barrier
between host tissue and microbes (Johansson et al.,
2008; 2011; Vaishnava et al., 2011), modification of bac-
terial products to make them less immunogenic (Bates
et al., 2007), production of antibodies that can directly
bind to and influence microbial function (Fagarasan
and Honjo, 2003; Peterson et al., 2007; Slack et al.,
2012) and anti-inflammatory T cells. Interestingly, spe-
cific members from the microbiota have been identified
that can directly co-ordinate many aspects of the host
immune response.
Tolerance to self tissue and resident commensals is, in
part, governed by a specialized subset of T lymphocytes
termed T regulatory cells (Tregs) (Josefowicz et al.,
2012). These cells are marked by the expression of a
transcription factor, Foxp3 (Fontenot et al., 2003). Muta-
tions in the Foxp3 gene result in a loss of Treg develop-
ment in both mouse and humans and subsequent
inflammation and autoimmunity at multiple organ sites,
demonstrating the importance of Treg populations to host
health. Several recent investigations have identified resi-
dent microorganisms that are capable of inducing these
cell types within the intestine of the host (Round and
Mazmanian, 2010; Atarashi et al., 2011). Initial experi-
ments demonstrated that Treg function is compromised in
germfree mice and can be restored by either mono-
association with the human commensal Bacteriodes
fragilis or with a defined mix of Clostridium strains from
groups IV and XIVa. Colonization of animals with either of
these organisms protects animals from colitis in a Treg-
dependent manner through distinct mechanisms. The
Clostridium strains induce TGF-β expression from intesti-
nal epithelial cells (IECs) to enhance the differentiation of
inducible colonic Tregs (Atarashi et al., 2013); while
B. fragilis utilizes a capsular polysaccharide, PSA, that
binds to TLR2 on both dendritic cells and T cells to induce
IL-10 and enhance the suppressive capability of Tregs
(Round et al., 2011; Shen et al., 2012). Other Bacteriodes
strains have also been reported to increase the total
numbers of Tregs within the colon, including B. caccae, B.
thetaiotaomicron, and B. vulgaris, although this is not
seen in all systems (Faith et al., 2014). Several other
strains of commensal bacteria have evolved the capacity
to induce Tregs and confer protection from inflammatory
disease. These include multiple strains of Lactobacillus
such as L. acidophilus and several strains of
Bifidobacterium, including B. breve, likely making induc-
tion of Tregs a common mechanism employed by bacteria
to induce tolerance in the gut. The mechanisms by which
these many of these organisms influence Treg biology
remain untested but likely include bacterial derived prod-
ucts such as short-chain fatty acids (SCFAs) (Schmidt
et al., 2010). SCFAs are microbial fermentation products
from dietary fibre and include propionate, acetate,
butyrate, and formate. These products have been shown
by multiple groups to be responsible for regulating the
Treg pool within the colon and provide protection from
experimental colitis (Arpaia et al., 2013; Furusawa et al.,
2013; Smith et al., 2013). Butyrate and propionate, but not
acetate, seem to be the most prominent SCFAs capable
of driving Treg responses. Butyrate, in particular, is
capable of blocking histone deacetylases that promote
DNA condensation (HDACs) and can thereby regulate
How changes in microbiota structure influence health 1025
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gene expression. Interestingly, if T cells are treated with
butyrate under Treg inducing conditions in vitro, there is a
marked increase in acetylation of the Foxp3 promoter
region as well as enhancer elements thereby allowing
Foxp3 to be expressed. SCFAs are sensed by the host
through a variety of receptors, including G-protein
coupled receptors GPCR43 and GPR109a (Smith et al.,
2013; Singh et al., 2014). Not surprisingly, GPCR43
expression is increased on Tregs specifically within intes-
tinal tissues (Smith et al., 2013). Consequently, loss of
these receptors leads to susceptibility of animals to
colonic inflammation and colon cancer.
While Tregs are a key component of tolerance induction
within the intestine, commensal organisms have evolved
other mechanisms to suppress inflammation. Patients
with IBD have elevated levels of inflammatory cytokines
such as TNF-α and IP-10. As discussed above, the levels
of these cytokines are often opposed by the induction of
Tregs, and this is the mechanism utilized by the host to
maintain homeostasis within the gut. Recently, however, a
group uncovered a mechanism by which commensal bac-
teria can directly reduce inflammation by targeting the
cytokines themselves. Lactobacillus paracasei and L.
casei both encode a protease called lactoceptin that spe-
cifically degrades the inflammatory cytokine IP-10 (von
Schillde et al., 2012). Degradation of secreted and cell-
associated IP-10 lead to reduced lymphocyte recruitment
during an animal model of ileitis. Thus, members of the
microbiota have evolved ways to directly antagonize the
effects of the host inflammatory response and therefore
directly aid in the maintenance of intestinal homeostasis.
Unlike T cells that recognize protein antigens, invariant
NKT cells (iNKT) recognize lipid antigens and play impor-
tant roles in innate and adaptive inflammation. Interest-
ingly, the development of these cell types is dynamically
regulated by the microbiota such that GF mice have
elevated numbers of these cells within the gut (Olszak
et al., 2012). Animals containing increased numbers of
iNKT cells are more susceptible to colitis, thus the iden-
tification of how the microbiota functions to suppress
iNKT cell numbers in the gut could lead to an important
therapeutic intervention. A recent report demonstrated
that mono-association of germfree mice with B. fragilis is
sufficient to suppress the development of this population
(An et al., 2014). B. fragilis contains a gene with
high homology to enzymes involved in sphinoglipid
biogenesis. Deletion of this gene in B. fragilis prevents
the suppression of iNKT cell development, indicating that
B. fragilis utilizes these lipids to influence iNKT cell
biology. Indeed, these investigators purified sphingolipids
from B. fragilis and showed that they are capable of
reducing iNKT cell activation and protecting animals from
disease. Importantly, early exposure to B. fragilis is
required to inhibit iNKT cell development, and mono-
colonization of adult germfree mice is insufficient to
protect against colitis. As discussed earlier, B. fragilis is
also able to modulate Treg responses (Ochoa-Reparaz
et al., 2010; Round and Mazmanian, 2010). These
studies reveal that a single commensal organism can
possess several mechanisms to positively influence host




Pathobiont expansion Reduced diversity Loss of beneficial microbes
Fig. 1. A loss of beneficial microbes,
expansion of pathobionts, and loss of diversity
are events that encompass dysbiosis. During
healthy, homeostatic conditions the microbiota
is composed of a diversity organisms that are
known to benefit host development and
health. However, environmental insults,
such as antibiotic use or diet can lead to
disruptions in the structure of the microbial
community. These disruptions can lead to a
loss of organisms that are beneficial to the
host and a subsequent overgrowth of
commensals that have the potential to cause
harm, termed pathobionts. Domination of the
microbiota by pathobionts can lead to
inflammation and pathology. Additionally,
multiple studies have described the diversity
of contributions made by the various
members of the microbiota. Oftentimes, these
are non-redundant influences on host health,
thus a total loss of diversity in the microbiota
can also influence disease progression or
severity and thus also represents a dysbiosis
event.
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Clinical investigations provide support for these animal
studies. Culture-independent analyses of patients with
CD and UC have revealed a distinct loss of symbionts
residing within the colonic mucosa as compared to
healthy individuals. Specifically, loss of Clostridium
groups XIVa and IV is observed within faecal and mucosal
samples in IBD patients (Gophna et al., 2006; Frank et al.,
2007). These observed reductions were seen consistently
whether patients were actively experiencing clinical symp-
toms or within remission and were not correlated with
recent antibiotics. This argues that the loss of beneficial
microbes is an underlying issue and not simply a reflec-
tion of increased inflammation or treatment. Conflicting
results have been reported for the phyla Bacteroidetes.
Using mucosal tissues from small intestines and colons
from 190 patients that included equal numbers of CD, UC,
and healthy controls, Frank et al. identified approximately
800–1600 OTUs and observed a significant decrease in
the OTUs and relative abundance of Bacteroidetes within
IBD patients. Other studies including microbial identifica-
tion from faecal samples have observed increases in
Bacteroidetes within IBD patients (Mangin et al., 2004;
Gophna et al., 2006). This, however, may reflect differ-
ences in culture-dependent versus -independent tech-
niques, the depth of microbial sequence sampling, or
tissue versus faecal sampling differences. Collectively,
these studies identify important ways in which commensal
bacteria positively influence mammalian biology, thus loss
of these organisms represents an important aspect of
dysbiosis.
Expansion of pathobionts
The microbiota also contains members that have the
capacity to cause harm to the host. These organisms
have been termed pathobionts to indicate their potential
to cause pathology (Chow and Mazmanian, 2010).
Pathobionts are typically kept at low levels within a
healthy gut and do not cause problems in immune-
competent hosts; however, there are several examples
that outgrowth of these organisms can contribute to
disease. Thus, expansion of pathobionts represents a
second category of dysbiosis.
The most often reported incidence of pathobiont
expansion is that of Proteobacteria and in particular the
family Enterobacteriaceae, which contains members
such as Escherichia coli, Shigella and Klebsiella (Lupp
et al., 2007). This is true in multiple mouse models of
colitis, including animal models carrying mutations within
genes that are associated with IBD (Ayres et al., 2012).
In particular, the deletion of TLR5, a Toll-like receptor
(TLR) responsible for recognizing flagellar proteins,
results in low grade inflammation, colitis and metabolic
syndrome with incomplete penetrance (Vijay-Kumar
et al., 2010; Carvalho et al., 2012; Cullender et al.,
2013). These disease phenotypes are lost when animals
are re-derived with a microbiota from Jackson labs,
suggesting a role for the composition of the microbiota
in driving disease. To identify microbial communities
associated with colitis in TLR5 deficient animals, the
microbiota was compared between colitic and non-colitic
TLR5−/− animals. Interestingly, animals that developed
spontaneous colitis also had a threefold increase
in Proteobacteria. More importantly, members of
Enterobacteriaceae, such as E. coli, were found to be
preferentially associated with the mucosa and able to
penetrate the tissue. To show the requirement for E. coli
for colitis induction in TLR5−/− animals, they antibiotic
treated TLR5−/− and WT animals and then treated the
mice with an adherent invasive E. coli (AIEC) strain.
TLR5−/− animals were unable to manage levels of these
flagellated bacteria and harboured a 10-fold larger bac-
terial load. Moreover, all TLR5−/− animals receiving this
strain succumbed to colitis, demonstrating that E. coli
were sufficient to cause colitis in the absence of TLR5.
Klebsiella pneumonia and Proteus mirabilis, both
members of the Enterobacteriaceae family, also
expanded to induce colitis within T-bet−/− X Rag2−/− mice
(Garrett et al., 2007). Rag deficient animals lack any T or
B cells and therefore crossing these mice causes a lack of
Tbet in cells of the innate immune system. Interestingly,
these species required an intact microbiota for disease
induction and were not sufficient to induce colitis on their
own. As a final example, when animals are treated with
antibiotics and subsequently induced for colitis using
DSS, expansion of a multi-drug-resistant E. coli strain
occurs that is able to penetrate the intestinal mucosa and
cause sepsis (Ayres et al., 2012). Multiple studies have
demonstrated how these organisms are able to exploit
the inflamed environment and expand their numbers,
and these mechanisms have been reviewed elsewhere
(Spees et al., 2013). Importantly, the expansion of
Enterobacteriaceae is also seen in patients suffering from
CD and UC in both tissue and faecal samples (Frank
et al., 2007), consistent with what is seen in mouse
models; however, much work needs to be done to better
understand whether these organisms truly initiate disease
or simply exacerbate disease progression.
Other types of organisms have been reported to
expand in other animal models of immune deficiency.
NLRP6 is a member of the nucleotide-binding
oligomerization domain protein like receptors (NLRs), a
class of cytoplasmic receptors that recognize bacterial
products. NLRP6−/− mice have an increased abundance of
Prevotella spp. and TM7 and are highly susceptible to
colitis induced by dextran sodium sulfate (DSS) (Elinav
et al., 2011). The colitis is transmissible as co-housing
NLRP6−/− and WT mice results in increased susceptibility
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to disease in the WT animals. Thus, the NLRP6 deficiency
is not required for pathology, but rather allows for
the expansion of a subset of organisms that promote
inflammation.
Finally, while the vast majority of our microbial inhab-
itants are bacteria, mammals are also colonized by
fungal and viral members. In general, yeast are not sus-
ceptible to antibiotic treatment, and one common side-
effect of antibiotic use is the outgrowth of yeast strains
such as Candida albicans. A recent study highlighted the
importance of controlling fungal overgrowth to intestinal
health by investigating the role of Dectin-1 within the gut
(Iliev et al., 2012). Dectin-1 is a receptor that recognizes
alpha-mannans from the cell wall of yeast, and mice defi-
cient in this receptor are more susceptible to DSS colitis
that can be treated with fluconazole, an antifungal drug
that does not target bacteria. These data indicate that
yeast outgrowth can worsen disease and our immune
system has evolved elegant mechanisms to regulate
yeast populations in the gut. Similarly, a study showed
that antibiotic treatment of animals allowed overgrowth of
C. albicans, which increased plasma concentrations of
prostaglandin E2 (PGE2) (Kim et al., 2014). The increase
in PGE2 caused susceptibility to allergies in these
animals that could be suppressed when PGE2 synthesis
was blocked. Thus, antibiotic treatment can allow for out-
growth of fungal species in the gut that can influence
extra-intestinal disease within the host. Viral members of
our microbiota are only just beginning to be identified,
presenting new players in the complex relationship
between genetic and environmental factors that lead to
disease. Polymorphisms within the gene ATG16L1 confer
a twofold higher risk to the development of IBD. When
mice contain a hypomorphic mutation within ATG16L1,
they experience histological abnormalities and increased
colitis similar to Crohn’s disease patients carrying
polymorphisms within the same gene (Cadwell et al.,
2010). Interestingly, chronic infection with a specific
strain of mouse norovirus is required for the observed
phenotype within mice. Although this is not an example
of expansion, it highlights the likelihood of unknown viral
pathobionts playing a role in the development of
dysbiosis associated diseases.
It is unlikely that pathobiont expansion alone would
cause disease, as decades of research have been dedi-
cated to identifying a single organism capable of inducing
IBD and none have been found. Supporting this, subclini-
cal twins and immediate family members posses a
microbiota that resembles that of a related IBD patient;
however, none of these infectious agents had the ability
to induce IBD within a healthy individual. Therefore, it
is possible that concomitant reductions in beneficial
microbes or a loss of diversity must also occur to promote
disease. Collectively, these studies investigate both well-
characterized and newly discovered pathobionts, capable
of inciting harmful effects on the host when given the
opportunity to expand.
Loss of diversity: more is better
There is evidence that members of the microbiota have
diverse and non-redundant contributions to host health.
For instance, some organisms promote the development
of anti-inflammatory networks while others induce protec-
tive inflammatory responses. Additionally, while some
host–microbe interactions can be initiated by multiple
species, others involve a more unique relationship with
exclusive community members (Faith et al., 2014).There-
fore, gaining the maximum health benefits from the
microbiota may require a more complex and diverse col-
lection of organisms, and, indeed, several recent experi-
ments support this notion. Thus, an important aspect
of dysbiosis can also include a loss of total microbial
diversity.
As discussed above, Treg function is compromised in
germfree animals. In order to identify organisms that com-
plement this deficiency, diluted human stool samples
enriched for chloroform-resistant bacteria were used to
colonize germfree animals. Interestingly, these Clostridia
species, containing over 30 different strains, induced
a threefold expansion of Tregs within the gut over
un-colonized controls. Importantly, Treg induction within
the host was diminished when mice were colonized with
only a single strain from this Clostridia collection, as
compared to animals colonized with over 15 different
Clostridia strains. These data suggest that a greater diver-
sity of organisms, even within the same family, can maxi-
mally induce host cellular development (Atarashi et al.,
2011; 2013). Whether these strains amplify Treg activity
through the same pathway or work through distinct
mechanisms remains unclear, but will be important to our
understanding of how these organisms influence host
health.
Early exposure to these diverse communities of
microbes appears to be an additional facet to maintaining
a healthy host–microbiota relationship (Cho and Blaser,
2012; Cho et al., 2012). The antibody isotype, IgE, is
associated with allergic responses, and animals with
increased concentrations of IgE develop worsened aller-
gic disease. Despite a reduction in all other isotypes,
IgE is greatly elevated in the serum of germ-free mice,
indicating a specific requirement for the microbiota in
suppressing this antibody (Cahenzli et al., 2013). Coloni-
zation of germfree mice early in life with a complex
microbiota reduces IgE levels and prevents allergy;
however, if germfree animals are colonized during adult
stages, suppression of IgE levels does not occur. To better
understand the minimal microbial diversity required for
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IgE suppression, germfree mice were first colonized by
a single species, E. coli, which was incapable of sup-
pressing IgE levels. Bi-colonization with two species,
Lactobacillus murinus and Parabacteriodes distasonis,
also failed to suppress IgE levels. When germfree animals
were colonized with eight different organisms that
included L. murinus and P. distasonis half of the animals
still displayed hyper-IgE production. Suppression of IgE
was only evident when the animals were colonized with
up to 40 different strains of bacteria. Taken together, these
studies suggest that a greater diversity of microbial organ-
isms is required for maximal benefits to the host.
While many studies have found correlations with
changes in the microbiota abundance and allergy, few
studies have been able to look at the microbiota early in
life and then follow the same children out to see if they
develop disease. However, a recent study was able to
collect microbiota samples from children during there first
week of life and again at 1 month and 12 months after
birth (Abrahamsson et al., 2013). These same children
were then assessed for allergic disease and asthma at
age seven. Interestingly, the children that developed
asthma all had lower microbial diversities early in life
when compared to the non-asthmatic children, suggesting
that early life microbial diversity might protect from
disease later in development. Rigorous studies still need
to be performed; however, these studies suggest that
increased microbial diversity is better. While we have dis-
cussed three distinct types of dysbiosis, it is likely that
dysbiosis encompasses all three of these manifestations
concomitantly to influence disease.
Rebiosis: establishing a microbial community back
to a healthy state
A handful of studies have now demonstrated that replace-
ment of beneficial bacterial species can protect and even
cure diseases in animal model systems and human
patients (Mazmanian et al., 2008; Sokol et al., 2008;
Ochoa-Reparaz et al., 2010; Round and Mazmanian,
2010). In humans, this has been best established for
Clostridium difficile infections (Aas et al., 2003). C. difficile
infection is a major cause of antibiotic-associated diar-
rhoea and becoming an increasing healthcare burden
(Kachrimanidou and Malisiovas, 2011). C. difficile infec-
tions can cause a wide range of diseases that include
severe diarrhoea, pseudomembranous colitis, and toxic
megacolon. Infection is usually treated with vancomycin
or metronidazole; however, in 25–30% of cases a recur-
rent disease follows, with each relapse increasing the
likelihood of another recurrence. Interestingly, when a
more narrow spectrum antibiotic is used that does less
damage to the microbiota, there are lower recurrence
rates of C. difficile, suggesting that the microbiota may
play a protective role during infection. It has now been
shown in both mouse models and, more importantly,
humans that a faecal microbiota transplant (FMT) from a
healthy donor can help displace C. difficile infection and
prevent recurrences. After a large number of uncontrolled
trials demonstrated high success rates for microbiota
transplantation in resolving C. difficile infections, a
randomized study recently revealed an 81% success rate
following a single transplant with a 98% success rate after
a second (van Nood et al., 2013; Vrieze et al., 2013;
Pamer, 2014). These studies highlight the potential thera-
peutic value of identifying ways to restore a ‘healthy’
microbiota, a process we will refer to as rebiosis.
There are several potential candidate approaches for
rebiosis aside from FMT described above. Multiple inves-
tigations have sought to identify functional members of
the microbiota that can be cultured and therefore used as
a probiotic either in the form of a pill or embedded in food
items. Given the importance of microbial diversity it is
likely that no one single organism will work most effec-
tively, but rather a complex assortment of organisms
will provide the maximum benefit. Indeed, yogurts and
probiotics are beginning to incorporate multiple strains of
organisms. The downside to this therapy is that it relies on
the ability to culture these organisms within the lab, yet it
is estimated that only 20–30% of these organisms are
culturable, meaning that a large, likely very important
constituent of the microbiota will not be sampled. Another
method to maintain or restore a healthy microbiota could
potentially be the use of pre-biotics, which are non-
digestible ingredients that stimulate the growth and activ-
ity of certain bacterial groups. There are a few known
substances that meet these criteria, such as inulin, but
much work is needed to identify the best nutritional
sources for the microbiota. A better understanding of how
host immune pathways influence the structure of the
microbial community might also open up new avenues for
improved therapies for manipulating microbial communi-
ties. Mammalian immune systems have acquired elegant
mechanisms for mounting antigen-specific immunity
against pathogens and therefore might also use similar
mechanisms to control the microbiota. If true, then engi-
neered therapies that target specific microbes while
keeping the rest of the microbiota intact would be possi-
ble. The microbiota represents an important aspect of
human health that we are only beginning to understand;
therefore, much work lies ahead to tap into the therapeutic
value of these microbial symbionts.
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Altered commensal communities are associatedwith
human disease. IgA mediates intestinal homeostasis
and regulates microbiota composition. Intestinal IgA
is produced at high levels as a result of T follicular
helper cell (TFH) and B cell interactions in germinal
centers. However, the pathways directing host IgA
responses toward the microbiota remain unknown.
Here, we report that signaling through the innate
adaptor MyD88 in gut T cells coordinates germinal
center responses, including TFH and IgA+ B cell
development. TFH development is deficient in germ-
free mice and can be restored by feeding TLR2 ago-
nists that activate T cell-intrinsic MyD88 signaling.
Loss of this pathway diminishes high-affinity IgA tar-
geting of the microbiota and fails to control the bac-
terial community, leading to worsened disease. Our
findings identify that T cells converge innate and
adaptive immune signals to coordinate IgA against
the microbiota, constraining microbial community
membership to promote symbiosis.
INTRODUCTION
The development and function of the mammalian immune sys-
tem is dependent upon signals conveyed by the microbiota
(Belkaid and Hand, 2014; Hooper et al., 2012; Kamada et al.,
2013). In particular, the abundance and type of T lymphocytes
in the gut is severely reduced in germ-free (GF) mice (Atarashi
et al., 2011; Ivanov et al., 2008; Mazmanian et al., 2005; Round
and Mazmanian, 2010). While T cell activation is governed by
ligation of the T cell receptor (TCR), the quality and nature of
the response is dependent on secondary signals such as the
cytokine milieu. The identification that T cells express receptors
associated with innate signaling such as Toll-like receptors
(TLRs) and the IL-1R suggests that T cells could directly utilize
these signals as an additional mechanism to control responses
(Caramalho et al., 2003; Kubinak and Round, 2012). This would
be particularly relevant within the gut, where a constant and
abundant source of commensal ligands exists. Supporting
this, a single commensal species utilizes TLR2 to promote its
own colonization (Round et al., 2011). Recent studies have
identified that MyD88 functions within splenic T cells to over-
come Treg suppression during immunization (Schenten et al.,
2014), identifying the relevance of this pathway to immunity.
However, it remains unknown whether these signals provided
by the microbiota act directly on T cells in the gut to influence
mutualism.
The synthesis of IgA has been shown to promote intestinal
health (Berry et al., 2012; Brandtzaeg, 2013; Fagarasan et al.,
2002; Kawamoto et al., 2012; Lindner et al., 2012; Slack et al.,
2009). IgA is the most abundantly produced antibody in mam-
mals, with most being secreted into the intestine. Because of
this, IgA represents a key host mechanism for regulating
commensal microbial communities. A recent study has shown
that IgA binds colitogenic members of the microbiota (Palm
et al., 2014), which highlights the role of IgA as an important
mediator of microbiota-induced inflammatory disease and a
potential diagnostic biomarker. T cell help is required for the gen-
eration of high-affinity antibody production. In particular, TFH
cells directly interact with B cells in the germinal center (GC) to
induce somatic hypermutation and class switching (Crotty,
2011). Our understanding of the molecular pathways that influ-
ence GC formation in the gut and how the microbiota influences
these pathways remains incomplete.
In this present study, we identify that a classic innate immune
molecule, MyD88, can function within the T cell compartment in
the gut. Loss of MyD88 signaling in T cells leads to reductions in
TFH cells and IgA-producing B cells, demonstrating a key role for
molecular pathways that converge on this adaptor molecule
leading to appropriate GC formation. Moreover, GC formation
in the gut is orchestrated by signals provided by the microbiota
in a T cell-intrinsic MyD88-dependent manner. Loss of GC
formation leads to reduced IgA production and disrupted target-
ing of commensal bacterial populations. Animals lacking MyD88
within the T cell compartment fail to control mucosally associ-
ated communities of bacteria, resulting in dysbiosis. Finally, we
demonstrate that animals lacking T cell-intrinsic MyD88 develop
worsened disease that can be rescued by a microbial transplant
from a healthy donor. Thus, we have identified a host molecular
pathway that can integrate signals from the microbiota to pro-
mote GC formation and IgA production against intestinal bacte-
ria to control the composition of these communities to ensure a
benign symbiotic interaction.











MyD88-Dependent Signaling in T Cells Influences GC
Responses in the Gut
Whether innate signaling by T cells influences the establishment
of beneficial bacterial communities and host health remains
to be elucidated. As MyD88 is a key molecule that governs
signaling through multiple innate receptors, we crossed
a MyD88-floxed animal with a T cell-specific Cre-driver to
produce an animal model where MyD88 is specifically knocked
out within T cells but retained in other cell types (the
T-MyD88!/! mouse) (Figure S1) (Chang et al., 2013; Schenten
et al., 2014). This allowed us to test whether innate and adap-
tive immune pathways converge to promote host-microbiota
symbiosis within the gut. Recent studies have identified that
T cell-intrinsic MyD88 signaling influences systemic induction
of TH1 and TH17 cells during immunization (Chang et al., 2013;
Raetz et al., 2013; Schenten et al., 2014). Thus, we first broadly
examined CD4+ T cell development during steady-state condi-
tions. We did not observe differences in TH17, TH1, or T regula-
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Figure 1. T Cells Utilize MyD88 Signaling to
Coordinate Germinal Center Responses
(A–C) GC-TFH cells from PPs, defined by
CD3+CD4+B220!CXCR5hiPD-1hi, were measured
by flow cytometry. (A) Representative plots were
previously gated on CD3+CD4+B220! cells. (B)
Frequency and (C) absolute numbers of GC-TFH
cells are shown (n = 21 WT, n = 18 T-MyD88!/!).
(D–F) GC B cells, defined by B220+IgDlowFas+GL-
7+, from PPs were measured by flow cytometry.
(D) Representative plots were previously gated on
B220+IgDlow cells. (E) Frequency and (F) absolute
numbers of GC B cells are shown (n = 21 WT,
n = 18 T-MyD88!/!).
(G–J) IgA+ plasmablasts, defined as B220!
CD138+IgA+, within the siLP and cLP were
measured by flow cytometry (G). Representative
plots were previously gated on CD138+B220!
cells from siLP. (H) Frequencies of IgA+ plasma-
blasts in siLP are shown (n = 6 WT, n = 7
T-MyD88!/!). (I) Representative plots were previ-
ously gated on CD138+B220! cells from cLP. (J)
Frequencies of IgA+ plasmablasts in cLP are
shown (n = 8 WT, n = 5 T-MyD88!/!). Unpaired
two-tailed Student’s t tests were used for all
comparisons. p < 0.05 (*); p < 0.01 (**); p < 0.001
(***). Lines in scatterplots represent means. See
also Figures S1–S4.
(MLNs), or colonic lamina propria (cLP)
(Figures S2 and S3). Consistent with pre-
vious reports, we observed slight de-
fects in the abundance of TH1 and TREGS
within the small intestinal lamina propria
(siLP) and TH17 cells within the Peyer’s
patch (PP) (Figure S3) (Reynolds et al.,
2010; Schenten et al., 2014). However,
the most striking difference observed
was within the TFH cell compartment in
both the PP and MLNs in T-MyD88!/! animals (Figure 1A and
Figures S4A–S4K). TFH cells are one of the most abundant sub-
sets of CD4+ helper T cells within the PPs and play a funda-
mental role in the generation of antibody-mediated responses
against the microbiota (Crotty, 2011; Linterman et al., 2012).
Therefore, we focused our analysis on GC formation in the
gut. TFH cells are broadly characterized by the expression of
two or more of the following surface markers: ICOS, CXCR5,
and PD-1. Subtypes of TFH cells can be delineated using
these markers. These include GC-resident TFH (GC-TFH) cells
(CXCR5hi PD-1hi) whose function is to promote class switching
and somatic hypermutation of naive B cells to produce high-
affinity IgA, and non-GC-resident TFH (non-GC-TFH) cells
(CXCR5intPD-1int) that will ultimately migrate into the GC to pro-
mote B cell activity (Shulman et al., 2013). Any combination of
these markers identifies a defect in any TFH subset in the PPs of
T-MyD88!/! animals that cannot be accounted for by changes
in PP cellularity (Figures 1A–1C and Figures S4A–S4I). These
data suggest that T cell-intrinsic MyD88 signaling impacts mul-
tiple stages of TFH development. Importantly, these effects
were gut specific because they were not observed in the spleen
154 Cell Host & Microbe 17, 153–163, February 11, 2015 ª2015 Elsevier Inc.
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(Figures S4L and S4M), indicating that T cell-intrinsic MyD88
signaling influences steady-state development of TFH cells in
the intestine.
TFH-dependent instruction of GC B cells induces IgA
+ plasma-
blast migration to the lamina propria of the small and large intes-
tine, leading to secretion of high-affinity IgA into the intestinal
lumen. Based on the observed deficiencies in TFH development,
intestinal B cell function was examined. Percentages and abso-
lute numbers of PP GC B cells were significantly reduced in
T-MyD88!/! mice (Figures 1D–1F), indicating a defect in the
GC response. Consequently, IgA+ plasmablasts in the siLP and
cLPwere also diminished (Figures 1G–1J). These results demon-
strate that MyD88 signaling within T cells regulates appropriate
GC formation within the gut.
Microbiota-Derived Signals Influence the Presence of
TFH Cells in the Gut
B cell responses within the gut are sensitive to the presence of
the microbiota. Indeed, GF mice have fewer B cells and lower
IgA levels. MyD88 functions downstream of TLRs, which are
involved in responses to bacterial products. Thus, our observa-
tions suggest that TFH development within the gut is influenced
by signals from the commensal microbiota. To test this we iso-
lated PPs from either GF or specific pathogen free (SPF) mice
from two different backgrounds of animals (Balb/c and C57BL/
6) and examined the TFH population. Both C57BL/6 and Balb/c
GF mice had significantly reduced numbers of GC-TFH cells
within the PPs when compared to SPF mice (Figures 2A–2D).
Moreover, GC-TFH cell populations were severely reduced
when C57BL/6 SPF animals were treated with an antibiotic
cocktail that depletes the microbiota (Figures 2E–2G). This dem-
onstrates that development and maintenance of GC-TFH cells
within the gut is promoted by the presence of commensal
organisms.
To determine whether live bacterial colonization is required
for induction of GC responses or whether bacterial products
alone are sufficient, we placed the TLR2 ligand, Pam3CysK, in
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Figure 2. Microbiota-Dependent TFH Devel-
opment Relies on T Cell-Intrinsic MyD88
Signaling
(A–C) GC-TFH cells from PPs, defined by
CD3+CD4+B220!CXCR5hiPD-1hi, were compared
between SPF and GF Balb/c mice with flow cy-
tometry. (A) Representative plots were previously
gated on CD3+CD4+B220! cells. (B) Frequency
and (C) absolute numbers of GC-TFH cells are
shown (n = 5 SPF, n = 7 GF).
(D) GC-TFH cells from PPs were compared be-
tween SPF and GF C57BL/6 mice with flow cy-
tometry (representative plots not shown) to obtain
absolute numbers of GC-TFH cells (n = 5 for each
group).
(E–G) GC-TFH cells from PPs were compared be-
tween SPF mice treated with oral antibiotics (ABX)
and non-treated SPF animals with flow cytometry.
(E) Representative plots were previously gated
on CD3+CD4+B220! cells. (F) Frequency and (G)
absolute numbers of TFH cells are shown (n = 8
SPF, n = 9 ABX).
(H) Pam3CSK was provided in the drinking water
of GF animals for 2 weeks to calculate absolute
numbers of TFH cells in animals given TLR ligand
(+) (n = 6) or not (!) (n = 8).
(I) Experimental schematic showing GF Rag!/!
mice reconstituted with either WT or T-MyD88!/!
bone marrow and subsequently treated with TLR2
ligand, Pam3CSK, in the drinking water.
(J–L) GC-TFH cells from MLNs were compared
between GF Rag!/! mice reconstituted with WT
or T-MyD88!/! bone marrow and fed the TLR2
ligand Pam3CSK. (J) Representative plots were
previously gated on CD3+CD4+B220! cells. (K)
Frequency and (L) absolute numbers of GC-TFH
cells are shown (dotted line represents the number
of cells within these populations when GF-Rag
mice are given bone marrow for either genotype
and not stimulated) (n = 4 WT and n = 3
T-MyD88!/!). p < 0.05 (*); p < 0.01 (**); p < 0.001
(***). Lines in scatterplots and bar graphs repre-
sent means.










a purified TLR2 agonist alone was capable of significantly
increasing GC-TFH abundance within PPs (Figure 2H). To defin-
itively test the relevance of T cell-intrinsic MyD88 signaling
during microbiota dependent TFH development in vivo, we re-
constituted GF Rag!/! mice with bone marrow from either WT
or T-MyD88!/! animals (Figure 2I). As GF Rag!/! animals do
not develop PPs and a bone marrow reconstitution does not
correct this, we analyzed the defect in TFH development within
the MLNs of these mice. Eight weeks after transfer, animals
were orally treated with a purified TLR2 agonist. Strikingly, TFH
development occurred in GF WT animals in response to purified
TLR2 ligands, while TFH development was not induced in TLR2-
treated GF animals reconstituted with T-MyD88!/! bone
marrow (Figures 2J–2L). This was not a result of differences
in reconstitution of GF Rag!/! animals, as baseline TFH
abundance is the same in Rag!/! animals receiving WT or
T-MyD88!/! bone marrow in the absence of TLR2 treatment
(Figure 2L). Collectively, these data argue strongly that cues
from the microbiota can act through MyD88 within T cells to
coordinate TFH biology, thus identifying a pathway by which
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Figure3. IgAProductionagainstCommensal
Antigens Is Perturbed in the Absence of
MyD88 Signaling in T Cells
(A) Concentrations of soluble IgA within gut
lumenal contents measured by ELISA and
normalized to fecal weight (n = 20 per group).
(B) Experimental schematic showing GF Rag!/!
mice reconstituted with either WT or T-MyD88!/!
bone marrow and subsequently mono-colonized
with B. fragilis-OVA.
(C) Raw abundances of DNA specific to the OVA
gene were detected via qRT-PCR to quantify
the loads of B. fragilis-OVA per 50 ng of fecal DNA
(n = 5 per group).
(D) ELISA was used to measure the concentration
of IgA within the lumen of these animals, normal-
ized to fecal weight (n = 5 per group).
(E) Abundance of OVA-specific IgA within gut
lumenal contents measured by ELISA and
normalized to fecal weight. Data are shown as
absorbance at 450 nm (n = 5 per group).
(F) IgA-bound bacteria in intestinal lumen was
measured by flow cytometry. Representative plots
were previously gated on SYBR Green+ events
( = bacteria).
(G) Frequencies of IgA-bound bacteria (n = 8 per
group) with dashed line showingmean nonspecific
binding in RAG!/! controls. Unpaired two-tailed
Student’s t tests were used for all comparisons.
p < 0.05 (*); p < 0.01 (**); p < 0.001 (***).
Lines in scatterplots represent means. Bar graphs
represent means ± SD.
T Cell-Intrinsic MyD88 Signaling
Coordinates IgA Responses against
the Microbiota
GC responses functionwithin the intestine
to produce high-affinity IgA against food,
self, and microbial antigens (Bemark
et al., 2012). As animals that lackMyD88within theTcell compart-
ment have reduced TFH and B cell responses within the gut, we
wished to test whether these deficiencies resulted in impaired
IgA production. Intestinal contents were isolated from WT and
T-MyD88!/! and analyzed for the production of secretory IgA
(SIgA) by ELISA. We found that total SIgA was reduced in
T-MyD88!/! mice (Figure 3A), illustrating the importance of this
pathway in T cells for the generation of productiveGC responses.
To determine whether this pathway regulates the generation of
antigen-specific IgA against the microbiota, we mono-colonized
GFRag!/!mice previously reconstitutedwithWT or T-MyD88!/!
bone marrow with a commensal bacteria strain that was
engineered to express themodel antigen ovalbumin (Bacteroides
fragilis-OVA). This allowed us to track a commensal-specific anti-
body response (Figure 3B). GF Rag!/! animals have no detect-
able OVA-specific IgAwithin the intestine (data not shown). While
B. fragilis-OVA colonization in the lumen was similar between
cohorts (Figure 3C), there was a complete absence of OVA-spe-
cific SIgA production in mono-associated T-MyD88!/! animals
(Figure 3D), despite similar levels of total SIgA being produced
(Figure 3E). These data indicate that MyD88 signaling within
T cells directs antigen-specific SIgA against the microbiota.
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Reports have indicated that IgA targeting of the microbiota is
modulated during intestinal disease in humans (van der Waaij
et al., 2004) and may target colitogenic members of the micro-
biota (Palm et al., 2014). SIgA can be produced in the intestine
as a result of either T cell-dependent (TD) or -independent (TiD)
mechanisms (Mantis et al., 2011; Stephens and Round, 2014).
TiD often results in low-affinity, cross-reactive antibody. TD re-
sponses, mediated by TFH cells, result in commensal targeting
via specific, high-affinity IgA binding (Lycke and Bemark,
2012). To better characterize the TD antibody defect in T-
MyD88!/! animals, we utilized a flow cytometry-based assay
to look at host-generated SIgA against the microbiota. T cell-
deficient animals have undetectable IgA-bound bacteria with
this method, so this assay quantifies high-affinity TD antibody
production (Slack et al., 2009, 2012). The microbiota was iso-
lated from animals and immunostained with antibody against
IgA and treated with the DNA dye SYBR Green. Consistent
with other reports (Palm et al., 2014), 1%–10% of SYBR+ micro-
biota was bound by IgA in WT mice, while a 10-fold reduction in
IgA targeting of the microbiota was observed in T-MyD88!/!
animals (Figures 3F and 3G). These results reveal that innate
recognition of commensal products by T cells influences the
abundance and quality of the TD SIgA response toward
commensal bacteria.
MyD88 within T cells Prevents Dysbiosis of Tissue-
Associated Microbial Communities
Defects in commensal-directed SIgA might have important ef-
fects on the microbial ecology of the gut (Cerutti et al., 2011;
Cullender et al., 2013; Fagarasan et al., 2002; Peterson et al.,
2007). Therefore, we sought to determine via high-throughput
16S rRNA sequencing whether the loss of T cell-intrinsic
MyD88 signaling could influence microbial composition. To con-
trol for differences in bacterial communities based on housing
conditions, we performed analyses on separately housed ani-
mals whose breeding lineswere originally derived from heterozy-
A
C
B Figure 4. Innate Recognition by T Cells In-
fluences the Composition of Mucosally
Associated Microbial Communities
(A) Principal coordinates plot of unweighted Uni-
Frac distances shows separation of microbial
communities by genotype and sample type within
separately housed animals. See also Table S1.
(B) Mucosal communities are more similar than
fecal communities (non-parametric t test; **p <
0.001, ***p = 0.0001). Boxplot whiskers = inter-
quartile range.
(C) Differences in mucosal communities between
genotypes are maintained in cohoused animals
(PERMANOVA; p = 0.0111). See also Table S1.
gote crosses as well as cohoused
animals. Regardless of housing condi-
tions, fecal and mucosal communities
were distinct in both genotypes (Figure 4A
and Table S1). Interestingly, greater vari-
ation exists between fecal communities
among individuals when compared to
mucosa-associated communities (Fig-
ure 4B). Since mucosal communities reside in closer proximity
to host tissue, this result suggests that the immune system ex-
erts stronger selection on community membership at this site.
Consistent with this, the differences in community composition
between genotypes are only maintained in mucosa-associated
communities (Figure 4C), but not fecal communities (Table S1),
during cohousing. Among these differences, we observed
increases in multiple taxa containing mucolytic members in T-
MyD88!/! animals, including Desulfovibrionaceae andMucispir-
illum (Figures S5A and S5B), as well as significant increases in
Ruminococcus (Figures S5A and S5B). Collectively, these data
indicate that loss of T cell-intrinsic TLR signaling results in signif-
icant shifts in microbial composition in the gut.
T Cell-Intrinsic MyD88 Signaling Governs IgA Targeting
of Mucosa-Associated Microbiota
We next investigated how innate signaling in T cells would influ-
ence SIgA targeting of microbial communities. To do this, we
developed an assay to purify IgA-bound bacteria with 94%purity
(Supplemental Information) and characterized SIgA-targeted
bacterial communities via high-throughput sequencing. IgAbinds
adistinctgroupofbacteriawhencompared toeither the total fecal
or mucosal community in either genotype, indicative of specific
targeting of commensal species by SIgA (Figure 5A and Table
S1). Additionally, the assemblage of bacterial species targeted
by the host via SIgA is altered in T-MyD88!/! mice compared to
WT animals (Figure 5A). The SIgA-bound fraction is more similar
to the mucosa-associated community than the fecal community
inWT animals, indicating that SIgA tends to targetmucosa-asso-
ciated organisms more so than fecal community members (Fig-
ure 5B). Remarkably, this IgA bias toward mucosal communities
is lost in T-MyD88!/! animals as IgA-bound species are equally
representative of mucosal and fecal communities (Figures 5B).
This is not just a result of blending of the mucosa-associated
and fecal communities, because these communities are as dis-
similar in T-MyD88!/! animals as they are in WT animals







Figure 5. T Cell-Intrinsic MyD88 Signaling Regulates IgA Selection of the Microbiota
(A) PCoA plot of unweighted UniFrac distances comparing IgA-bound and mucosa-associated bacterial communities between genotypes (PERMANOVA;
p < 0.01 for all pairwise comparisons). See also Table S1.
(B) Community dissimilarity (weighted UniFrac distance) between IgA-bound versus fecal and IgA-bound versus mucosal communities for each genotype.
Non-parametric t test. p = 0.0001 (****). Increasing values along the y axis represent increasing community dissimilarity among individual samples within a given
cohort. Boxplot whiskers = interquartile range.
(C) UniFrac distances between fecal and mucosal communities are not significantly different between genotypes (non-parametric t test). Boxplot whiskers =
interquartile range.
(D) Plot of the mean relative abundance of individual OTUs in all mucosal and IgA-bound samples colored by class of the OTU. A linear model fit to the data is
shown and is plotted on log scale.
(legend continued on next page)
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(Figure 5C). These results indicate that the host IgA response is
primarily directed toward specific bacteria within the mucosa
and that this bias is disrupted in T-MyD88!/! animals.
Given these results, we focused on how a loss of IgA mucosal
bias, as seen in T-MyD88!/! animals, would influence the micro-
bial community. There is a significant positive correlation be-
tween bacterial species (OTU) abundance in the total mucosal
community and in the IgA-bound fraction, which implies that in
general IgA binds the most abundant organisms (Figure 5D).
Additionally, several taxonomic groups were targeted differently
betweenWT and T-MyD88!/! animals (Figure 5E). These include
reduced binding of the classes Clostridia and Actinobacteria and
more robust targeting of many OTUs in the Bacteroidia (primarily
within the uncultured S24-7 family) in T-MyD88!/! animals (Fig-
ure 5E). Resolution of microbial communities at finer taxonomic
depth reveals a reduction of IgA targeting of Bifidobacterium
pseudolongum and increased IgA binding of Ruminococcus
gnavus and unclassified Prevotella species in T-MyD88!/! ani-
mals (Figure 5E and Figure S5A). Additionally, OTUs of the genus
Lachnospiraceae were the most differentially targeted by IgA
(including cohoused animals) (Table S2), as has been observed
in a mouse model of colitis (Berry et al., 2012). Differences in
IgA targeting in T-MyD88!/! animals did not simply reflect signif-
icant differences in OTU abundance in the mucosa-associated
community (Figure 5E), suggesting that abundance alone
does not dictate the specificity of IgA targeting. Importantly,
we observed significantly increased dissimilarity among individ-
ual T-MyD88!/! animals in both their IgA-bound and mucosa-
associated communities compared to WT animals (Figure 5F),
suggesting that there is greater variability in which species
persist in the gut of a T-MyD88!/! animal. We also observed
an increased total bacterial load at the mucosa in T-MyD88!/!
animals (Figure 5G). Collectively, these data demonstrate that
innate signaling by T cells dictates IgA specificity to constrain
the composition of the microbial community, while also limiting
mucosal association of commensal microbes.
We next sought to determine whether any of the observed
defects in the host humoral response were associated with
changes in microbial community composition. Consistent with
previous reports, we found a significant positive correlation
between the relative abundance of GC B cells and mucosal
community diversity (Figure 6A). This implies that a stronger
GC response promotes diversity, perhaps by opening niches
for rare species by limiting the densities of abundant members.
Similarly, we utilized a Mantel’s test to demonstrate that the
magnitude of difference in immune phenotype among individuals
was positively associated with dissimilarity between microbial
communities (Figure 6B). This effect was observed for multiple
immune parameters and was driven by differences between
host genotypes (Figure 6B). Thus, differences in microbial
composition between WT and T-MyD88!/! animals are directly
associated with differences in their immune response. Collec-
tively, these data demonstrate that host humoral responses
sculpt microbial communities in the gut through IgA-mediated
selection and that innate sensing of microbial products by
T cells regulates this process.
Alterations to the Microbiota in T-MyD88–/– Animals
Results in Increased Intestinal Disease
Changes tomicrobial communities have been shown to promote
inflammatory disease in the gut. Our observed shifts in Lachno-
spiraceae are similar to those seen in colitogenic animals, and
R. gnavus has been associated with intestinal disease in humans
(Hansen et al., 2013; Png et al., 2010). Moreover, defects in
antibody targeting of bacteria have been seen in patients with
IBD (Harmsen et al., 2012; van der Waaij et al., 2004), suggesting
that a reduced ability to control the microbiota within T-
MyD88!/! animals could lead to harmful consequences to the
host. To determine whether changes in microbial community
composition observed in T-MyD88!/!mice led to worsened dis-
ease, we examined colitis susceptibility in this model. Typical of
the TNBS colitis model in C57BL/6 animals, WT animals lost
(E) Class, genus, and species abundances detected as significantly different in the IgA-bound fraction are shown along with their abundances in mucosa-
associated communities. Welch’s t test. p < 0.05 (*); p < 0.001(***). Bar graphs represent mean taxa abundance ± SD. See also Table S2.
(F) Comparison of community dissimilarity between genotypes for IgA-bound andmucosa-associated communities. Non-parametric t test. p < 0.05 (*); p < 0.001
(***); p = 0.0001 (****). Boxplot whiskers = interquartile range.
(G) Total bacterial load in mucosa of WT and T-MyD88!/! animals as measured by qPCR. Student’s t test. p < 0.05 (*). Bars represent means.
Immune Response 
(IR)  Community  Mantel r P 
TFH cell (%) IgA Bound 0.36 0.003 
TFH cell (%) Mucosal 0.44 0.008 
GC B cell (%) IgA Bound 0.28 0.024 
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Figure 6. Phenotypic Variation in Immune Response Correlates with Microbial Community Similarity
(A) Phylogenetic diversity in mucosal communities is correlated with GC B cell abundance (%).
(B) Left: A representative plot defines the axes and pairwise comparisons used to derive results of a Mantel’s test. Right: Correlations and p values for the
association between the differences in immune response (IR) and community dissimilarity among individuals. IR dissimilarity and community dissimilarity are
estimates calculated from distance matrices built from immune phenotype and microbial community phylogenetic (UniFrac) data, respectively.
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!10% of their body weight and quickly regained their original
mass. However, T-MyD88"/" animals lost more weight and did
not recover toWT levels by the end of the experiment (Figure 7A).
Histological analysis of these colons revealed that T-MyD88"/"
mice had increased inflammatory infiltrate and greater crypt
loss than WT animals (Figures 7B and 7C). Increased bacterial
loads at the mucosa or differences in the assemblage of species
living at this site could explain this. To determine whether micro-
bial composition in the gut influenced disease progression,
we tested whether susceptible T-MyD88"/" animals could be
rescued with a WT microbiota. To this end, cohorts of T-
MyD88"/" animals were treated with antibiotics to clear endog-
enous commensals and subsequently given a transplant with
either WT or T-MyD88"/" microbiota. Animals that received a
microbial transplant from a T-MyD88"/" animal developed se-
vere crypt loss (Figures 7B and 7C). Remarkably, the extent of
disease observed in T-MyD88"/" animals provided a microbiota
from WT mice was significantly reduced and indistinguishable
from that observed in WT animals (Figure 7C). Notably, WT GF
mice given a T-MyD88"/" microbiota had no difference in dis-
ease severity (data not shown), indicating that the microbial
composition formed in T-MyD88"/" animals is not sufficient to
cause disease in an immune-competent host. Thus, this model
closely mirrors the complexity seen in human IBD whereby ge-
netic and environmental factors interact to promote disease.
These data also highlight the potential curative value of fecal
transplantations from healthy donors.
DISCUSSION
While originally thought to play a role only within the innate
immune compartment, emerging data support that MyD88 func-
tions also in cells of the adaptive immune system such as T lym-
phocytes (Chang et al., 2013; Schenten et al., 2014). How this
pathway could function to influence resident commensal com-
munities has remained unexplored. MyD88 functions down-
stream of multiple receptors including the cytokine receptors,
IL-1, IL-18, and IL-33, as well as all the TLRs with the exception
of TLR3. The microbiota is an abundant source of TLR ligands
and can induce the basal expression of these cytokines, making
MyD88 an attractive molecule to integrate multiple signals
induced by the microbiota to directly control host T cell function.
Indeed, here we identify that MyD88 signaling in T cells governs
the development of functional GCs within the gut. It is unclear at
this stage what exact signals are triggering activation of MyD88
within T cells to control GC responses. However, it is likely that
multiple signals act directly on T cells and converge on MyD88
as T cells express several of these TLRs and cytokine receptors
(Reynolds et al., 2010). The use and development of new condi-
tional animal models to study these individual signals will be
required to fully understand how innate signals elicited by the
microbiota can directly influence T cell development and func-
tion within the gut.
One of the primary mechanisms to promote homeostasis
within the gut is through the production of antigen-specific
IgA. Understanding the mechanisms by which this pathway gov-
erns antigen-specific TFH responses will be an important future
endeavor. By employing a newly developed technology, we
were able to determine that antigen-specific IgA toward the
microbiota is influenced by MyD88 in T cells (Cullender et al.,
2013; Kawamoto et al., 2012; Palmet al., 2014). There is evidence
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Figure 7. Increased Intestinal Disease Observed in T-MyD88–/–
Animals Is Dependent on the Composition of the Microbiota
(A) TNBS-induced weight loss (represented as the percentage of initial weight)
was compared among WT and T-MyD88"/" animals. EtOH vehicle controls
are shown for comparison. Points represent means ± SEM (representative of
two independent experiments).
(B) Representative H&E-stained colon sections from WT and T-MyD88"/"
mice following TNBS-induced colitis.
(C) Histology scores reflecting disease severity for TNBS-treated animals
(WT animals, n = 10; T-MyD88"/" animals, n = 11; T-MyD88"/" animals
with WT microbiota transplant, n = 8; T-MyD88"/" animals with T-MyD88"/"
microbiota transplant, n = 7). Dotted line represents scores for mice treated
with EtOH only. A Student’s t test was used for all comparisons. p < 0.05 (*);
p < 0.01 (**); p < 0.001 (***).
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gut, including organisms that are in close proximity to the host
(tissue- or mucosa-associated communities) and those that are
found to reside away from the host within the intestinal lumen.
We identify that host IgA tends to target tissue-associatedmicro-
bial communities in a healthy animal. However, in the absence of
MyD88 signalingwithin the T cells, themucosal bias of IgA is lost,
indicating that this pathwayserves todictate IgAspecificitywithin
the gut. More importantly, loss of this signaling pathway in T cells
leads to defective control over microbial community composi-
tion, resulting in worsened intestinal disease.
Immune systems evolved within a microbe-dominated world
under strong selection to protect host tissues from pathogenic
invasion. However, the dependence of host health on the micro-
biota strongly suggests that the immune system evolved to serve
an additional purpose: to promote colonization bymicrobial spe-
cies whose presence can be exploited to benefit host health
(McFall-Ngai et al., 2013). Thus, coevolutionary forces between
resident microbes and hosts have resulted in mechanisms to
respond to one another, creating a flexible dialog to ensure
stability of symbiosis. IgA represents one host tool to directly in-
fluence bacterial communities; however, it has been unclear
whether IgA binds to specific members of the community and,
more importantly, what host molecular machinery governs this
specificity. Our data support a model whereby signals from
commensal microbes are perceived directly by host T cells
to promote the production of TFH and GC B cell responses,
leading to the generation of high-affinity IgA toward commen-
sals. This represents an important mechanism through which
hosts can maintain a benign assemblage of microbial species
in the gut.
Segregation of innate and adaptive arms of the immune
system would be appropriate in sterile environments (like the
systemic compartment) as this would provide a binary switch
to respond to microbial invasion. However, in tissues with
persistent bacterial exposure, cellular convergence of innate
and adaptive immune pathways could provide more flexibility
to fine-tune antigen-specific signaling and respond to environ-
mental changes properly. Thus, modulation of T cell responses
through microbiota-derived signals might provide a therapeutic
target to prevent disease associated with human autoimmunity.
EXPERIMENTAL PROCEDURES
Animal Models
MyD88fl/fl (Jackson Labs) mice were crossed to CD4-cre+mice (Taconic) (both
on C57BL/6 background) to produce the T-MyD88!/! (MyD88fl/fl-CD4cre+)
mouse model. MyD88+/+-CD4-cre+ mice were used as wild-type (WT) controls
for all comparisons. GF animals were on a C57BL/6 background except when
noted in the figure legend. Animal use adhered strictly to federal guidelines and
those set forth by the University of Utah’s Institutional Animal Care and Use
Committee.
In Vitro Activation Experiments
Purified cells were plated in 250 ml of supplemented RPMI containing 20 ng/ml
IL-2 in 96-well plates (23 105 cells per plate) that had been previously coated
with 5 mg/ml purified anti-CD3. For TFH skewing conditions, 1 mg/ml of the
costimulatory antibody anti-CD28, 5 mg/ml anti-CD3e, 10 mg/ml anti-IFNg,
50 ng/ml IL-21, and 50 ng/ml IL-6 were added. For TLR ligand stimulation,
1 mg/ml of either Pam2CSK (Invivogen), Pam3CSK (Invivogen), flagellin from
S. Typhimurium (Invivogen), or LPS (Invivogen) was added. Cells were cultured
for 4 days at 37"C in these conditions before being analyzed by flow cytometry.
RNA Isolation and RNA-Sequencing of Purified TFH Cells
mRNA was collected from #50,000 TFH cells with the QIAGEN miRNeasy Mini
Kit (QIAGEN) following kit instructions. mRNA was prepared following QC
via an Illumina TruSeq Stranded RNA Sample Prep with RiboZero treatment
(human, mouse, rat, etc.) and analyzed with Illumina HiSeq Sequencing.
Disease Model-TNBS Colitis
One hundredmicroliters of a 50/50 (v/v) mixture of EtOH and TNBSwas admin-
istered intra-rectally on days 0 and 5. Weights were collected daily for the first
5 days, and tissue was collected on day 7. Animals were scored as described
in detail in the Supplemental Information and as reported in Round and Maz-
manian, 2010.
GF Model
GFmiceweremaintained in sterile isolators and assayedmonthly for GF status
by plating and PCR. Balb/c GF mice were compared to SPF mice to measure
TFH cells. GF Rag1
!/! mice from the C57BL/6 background were given bone
marrow fromWT or T-MyD88!/!mice and allowed to reconstitute for 8 weeks.
Mice were either given Pam3CSK in their drinking water or were gavaged with
B. fragilis-expressing OVA.
Quantification of IgA+ Fecal Bacteria
Fecal microbiota were stained with SYBR Green dye and a PE-conjugated IgA
antibody to enumerate IgA-coated bacteria via flow cytometry. Please see
detailed Supplemental Experimental Procedures.
Sequencing of Microbiota Communities
DNA was extracted with bead beating methods from fecal, mucosal, and IgA-
bound enriched samples from each animal. The V3 and V4 regions of the bac-
terial 16S rRNA gene were amplified and sequenced on an Illumina MiSeq with
300 cycles from each end. Sequences were processed and analyzed with
mothur 1.32 (Schloss et al., 2009) and Qiime 1.8.0 (Caporaso et al., 2010).
Statistical Analysis
Figure creation and statistical analysis were performed with the Prism6.0 sta-
tistical software, R 3.1.0, STAMP 2.0.5 (Parks and Beiko, 2010), and utilities
within the Qiime software. Unpaired two-tailed Student’s t tests were used
for statistical comparisons unless otherwise noted (see Supplemental Informa-
tion). Non-parametric t tests were performed with 9,999 Monte Carlo simula-
tions. All statistical tests, and estimates of dispersion, are referenced in the
figure legends.
Animal Housing/Cohousing Experiments
SPFmice in our facility are housed under identical conditions and fed the same
diet, whichminimizes the effect of environmental variability on host phenotypes
and microbial communities. In an effort to standardize any potential effect of
isolation (across cages and between genotypes) on microbiota communities,
multiple independent homozygous WT and T-MyD88!/! breeder pairs were
set up at the same time from initial heterozygous crosses. Clustering of geno-
types in 16S microbiota analysis confirms that host genotype and not isolation
is the primary driver of differences among individuals in their communities. For
cohoused experiments, pregnant homozygous WT or T-MyD88!/! animals
gave birth to litters in the same cage (births occurred within 1 week of each
other). Animals remained in the same cage until weaning (4 weeks of age)
and were subsequently housed separately until analysis (8 weeks of age).
Lamina Propria Lymphocyte Isolation
Lamina propria lymphocytes (LPLs) were isolated with a combination of two
previously described methods (Atarashi et al., 2011; Round et al., 2011). Prior
to LPL isolations of small intestines (SI), all visible Peyer’s patches were
removed. Colons and SI tissue were opened longitudinally and mucus was
removed by gently scraping and then rinsing in sterile 1X HBSS. The tissue
was cut into small pieces and incubated in sterile 1X HBSS (without Ca2+
and Mg2+) containing 5 mM EDTA (Cellgro) and 1 mM DL-Dithiothreitol (DTT)
(Sigma) for 45 min at 37"C on a shaker. Supernatant was removed by filtering
through a 100 mM filter, and remaining tissue was incubated in a solution con-
taining sterile 1X HBSS containing 5% (v/v) fetal bovine serum (GIBCO BRL),
50 U/ml Dispase (Roche), 0.5 mg/ml Collagenase D (Roche), and 0.5 mg/ml
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DNaseI (Sigma) for 45 min at 37!C on a shaker. The supernatant was filtered
over a 40 mm cell strainer into ice-cold sterile 1X HBSS. Cells were passed
through a Percoll (GE Healthcare) gradient (40%/80% [v/v] gradient) and
spun at 620 3 g for 20 min with no brake. Cells at the 40/80 interface were
collected and washed twice with supplemented HBSS (10 mM HEPES [Cell-
gro], 2 mM EDTA [Cellgro], and 0.5% [v/v] fetal bovine serum [GIBCO BRL])
and prepared for flow cytometry analysis. While this isolation strategy is widely
used as an approach for isolating lamina propria tissue-resident lymphocytes,
it does not prohibit contamination by lymphocytes residing within the microen-
vironment of isolated lymphoid follicles (ILFs), which are organized lymphoid
structures found throughout the lamina propria; therefore we cannot
completely exclude the possibility that some of the cells we are assaying
reside with ILFs.
Flow Cytometry Staining of Isolated Lymphocytes
Lymphocytes were isolated from the colonic and small intestinal lamina prop-
ria as mentioned above. Spleen, MLN, or Peyer’s patch tissues were gently
pushed through a 40 mM filter to obtain white blood cells. Spleen cells were
additionally treated with 1X RBC Lysis Buffer (Biolegend) to lyse and remove
red blood cells. Surface staining for lymphocytes was done in sterile 1X
HBSS (Corning) supplementedwith 10mMHEPES (Cellgro), 2mMEDTA (Cell-
gro), and 0.5% (v/v) fetal bovine serum (GIBCO BRL) for 20 min at 4!C. Cells
were then washed twice in supplemented 1X HBSS and enumerated via
flow cytometry. The following antibodies were used: anti-CD4 (Biolegend:
clone GK1.5 APC/Pacific Blue, clone RM4-5 FITC; eBioscience clone RM4-5
PerCP-Cy5.5), anti-CD3 (Biolegend: 145-2C11 Pacific Blue), anti-B220 (Bio-
legend: clone RA3-6B2 PerCP-Cy5.5), anti-CD138 (Biolegend: clone 281-2
PE), anti-CXCR5 (eBioscience: clone SPRCL5 PE), anti-PD-1 (Biolegend:
RMP1-30 Pe/Cy7), anti-ICOS (eBioscience: clone 7E.17G9 FITC), anti-GL-7
(eBioscience: clone GL-7 Alexa Fluor 488), anti-Fas (BD Biosciences: clone
Jo2 PE-Cy7), anti-IgD (Biolegend: clone 11-26c.2a Alexa Fluor 647), or anti-
IgA (Southern Biotech goat anti-mouse IgA FITC). For intracellular staining,
cells were first stimulated with ionomycin (500 ng/ml), PMA (5 ng/ml), and Bre-
feldin A (5 mg/ml) (Biolegend) for 4 hr at 37!C. Cells were surface stained,
washed, and then permeabilized and fixed in 100 ml Perm/Fix buffer
(eBiosciences) at 4!C overnight. Cells were washed twice in Perm/Wash buffer
(eBioscience) and then stained for intracellular cytokines with the following
antibodies: anti-Foxp3 (eBioscience: clone FJK-16 s APC/PerCP-Cy5.5),
anti-IL-17A (eBioscience: clone eBio17B7 eFluor 660), or anti-IFNg (Bio-
legend: clone XMG1.2 PE). Cells were again washed twice in Perm/Wash
buffer and then placed with supplemented HBSS (10 mM HEPES [Cellgro],
2 mM EDTA [Cellgro], and 0.5% [v/v] fetal bovine serum [GIBCO BRL]) and
enumerated via flow cytometry. Gating and analysis of positive cell popula-
tions was done utilizing respective isotype controls for antibodies against
ICOS, CXCR5, GL-7, and PD-1. Other cell populations were identified with sin-
gle stain controls. These data were collected with a BD LSR Fortessa and
analyzed with FlowJo software.
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  Sample Subset Mucosa IgA Bound Fecal WT Only TMyD88-/- Only WT Only TMyD88-/- Only 
Test WT vs. TMyD88 WT vs. TMyD88 WT vs. TMyD88 Mucosal vs. IgA Bound 






















UniFrac 0.0005 0.0013 0.0005 0.0023 0.0004 0.0016 0.0123 
Weighted 
UniFrac 0.0014 0.0087 0.1245 0.0143 0.0087 0.0094 0.0004 












UniFrac 0.0111 0.1267 0.1000 0.0002 0.0001 0.0006 0.0001 
Weighted 
UniFrac 0.4578 0.4100 0.6234 0.0007 0.0020 0.0053 0.0020 
Bray-Curtis 0.0681 0.0519 0.0827 0.0002 0.0001 0.0138 0.0002 
Table S1.  
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Reference OTU ID * WT Mean † 
T-MyD88-/- 
Mean † P-value P-value (FDR) Order  Family Genus 
263907 0.90 4.45 0.0005 0.0233 Clostridiales Lachnospiraceae UNCLASSIFIED 
274021 2.90 11.55 0.0005 0.0233 Clostridiales Lachnospiraceae UNCLASSIFIED 
262104 4.10 0.82 0.0034 0.1054 Clostridiales Lachnospiraceae UNCLASSIFIED 
327900 0.50 4.09 0.0118 0.2434 Clostridiales Ruminococcus UNCLASSIFIED 
214116 13.40 2.45 0.0143 0.2434 Clostridiales UNCLASSIFIED UNCLASSIFIED 
276312 4.80 16.91 0.0157 0.2434 Clostridiales UNCLASSIFIED UNCLASSIFIED 
311695 18.70 56.91 0.0207 0.2581 Clostridiales UNCLASSIFIED UNCLASSIFIED 
de novo 2.40 8.18 0.0222 0.2581 Clostridiales Lachnospiraceae UNCLASSIFIED 
209030 8.20 14.09 0.0459 0.4650 Bacteroidales UNCLASSIFIED UNCLASSIFIED 
* Greengenes 13_8 Reference OTU IDs, except as noted for single de novo OTU. 
† Mean abundance per 1500 sequences per sample 




Conventionally colonized (SPF) mice. C57Bl/6 MyD88 LoxP/LoxP mice (Jackson 
Laboratories) were crossed to C57Bl/6 CD4-Cre animals (Taconic) to produce 
MyD88WT/WT CD4-Cre+ mice (WT) and MyD88LoxP/LoxPCD4-Cre+ (T-MyD88-/-) animals. 
Age matched male and female animals were used to compare phenotypic differences 
between genotypes as well as severity of TNBS induced colitis. For the antibiotics 
experiment, age matched FoxP3-GFP+ mice (Jackson Laboratories) were compared for 
phenotypic differences in TFH cells within gut associated lymphoid tissues. Aged 
matched female C57Bl/6 WT and IL1R-/- mice (Jackson Laboratories) were used to 
compare TFH development and germinal center responses in this absence of IL1 
signaling. The use of animals in all experiments was in strict adherence to federal 
regulations as well as the guidelines for animal use set forth by the University of Utah 
Institutional Animal Care and Use Committee.  
Germ-free (GF) mice. GF mice were maintained in sterile isolators and verified monthly 
for GF status by plating and PCR of feces. GF BALB/c, GF C57Bl/6, and GF RAG1-/- 
animals were used in this study. Age matched GF BALB/c mice were compared to SPF 
BALB/c mice to compare phenotypic differences in TFH cells within gut associated 
lymphoid tissues. The TLR-ligand experiment: GF C57Bl/6 mice were born GF and then 
given ad libitum access to drinking water containing 10µg/mL of Pam3CSK4 (Invivogen) 
for two weeks. Bone marrow (BM) reconstitutions of the T and B cell compartments: GF 
Rag1-/- mice were reconstituted with bone marrow (~2.5x106 cells) from WT and T-
MyD88-/- mice via retro-orbital injection. Mono-association experiments,: BM 
reconstituted GF Rag1-/- mice were colonized with an erythromycin/gentamicin resistant 
strain of Bacteroides fragilis that was engineered to express OVA (B.fragilis-OVA; kindly 
provided by Dr. Sarkis Mazmanian (California Institute of Technology)). Animals were 
maintained for two months with 1mg/mL of both erythromycin and gentamicin in drinking 
water under SPF housing conditions and were validated to be correctly colonized by 
aerobic & anaerobic plating as well as PCR of feces. BM reconstituted GF Rag1-/- mice 
were analyzed two-months post-colonization. TLR-ligand feeding experiment: 
reconstituted GF Rag1-/- mice were maintained on 1mg/mL of ampicillin (Fisher 
Scientific), neomycin (Fisher Scientific), erythromycin (Fisher Scientific), and gentamicin 
(GoldBio) for two months. During the last two weeks, 10µg/mL of Pam3CSK4 
(Invivogen) was added to antibiotic cocktails. For IL1β blocking experiments, GF Rag1-/- 
mice were reconstituted with WT bone marrow (~2.5x106 cells). Reconstituted mice 
were maintained on 1mg/mL of ampicillin (Fisher Scientific), neomycin (Fisher 
Scientific), erythromycin (Fisher Scientific) and gentamicin (GoldBio) for two months. 
10µg/mL of Pam3CSK4 (Invivogen) was added to antibiotic cocktails during the final two 
weeks of the experiment. During this two-week period, 50µg of anti-IL1β neutralizing 
antibody (Thermo Scientific Cat#MM425B) or 50µg of IgG control antibody (Thermo 
Scientific Cat#31903) were administered to mice every other day via retro-orbital 
injection1 . Mice were sacrificed less than 24 hours after the final injection of antibody. 
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Enzyme-linked immunosorbant assay (ELISA) 
 
To quantify luminal IgA, colons were cut open longitudinally and feces and mucus were 
scraped out and placed into 1.5mL Eppendorf tubes. Luminal contents were re-
suspended in 500µL of sterile 1X HBSS and spun at 400 x g for 5 minutes to remove 
course materials. Supernatants were then placed in a new 1.5mL Eppendorf tube and 
spun at 8000 x g for 5 minutes to pellet bacteria. This step was repeated until samples 
were clear of bacterial pellets. Supernatants (containing IgA) were then placed in a new 
1.5mL Eppendorf tube and used as samples (1/10 and 1/100 (v/v) dilutions) for an IgA-
specific ELISA kit (eBioscience; performed per kit instructions). Absorbance was read at 
450nm and concentrations of IgA were calculated with a standard curve. Concentrations 
were normalized to fecal weight. For quantification of OVA specific IgA, supernatants 
containing IgA were collected as above and IgA quantification was performed with the 
same IgA-specific ELISA kit with slight modification. Instead of coating plates with 
capture antibody specific for IgA, plates were coated overnight at 4°C with 4µg/mL 
ovalbumin in 1X PBS. Absorbance was read at 450nm and normalized to fecal weight.  
  
T cell isolation  
 
Lymphocytes were isolated from spleens  and the resulting cells were sorted through 
MACS columns with either positive (CD4 microbeads (Miltenyi)) or negative selection 
(CD4+ T Cell Isolation Kit II (Miltenyi)). Lymphocyte enrichment was performed following 
kit instructions. Isolated T cells were further purified via FACS with a BD FACSAria Cell 
Sorter. For Naïve T cells, CD3+CD4+CD62L+CD25- cells were collected into RPMI media 
(Corning) supplemented with 10% fetal bovine serum (v/v) (Gibco BRL), 50 U/mL 
penicillin, 50 µg/mL streptomycin (Cellgro), 5µM 2-Mercaptoethanol (CalBiochem), 1µM 
sodium pyruvate (Cellgro), 1X MEM Nonessential Amino Acids (Cellgro), and 2.05mM 
L-glutamine (Cellgro). Purified TFH cells (CD3+CD4+B220-CXCR5+PD1+) and TFH-




TNBS-Induced Colitis and Microbial Rescues 
 
Age matched WT and T-MyD88-/- mice were challenged with TNBS as previously 
described4 with a few modifications. Briefly, 100µL per mouse of 2.5% (v/v) 
Picrylsulfonic acid (Sigma) in 100% EtOH was administered intra-rectally with a silicone 
catheter (Solomon Scientific). Weights were collected just prior to challenge and for five 
days following challenge to quantify weight loss. On the fifth day after challenge a 
second dose of TNBS was administered and tissues were collected for histology two 
days later. Histology was performed blindly according to previously published criteria 
(9). Briefly, both crypt loss and inflammation was scored according to the following 
guidelines. The entire length of the colon from just under the cecum to the rectum was 
analyzed and percent of crypt loss and percent of colon affected by inflammation was 
also taken into consideration. Therefore each animal received a score for crypt loss and 
inflammation severity as well as the percent of the colon affected. For crypt loss severity 
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a score of 0-3 was given (0=no crypt loss; 1=mild crypt loss, most crypts still visible with 
a few areas effected; 2=medium severity, greater crypt loss, fewer crypts visible in large 
areas; 3=very large areas of total crypt loss, places where crypts are completely gone). 
For inflammation a score was given from 0-3 (0=no evidence of inflammatory infiltrate; 
1=very low level of cells infiltrating into the tissue; 2=thickening of lamina propria, and 
clear infiltrating lymphocytes into epithelial tissue; 3=thickening of lamina propria and 
large boluses of inflammatory infiltrates that correspond with areas a crypt loss). The 
percentage scoring was as follows: 0=no area affected; 0.5=1-5%; 1=5-20%; 1.5=20-
30%; 2=30-45%; 2.5=45-60%; 3:=60-70%; 3.5=70-80%; 4=>80%. This was the same 
scoring system used for crypt loss and inflammation.  
For microbiota-rescue experiments, T-MyD88-/- mice were treated with 0.5mg/mL of 
ampicillin (Fisher Scientific), neomycin (Fisher Scientific), erythromycin (Fisher 
Scientific), and gentamicin (GoldBio) for one week. Antibiotic treatment was then 
terminated and mice were orally gavaged daily for one week with 100uL of microbiota 
stock derived from either WT or T-MyD88-/- mice. Microbiota stocks were prepared from 
luminal contents (fecal material and mucus scrapings) that were suspended in sterile 1X 
HBSS (1mL/gram materials) and then gently spun down at 400 x g for 5 minutes to 
remove course materials. Mice were administered TNBS as described above one week 
after the last gavage. 
 
qPCR measurement of total bacterial load in feces and mucosa.  
Animals were sacrificed and a single fecal pellet as well as a 1cm length of colon (immediately 
distal to the cecum) were collected, placed in 1X cell lysis solution (sterile water containing 
10mM TRIS HCL-pH8.0, 25mM sterile EDTA, and 1% (v/v) sterile SDS), and stored at -20oC  
until DNA extraction. Prior to storage, colon sections were gently flushed of residual feces with 
sterile 1X HBSS buffer. A two-day DNA isolation protocol (with a 24 hour proteinase K lysis 
step) was followed. Briefly, one mouse fecal pellet (or a 1cm snippet of colon) was placed in 
500µl 1X cell lysis. 3µl of proteinase K (20mg/mL (Thermo Scientific)) was added and then 
samples were placed in a thermal block for 24 hours at 55oC. Samples were then cooled to RT, 
then 3µl of RNase A (10mg/mL (Thermo Scientific)) were added and samples were incubated at 
37oC for 30 minutes. Samples were then cooled to RT and 200µl of 5M ammonium acetate was. 
To precipitate out proteins, samples were subsequently vortexed for 10 seconds, placed in an 
ice bath for 10 minutes, and then centrifuged at 20000 x g for 6 minutes. Supernatants 
(excluding pelleted proteins) were then placed in a new 1.5mL Eppendorf tube and mixed with 
600µl of 100% isopropanol containing glycogen (20mg/mL (Thermo Scientific)). Samples were 
gently inverted 50 times to mix and then left to sit at RT for 10 minutes. Samples were spun at 
20000 x g for 6 minutes. Two washes of the DNA pellet were then performed. For each wash, 
DNA pellets were re-suspended in 600µl of 70% (v/v) EtOH and spun at 20,000 x  g for 6 
minutes. After the second wash, tubes were inverted onto a sterile tissue and allowed to air-dry 
for 15 minutes. DNA pellets were then re-suspended in 100µl sterile H2O and stored at -20oC. 
Sample DNA concentrations were quantified with a Nanodrop spectrophotometer (Thermo 
Scientific). The total amounts of bacteria within the feces and mucosa was then quantified with 
Eubacteria-specific 16S primers (see Supplementary Table 1). All qPCR reactions were 
conducted in 12.5µl volumes with the GoTaq qPCR Master Mix (Promega). qPCR experiments 
were conducted on a Lightcycler LC480 instrument (Roche) with the parameters described 
above.    
 




Fecal pellets were collected from animals and homogenized in 500µl of sterile 1X HBSS 
buffer. Samples were spun once at 400 x g to remove course materials from the fecal 
suspension. Supernatants (containing bacteria) were collected and placed in a new 
1.5mL tube. Samples were spun at 8000 x g for 5 minutes to pellet bacteria. Bacterial 
pellets were washed twice by re-suspending pellet in 500µl of sterile 1X HBSS and 
spinning for 5 minutes at 
8000 x g. Bacterial 
suspensions were then 
blocked on ice for 15 
minutes in 500µl sterile 
1X HBSS containing 1% 
(v/v) BSA. Samples were 
spun at 8000 x g for 5 
minutes. Bacterial pellets 
were then stained for 20 
minutes at 4oC in the 
dark in 500µl of sterile 
1X HBSS containing a 
1/250 (v/v) dilution of a rat anti-mouse IgA antibody conjugated to a PE fluorochrome 
(Southern Biotech, cat#1165-09L). Pellets were washed twice as above in sterile 1X 
HBSS containing 1% (v/v) BSA. Pellets were then stained for 20 minutes at 4oC in 500µl 
of sterile 1X HBSS containing SYBR green I (1/10000 (v/v) dilution, Life Technologies). 
After SYBR staining samples were analyzed on an LSRFortessa flow cytometer (BD 
Biosciences).  A representative flow cytometry plot is provided.  
 
Isolation and 16S rRNA sequencing of IgA-bound, fecal and mucosal bacteria. 
 
Animals were sacrificed and their entire lower digestive tract (from duodenum to rectum) 
was removed and longitudinally sectioned.  One fecal pellet and a 1cm section of the 
distal colon were collected from each animal to characterize the fecal and mucosal 
microbiota communities, respectively. The colon section was scraped and rinsed in 
sterile 1X HBSS during collection. Fecal and mucosa samples were immediately frozen 
at -80oC in 2mL screw cap tubes containing ~250 mg of 0.15 mm garnet beads (MoBio, 
cat# 13122-500) for down-stream DNA extraction.  For IgA-bound sample collection the 
luminal contents, including mucosal scrapings, from distal ileum to rectum were 
collected with forceps, placed in a 15mL conical tube, and spun briefly to sediment 
materials. 2mL of sterile 1X HBSS (without Ca2+) was then added to each sample.  
Samples were vortexed at medium speed for 20 seconds and then spun for 5 minutes 
at 60 x g at 4oC to collect coarse material.  1.5 mL of the supernatant was collected in a 
1.5 mL Eppendorf tube and kept on ice while 2mL of new sterile 1X HBSS was added to 
the sample. This process was repeated 4 times to collect 4-1.5ml Eppendorf tubes per 
animal sample containing bacteria separated from the most coarse fecal material.  
Tubes were then spun at 5000 x g for 5 minutes and supernatant was discarded to 
remove unbound Ig.  Pellets were washed with 600µl sterile 1X HBSS and 2 sets of 2-
1.5mL Eppendorf tubes from each sample were combined.  Tubes for each sample 
were then spun again at 5000 x g for 5 minutes. Supernatants were discarded and the 
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pellets were re-suspended in 500µl of sterile 1X HBSS with 0.1% (v/v) BSA.  Pairs of 
tubes for each sample were then combined into a single 1.5mL Eppendorf tube to 
obtain ~1 mL of bacterial suspension depleted of unbound Ig. This suspension 
contained Ig-bound and unbound bacteria.  125µl of streptavidin-coated magnetic beads 
(CELLection Biotin Binder Kit, Life Technologies cat. # 11533D) per sample were 
washed and pre-incubated with 10µg of biotinylated anti-mouse IgA (Biolegends, cat. # 
407004) for 30 minutes at room-temperature (with gentle rocking) according to the 
manufacturer’s specifications.  The pre-incubated bead-antibody mixture was then 
added to the 1mL of bacterial sample and incubated for 30 minutes at 4oC with gentle 
shaking.  After incubation, 1mL of sterile 1X HBSS supplemented with 0.1% (v/v) BSA 
and 2 mM EDTA was added. Samples were transferred to a sterile 5mL Falcon tube 
(BD Biosciences) and placed on a magnet. The solution contained unbound bacteria 
was removed by pipette and the tube was then removed from the magnet. Magnetic 
beads (with IgA-bound bacteria) were re-suspended in 1X HBSS supplemented with 
0.1% (v/v) BSA to wash. This was done three times to thoroughly wash beads 
containing IgA-bound bacteria. Buffer was removed and samples were washed three 
then washed three times with HBSS with 0.1% (v/v) BSA.  After the final wash was 
removed, samples were removed from the magnet and 200 µl of sterile TE (pH 8.0) with 
0.1% (v/v) Tx-100 (filter sterilized through 0.22 µm filter) was added.  The suspended 
magnetic bead and IgA-bound bacteria mixture was added to 2 mL screw cap tubes 
containing ~250 mg of 0.1 mm zirconia/silica beads (Biospec, cat. # 11079101z) and 
immediately frozen and stored at -80oC for down-stream DNA extraction. 
 IgA-bound, fecal and mucosal samples were all processed similarly for DNA 
extraction and sequencing.  First, each sample that already contained beads and 200µl  
TE with 0.1% (v/v) Tx-100 was thawed at 75oC for 5 minutes and then chilled on ice. 
200µl lysis buffer AL was added (Qiagen, cat. # 19075) and bead-beating for 1 minutes 
with a Mini-Beadbeater-16 (Biospec, cat. # 607) was performed.  Mucosal tissue 
samples were bead-beat for an additional minute to complete homogenization, with 5 
minutes on ice in between beatings to prevent sample heating.  Samples were then 
spun down for 1 minute at 8,000 x g to avoid foaming prior to adding 200µl of 100% 
ethanol and vortexing.  Samples were spun down again to avoid transfer of any 
remaining coarse material and supernatant was added to a Qiagen DNeasy (Qiagen, 
cat. # 69504) (fecal and mucosal samples) or Qiagen DNA micro (Qiagen, cat. # 
56304)(IgA-bound) column.  IgA-bound samples were first placed against a magnet to 
remove the magnetic beads prior to loading on columns.  All samples were then further 
processed according to Qiagen’s specifications after loading on columns. DNA was 
eluted in 65µl of Qiagen’s buffer AE.   
 In order to amplify the bacterial 16S rRNA and obtain high-quality, long reads, we 
targeted the hypervariable regions 3 and 4, initially primer sequences based off the S-D-
Bact-0341-b-S-17/S-D-Bact-0785-a-A-21 pair identified by Klindworth, et al 20135.  
However, empirically, we determined these primers to have strong amplification 
efficiency of host genomic and mitochondrial DNA in addition to the bacterial 16S rRNA 
gene.  We modified them to avoid human and mouse amplification while having similar 
in silico predicted coverage of bacterial taxa.  Then, in a strategy based off that 
developed by Kozich, et al . 20136, we added 2 nucleotide linkers non-complementary 
to most bacteria sequences followed by Illumina adapter sequences with different 8 
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nucleotide barcodes on forward and reverse primers.  We differ from Kozich’s strategy 
in that we used Illumina’s sequencing primers to initiate reads and subsequently 
trimmed our primer sequences from the raw reads, instead of using the 16S primers 
themselves to initiate Illumina sequencing reads.  The modified primers (Supplemental 
Table 1) resulted in less than 0.06% of our quality-filtered reads from either end aligning 
to the host (mouse) genome (data not shown).  PCR cycling conditions were as follows: 
98oC initial denaturation for 2 minutes; 26 cycles of 98oC for 30 sec seconds, 53.6oC 
anneal for 20 seconds, 72oC extension for 30 seconds; final single extension at 72oC for 
2 minutes.  Each PCR was done in triplicate with Phusion HotStart II (Thermo Scientific, 
cat. # F-549L) with the supplied GC buffer and 200nM of each primer in 25µl reaction 
volumes, then combined and cleaned up with ZR-96 DNA cleanup-kit (Zymogen, cat. 
#D4017).  Cleaned, barcoded PCR amplicons from each sample were multiplexed then 
mixed with PhiX control (5% of final library)(Illumina, cat. #FC-110-3001) to increase 
base diversity, and sequenced on an Illumina MiSeq at the University of Utah’s high-
throughput sequencing core with paired-end 300 cycle sequencing. 
 De-multiplexed sequences were processed with mothur7, Qiime 8, and custom 
perl scripts.  Briefly, mothur’s make.contigs was first used to trim primer and linker 
sequences and combine each set of paired-end reads into a single long contig, 
requiring a minimum of 20 nucleotides overlap (thereby discarding contigs greater than 
536 nucleotides after primer and linker trimming) and a maximum quality score 
difference of 6 between overlapping bases.  We then discarded sequences that had any 
‘N’ nucleotides (initially uncalled by MiSeq or introduced by mothur due to difference in 
pairs of overlapping reads), homopolymer stretches greater than 15, or those that did 
not align to the region targeted by our primers.  Finally, quality-filtered long contigs were 
used in Qiime 1.8.0 to pick open-reference 97% OTUs with uclust 9 and make 
taxonomic calls against the Greengenes 13_8 10reference set and taxonomy, requiring a 
minimum OTU cluster size containing 10 sequences.  Chimeric sequences were 
subsequently screened out with ChimeraSlayer 11 and a phylogeny made with the 
program FastTree 212. All analyses involving fecal and mucosal samples were based off 
an OTU table rarefied to 1,500 sequences per sample allowing us to maximize retention 
of biological replicates, whereas analyses involving comparisons within only IgA-bound 
samples were rarefied to 5,100 sequences per sample due to a more even sequencing 
depth among these samples. 
 
  
qPCR validation of conditional MyD88 expression knockout.  
CD4+, CD8+, and non T cells were sort purified via FACS on a FACS ARIA instrument 
(BD) from the spleens of a WT and T-MyD88-/- animal and qPCR was used to determine 
the fold reduction in MyD88 expression. Briefly, cellular RNA was extracted via phenol-
chloroform precipitation and cDNA was created with the qScript cDNA synthesis kit 
(Quanta Biosciences). qPCR was conducted as described above with the GoTaq qPCR 
Master Mix (Promeg !!
Primers'used'in'this'study.'
Primer Name Use Sequence (5' - 3') * Reference 
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ill_S%D%Bact%0346%a%S%171†1 Microbiota Sequencing AATGATACGGCGACCACCGAGATCTACACXXXXXXXXACACTCTTTCCCTACACGACGCTCTTCCGATCTTAGGGRGGCWGCAGTRRGG 
  
ill_S%D%Bact%0781%b%A%231†1 Microbiota Sequencing CAAGCAGAAGACGGCATACGAGATXXXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTTCTACHVGGGTATCTAATCCTGTT 
  
UniF340 Total Bacteria qPCR ACTCCTACGGGAGGCAGCAGT 
Barman, et al. 
200813  
UniR514 Total Bacteria qPCR ATTACCGCGGCTGCTGGC 
Barman, et al. 
200813  
OVAqPCR F B. fragilis OVA qPCR AGAAATGTCCTTCAGCCAAGCTC   
OVAqPCR R B. fragilis OVA qPCR GCCCATAGCCATTAAGACAGATGTG   
MyD88-F MyD88 qPCR KO validation CCCACTCGCAGTTTGTTG Ling, et al. 201314 
MyD88-R MyD88 qPCR KO validation TGCCTCCCAGTTCCTTTG Ling, et al. 201314 
* Bold nucleotides indicate linker sequence, underlined nucleotides indicate the 16S rRNA gene targeting sequences, the 8 nucleotide barcode 
position is indicated by 'X' 
† Naming after "ill_" by convention in (Alm., 1996.15) 
  !
 
Statistics   
Pair-wise comparison of experimental groups in Figures 1, 2, 3, and 5, as well as their 
respective Extended Data Figures, were performed with an unpaired two-tailed Student’ 
t-test. A Welch’s correction was used for data sets with unequal variance (Figure 1b, 1c, 
1f, 2g, 3a, 3g). For microbial community similarity comparisons, pairwise comparisons 
of phylogenetic similarity (Figure 4b, 4d, 5b, 5e) was performed with an unpaired two-
tailed non-parametric t test with 9999 Monte Carlo simulations. Significance testing of 
genotype and sample type effects in 4a, 4c and 5a were performed with a 
PERMANOVA incorporating 9,999 permutations on relevant distance matrices as noted. 
A Mantel’s test was used to test for significant correlations between distance matrices 
summarized in Figure 6b. Estimates of dispersion in all figures represent standard 
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mice lack expression of MyD88 specifically within T cells (CD4+ and 
CD8+), Related to Figure 1. (A) A schematic representing the insertion of loxP sites flanking 
exon 3 in MyD88
fl/fl
 animals. Primer locations (shown in blue) and expected PCR product 
lengths shown on the representative gel. DNA bands from CD4-Cre specific primers are also 
shown on a representative gel. (B) MyD88 mRNA expression was measured by qPCR as 




 were compared to T-
MyD88
-/-




 (C) RNA-sequencing of samples from genotypes 
revealed a specific loss of RNA from the third exon of the MyD88 gene within T-MyD88
-/- 
T cells.  
 
Fig. S2. Analysis of TH1, TH17, and TREG population frequencies within spleens and 
mesenteric lymph nodes (MLNs) of WT and T-MyD88
-/- 
mice, Related to Figure 1. (A-E)  T 
cell subsets within the spleen were measured by flow cytometry. Representative plots were 
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and TH17 cells 






; Data are compiled for (B) TH17 frequencies, (C) TH1 






; data are 
compiled for (E) TREG frequencies (n=7 for each group). (F-J) T cell subsets within the MLNs 


















Data are compiled for (G) TH17 frequencies, (H) TH1 frequencies (n=11 for each group).  (I) TREG 






; data are compiled for (J) TREG frequencies (n=8 for each 
group). P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) using an unpaired, two-tailed t 
test.  Related to Figure 1  
 
Fig. S3.  Analysis of TH1, TH17, and TREG population frequencies within cLP, siLP, and PPs 
of WT and T-MyD88
-/- 
mice, Related to Figure 1. (A-E)  T cell subsets within the cLP were 
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are compiled for B TH17 frequencies, c, TH1 frequencies (n=9 WT and n=14 T-MyD88
-/-
). (D) TREG 






; data are compiled for (E) TREG frequencies (n=10 for 
each group). f-j, T cell subset within the siLP were measured by flow cytometry. Representative 

















; Data are compiled for (G) TH17 frequencies, (H) TH1 
frequencies (n=9 WT and n=7 T-MyD88
-/-







are compiled for j, TREG frequencies (n= 10 WT and n=8 T-MyD88
-/-
).  (K-O) T cell subset within 


















; Data are compiled for (L) TH17 frequencies, (M) TH1 frequencies (n=10-11). (N) TREG cells 






; data are compiled for o, TREG frequencies (n=10-11). P-
value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) using an two-tailed, unpaired t test.  
Related to Figure 1 
 
Fig. S4. Analysis of PP cellularity and TFH populations within PPs, spleen, and MLNs, 
Related to Figure 1.  (A-F) TFH populations within PPs were measured by flow cytometry. 

















. Data are compiled for (B) TFH frequencies (n=15 WT 
and n=13 T-MyD88
-/-











are compiled for d, TFH frequencies (n=21 WT and n=18 T-MyD88
-/-











. Data are compiled for f, TFH frequencies (n=15 WT 
and n=13 T-MyD88
-/-











 representative facs plot and h, data compiled (n=15 WT and 
n=13 T-MyD88
-/-
). i, Data are compiled from the quantification of Trypan Blue (HyClone) 
resistant cells from single cell suspensions of PPs.  (J,K) TFH populations within MLNs were 
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. Data are compiled for (H) 
TFH frequencies (n=7 for each group). (L,M)  TFH populations within the spleen were measured 






 cells  l, TFH 










. Data are compiled for m, TFH 
frequencies (n=7 for each group). P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) using 
an unpaired, two-tailed t test.  Related to Figure 1. 
 
Fig. S5. Most significant taxonomic differences in mucosa, IgA bound and fecal 
communities between WT and T-MyD88
-/-
. Related to Figure 4 and 5. (A) Genera mean 
abundances (± SD) detected in IgA bound, mucosal and fecal fractions of intestinal microbial 
communities.   Only genera detected as > 0.1% average relative abundance within a sample 
type group are shown. UC, Unclassified.  A large number of OTUs can only be classified to the 
order level within the Clostridiales. (B) Boxplots showing the abundance within the mucosal 
fraction of four taxonomic groups containing known mucolytic bacteria are shown. Despite the 
trend towards increased mucolytic bacteria in the mucosal fraction of T-MyD88 animals, only the 
genus Ruminococcus attains significance due to large variability between animals. (* P-
value<0.05, *** P-value<0.001. Welch’s t-test).  Related to Figure  4 and 5.  
 
Table S1. Table of P-values for microbial community dissimilarities, related to Figures 4 
and 5.  Values are based on PERMANOVA with 9999 permutations shows that most observed 
patterns are robust to weighted, unweighted UniFrac as well as the non-phylogenetic Bray-
Curtis.  Related to Figure 4 and 5 
 
Table S2. 9 OTUs identified as significantly different in separately housed animals as well 
as cohoused animals, related to Figure 5D. P-values (non-parametric t-test with 9,999 Monte 
Carlo simulations) are shown for differences between genotypes in cohoused animals, 
illustrating the conservation of patterns among some OTUs between different housing 
conditions, as well as different direction of shifts in abundance of OTUs identified as belonging 




 DIRECT RECOGNITION OF TLR2 LIGANDS 
INFLUENCES TFH DIFFERENTIATION  




 A key component of the host immune response is T cell-dependent B cell 
activation that results in antibody responses. These interactions occur within 
lymphoid follicles and result in rapid B cell mutation and cellular turnover whose 
end product is a GC B cell capable of producing high affinity, antigen-specific 
immunoglobulins (1). Of the many subsets of T helper cells, TFH cells are tasked 
with driving and maintaining germinal center responses. While this immune 
response is particularly important during a pathogenic invasion, it occurs at 
steady-state conditions within gut-associated lymphoid tissue (GALT) in order to 
direct sIgA targeting towards colonizing commensal microbes (2).  
 The decision point for a naïve T cell to differentiate into a TFH cell occurs 
upon its initial interaction with an antigen presenting cell (APC), through 
expression and ligation of Inducible T cell Costimulator (ICOS) (1, 3). 
Costimulation of ICOS supports the expression of BCL6, a master transcription 
factor required for the TFH lineage (4-6). Indeed, ICOS deficient mice lack TFH 
cells, and blocking the interaction between ICOS and its ligand (ICOSL) leads to 
a reduction of TFH populations (3).  Commitment to the TFH cell fate requires a 
concerted network of cellular signaling that result in the secretion and co-
localization of surface proteins required to form cell-cell interactions with B 
cells. These include CXCR5, a chemokine receptor found on both T cells and B 
cells that promotes co-localization at the follicle; PD1, CD40L, and SLAM, which 
interact and ligate with B cell surface proteins in order to promote activation and 
class switching within GC B cells; and cytokines IL-6 and IL-21, whose
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extracellular secretion provides necessary autocrine activation to TFH cells as 
well as maintenance of GC B cell responses (1). The resulting T cell- B cell 
interactions lead to downstream cell signaling activation of the PI3K/AKT/mTOR 
pathway that provide metabolic shifts necessary to support TFH cell populations 
and GC response. 
 Seminal studies have provided careful mechanistic insight into the 
antigen-specific interactions that occur during pathogen infections within the 
systemic compartment. However, how TFH cell responses were regulated within 
mucosal sites to commensal antigens has remained ill-defined. While 
immunoglobulin G (IgG) is the major antibody produced within the systemic 
compartment, GC responses within the GALT primarily result in the secretion of 
highly specific IgA (2). 
T cells and other host immune cells experience a constant inundation of 
microbial cues that shift in relationship with changes within the microbiota. While 
T cells are classically considered to be dependent on APC activation and co-
stimulation before committing to a T helper cell fate, whether or not T cells could 
directly recognize microbial cues and dynamically respond to the microbiota had 
been previously unknown. One such way this might be occurring is through 
innate signals recognized by Toll-like receptors (TLRs) that signal through a 
common signaling adaptor, MyD88 (7). Indeed, we have recently uncovered a 
mechanism by which MyD88 dependent signaling in T cells is required for 
germinal center development within the gut and IgA secretion into the mucosa to 
provide commensal specific targeting of the microbiota (8). Mice lacking T cell 
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specific MyD88 signaling experience less IgA secretion and defective targeting of 
the microbiota that results in dysbiosis and susceptibility to colitis. This study 
provided a novel pathway by which innate signals could alter TFH populations 
and germinal center responses towards the microbiota.  
 In our current study, we aimed to identify a mechanism by which MyD88 
signaling could influence TFH differentiation and interrogate whether T cells 
could directly respond to microbial cues independent of APC signals. We 
demonstrate that T cells express TLR1, TLR2, and TLR6, which respond to TLR2 
ligands, including Pam3CSK, in order to promote the expression of ICOS. In 
agreement with this, we uncovered defects in ICOS expression within T-MyD88-
/- T cells in peyer’s patches (PPs) throughout the gut as well as reduced 
proliferation. However, further experimentation revealed the likelihood that 
multiple pathways rely on MyD88 signaling to promote TFH differentiation and 
germinal center responses. Finally, we uncovered a potential mechanism by 
which commensals may utilize TLR2 signaling to instruct extra-intestinal T cells 
to prime antigen-specific responses within the systemic compartment.  
 
Results 
ICOS expression in gut T cells is deficient in the  
absence of MyD88 signaling 
MyD88 is a common signaling adaptor that propagates TLR ligand and 
cytokine detection to downstream transcriptional and metabolic responses. TFH 
populations are heavily dependent on concerted transcriptional and metabolic 
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pathways that influence differentiation, function, proliferation, and survival. We 
previously demonstrated that mice lacking MyD88 signaling within T cells were 
defective in both frequency and number of TFH populations within the gut.  We 
sought to understand which pathways downstream of MyD88 were responsible 
for promoting TFH differentiation and maintenance.  
Using flow cytometry, we identified that PPs within T-MyD88-/- mice 
contain significantly fewer ICOS+ T cells (Figure 4.1a). Expression of ICOS was 
also reduced in ICOS+ T cells within T-MyD88-/- PPs, suggesting that, even 
when the protein is expressed, MyD88 is required to maintain proper expression 
levels within T cells (Figure 4.1b). Expression and ligation of the ICOS receptor is 
required at numerous stages of TFH differentiation. This initially begins when 
non-TFH cells interacting with dendritic cells, but continues through migration into 
the follicle, and maintenance of the GC-TFH population through B cell 
interactions, making ICOS induction a key event in coordinating TFH biology.  
We compared ICOS expression throughout TFH differentiation by gating on non-
TFH cells, cells that had differentiated to TFH phenotype but were not residing 
within the germinal center, and germinal center TFH cells (Figure 4.2a). As cells 
differentiate from non-TFH cells to GC-TFH cells, there was a stepwise decrease 
in the percentage of ICOS+ cells within T-MyD88-/- mice, as well as a decrease 
in ICOS expression on a per cell basis (Figure 4.2bc). Notably, this was specific 
for ICOS. We compared the expression of CXCR5, PD1, and CD40L within TFH 
cells of WT and T-MyD88-/- mice and found no significant differences in protein 












Figure 4.1 T-MyD88-/- PPs have less ICOS+ T cells. A-B) ICOS expression on T 
cells within PPs was measured by flow cytometry. A) Representative plots were 
previously gated on CD3+CD4+ cells to measure frequency of ICOS+ T cells. B) 


















































Figure 4.2 ICOS expression becomes increasingly defective on T-MyD88-/- T 
cells as they differentiate to TFH cells. ICOS expression on non-TFH cells, non-
GC-TFH cells, and GC-TFH cells within PPs was measured by flow cytometry. A) 
Representative plots were previously gated on CD3+CD4+. Non-TFH cells were 
defined as CD3+CD4+CXCR5-PD1-. Non-GC-TFH cells were defined as 
CD3+CD4+CXCR5lowPD1low.GC-TFH cells were defined as 
CD3+CD4+CXCR5highPD1high. B) Frequency of ICOS+ non-TFH cells, non-GC-
TFH cells, and GC-TFH cells. C) MFI of ICOS on non-TFH cells, non-GC-TFH 
cells, and GC-TFH cells. D) MFI of CD40L, CXCR5, PD1, and ICOS on TFH cells, 
defined as CD3+CD4+CXCR5+PD1+. 
 









































































































for their proper expression (Figure 4.2d). Collectively, these data strongly 
suggest that MyD88 promotes expression of the ICOS receptor in order to 
promote TFH differentiation.  
 
Direct detection of TLR2 ligands by T cells promotes  
ICOS expression in gut T cells 
We previously created WT and T-MyD88-/- germfree mice and 
demonstrated that the presence of TLR2 ligands alone in drinking water is 
sufficient to promote TFH differentiation in a T cell intrinsic MyD88 dependent 
manner.  In addition to having fewer TFH cells within germfree T-MyD88-/- mice 
that were fed TLR2 ligands, these animals also had significantly less ICOS 
expression on their surface as well (Figure 4.3). These data demonstrate that the 
presence of TLR2 ligands alone are able to promote ICOS expression and TFH 
differentiation, however, it was not clear whether T cells are directly capable of 
detecting those microbial cues themselves.  
MyD88 is a downstream adaptor for TLR ligands and host cytokines, such 
as IL1b and IL18. To understand whether T cells can directly recognize TLR2 
ligands or are dependent on secondary host cytokines to differentiate and 
maintain TFH cell populations, we performed RNA-seq on T cells within Peyer’s 
patches and looked for the expression of TLRs in non-TFH cells and TFH cells 
(Figure 4.4a). We found that the receptors involved in the TLR2 pathways, TLR2, 
TLR1, and TLR6 were all expressed on both non- TFH and TFH cells. In contrast, 










Figure 4.3 TLR2 ligands alone promote ICOS expression in vivo in T cells with 
MyD88 signaling. ICOS expression on T cells within PPs was measured by flow 
cytometry. Representative plots were previously gated on CD3+CD4+ cells to 





















































Figure 4.4 T cells directly recognize TLR2 ligands to increase ICOS expression in 
vitro. A) RNA-seq expression in non-TFH cells and TFH cells within PPs. B-E) 
ICOS expression on sort purified naïve T cells, defined as 
CD3+CD4+CD62L+CD69-, cultured for 3 days in the presence of anti-CD3, with 
or without TLR or cytokine activation. B) Representative plots were previously 
gated on CD3+CD4+ to measure percent increase in ICOS MFI of naïve T cells 
cultured with anti-CD3 and Pam3CSK (P3CSK), Pam2CSK (P2CSK), 
Lypopolysaccharide (LPS), or Flagellin compared to naïve T cells cultured with 
anti-CD3 along. C) Representative plots were previously gated on CD3+CD4+ to 
measure ICOS MFI of naïve T cells cultured with anti-CD3 alone (Media) or in 
combination with Pam3CSK (P3CSK), Interleukin-18 (IL-18), or Interleukin-1beta 
(IL-1beta) for 1, 2, and 3 days. D) ICOS MFI was calculated on naïve T cells 
cultured with anti-CD3 alone (Media) or in combination with Pam3CSK (P3CSK), 
Interleukin-18 (IL-18), or Interleukin-1beta (IL-1beta) in the presence of DMSO or 
and NFkB inhibitor. E) Representative plots were previously gated on 
CD3+CD4+ to measure ICOS MFI of naïve WT or T-MyD88-/- T cells cultured 





















































































































































detected. To test a role for T cell intrinsic TLR signaling during the induction of 
ICOS, fluorescence activated cell sorting (FACS)-purified T cells were stimulated 
with various TLR ligands in vitro. In agreement with our sequencing data, TLR2 
ligands, in concert with TCR stimulation, robustly induced ICOS, while TLR4 or 
TLR5 ligands did not (Figure 4.4b). Promotion of MyD88 pathway is specific to 
TLR2 and does not require IL1b or IL18, neither of which were able to increase 
ICOS expression over media during a three-day period (Figure 4.4c) Importantly, 
the upregulation of ICOS requires the downstream transcription factor, NFkB 
(Figure 4.4d). Inhibition of this transcription factor reduced ICOS expression to 
that of media alone. Furthermore, T cells lacking MyD88 were unable to 
upregulate ICOS in the presence of TLR2 ligands (Figure 4.4e).  These data 
suggest that direct recognition of TLR2 ligands by T cells leads to MyD88 
signaling to NFkB to upregulate ICOS expression and TFH differentiation. 
 
MyD88 signaling is required for systemic TFH responses 
to immunization 
 Peyer’s patches are an important site for T cell dependent IgA targeting of 
microbial populations with the gut. TFH populations at this site along the gut are 
required to respond to shifts within microbial cues in order to shape the 
microbiota and maintain healthy interactions between the microbiota and the host 
immune system. We previously demonstrated that disruption of MyD88 signaling 
in T cells led to a reduction in T cell dependent IgA responses at steady-state 
conditions. We next sought to understand whether MyD88 signaling was required 
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for systemic TFH development as well. At steady-state conditions, there is a very 
low frequency of TFH populations within spleens of healthy animals, however, 
the frequency of these cells is increased during an immune challenge to provide 
antigen-specific direction to germinal center B cells, leading to the production of 
highly specific antibodies. To understand how MyD88 promotes TFH 
development during an antigen-specific immune response, we immunized 
animals with ovalbumin (OVA) in the presence of Pam3CSK to provide a TLR2 
activated immune response. Compared to WT mice, T-MyD88-/- mice were 
defective in their ability to promote systemic TFH responses to ovalbumin (Figure 
4.5a). Reduced TFH differentiation within T-MyD88-/- mice resulted in fewer GC 
B cells (Figure 4.5b). To identify the impact that these reductions in systemic 
germinal center responses had in antigen-specific antibodies, we performed 
ELISAs to measure both total IgG as well as OVA specific IgG. While we 
detected no defects in total IgG antibodies within the T-MyD88-/- mouse serum, 
these animals contain less OVA specific IgG within the serum (Figure 4.5c). This 
demonstrates that, while MyD88 is not necessary for steady-state responses 
within the systemic compartment, it is required to upregulate TFH responses 
during an immune response.  
 
MyD88 signaling promotes TFH differentiation through a 
cell intrinsic mechanism 
The T-MyD88-/- mouse is lacking MyD88 within all CD4+ and CD8+ T 







Figure 4.5 OVA immunization of T-MyD88-/- mice results in significant defects in 
TFH and GC responses. A) Representative plots were previously gated on 
CD3+CD4+ cells to measure frequency and total numbers of TFH cells, defined 
as CD3+CD4+CXCR5+PD1+ within spleens. B) Representative plots were 
previously gated on B220+IgDlow cells to measure frequency and total numbers 
of GC B cells, defined as B220+IgDlowFas+GL7+ within spleens. C) Enzyme-
linked Immunosorbant Assay (ELISA) was used to quantify Total IgG and OVA 







































































































whether this is a cell intrinsic defect that occurs during TFH differentiation or was 
due to T cell-wide defects that result in an extracellular environment that reduces 
TFH differentiation and germinal center responses. We created mice that have 
OVA specific CD4+ T cells (OTII) that either contained or lacked MyD88.  We 
then transferred these cells into WT B6 mice and immunized them with OVA 
along with Pam3CSK. Despite the presence of WT endogenous T cells, OTII 
cells lacking MyD88 were less able to differentiate to TFH cells than WT OTII 
cells, arguing that it is disruption of a cell intrinsic pathway required for TFH 
differentiation that reduces the presence of TFH cells within T-MyD88-/- mice 
(Figure 4.6a). However, the GC response was the same in mice that had 
received either WT OTII cells or T-MyD88-/- OTII cells, indicating that there 
is likely a second, extracellular component that MyD88 signaling stimulates to 
produce an effective germinal center response (Figure 4.6b). 
Defects within splenic TFH responses are independent of 
ICOS signaling 
The TFH and germinal center defect observed within PPs is recapitulated 
in the systemic compartment during OVA immunization. We measured ICOS 
expression within spleens during the OVA immune response, however, and did 
not detect any significant difference between ICOS expression within WT T cells 
or T-MyD88-/- T cells (Figure 4.7a). This was true for both endogenous T cell 
experiments as well as OTII experiments (Figure 4.7b). Additionally, efforts to 
rescue ICOS expression within T-MyD88-/- T cells during OVA immunization in 
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Figure 4.6 T cell intrinsic MyD88 signaling promotes GC responses through a 
combination of cell intrinsic and extrinsic mechanisms. A) Representative plots 
were previously gated on CD3+CD4+ cells to measure frequency and total 
numbers of TFH cells, defined as CD3+CD4+CXCR5+PD1+ within spleens. B) 
Representative plots were previously gated on B220+IgDlow cells to measure 



























































































Figure 4.7 MyD88 promotes TFH differentiation in an ICOS dependent manner. 
A) Representative plots were previously gated on CD3+CD4+ cells to measure
frequency and total numbers of TFH cells, defined as CD3+CD4+CXCR5+PD1+
within spleens of WT or T-TLR2-/- mice. B) Representative plots were previously
gated on CD3+CD4+ cells to measure frequency and total numbers of TFH cells,
defined as CD3+CD4+CXCR5+PD1+ within spleens of mice given WT or T-
TLR2-/- OTII T cells. C) Representative plots were previously gated on GFP+
MIGR plasmid transfected 293T cells to measure ICOS+ 293T cells. B) ICOS



































































order to promote TFH differentiation were unsuccessful. We created a plasmid 
capable of overexpressing ICOS within transfected 293T cells, however, T cells 
transfected with this plasmid showed no increased expression of ICOS, 
preventing us from testing whether ICOS overexpression could rescue the 
defects seen in TFH differentiation (Figure 4.7c,d). Regardless, the fact that 
splenic T-MyD88-/- T cells show no defect in ICOS expression, but experience 
reduced TFH populations, suggests that MyD88 might influence multiple 
pathways important for TFH populations.  
MyD88 signaling promotes TFH proliferation to maintain 
TFH subsets 
We expanded our search to look at defects within cell death or 
proliferation that might contribute to the reductions in TFH populations. There is 
no difference in cell death of TFH cells within PPs between WT and T-
MyD88-/- mice, as measured by cells that are annexin-V positive and 7-AAD 
positive (data not shown). To interrogate the requirement of MyD88 for T cell 
proliferation, we analyzed the percentage of Ki-67+ non-TFH and TFH cells 
within peyer’s patches of WT and T-MyD88-/- mice. Ki-67 is absent in 
resting cells, but becomes expressed once cells have entered into the cell 
cycle. While MyD88 does not influence proliferation of Ki-67 in non-TFH cells 
(Figure 4.8a), T-MyD88-/- mice had significantly fewer Ki-67+ TFH cells within 
their PPs (Figure 4.8b), suggesting that defects in proliferation might contribute to 
the observed reductions of TFH cell populations within the guts of these mice.  
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Figure 4.8 MyD88 signaling promotes proliferation to maintain TFH populations. 
A) Representative plots were previously gated on CD3+CD4+CXCR5+PD1+
cells to measure frequency of Ki67+ TFH cells. B) Representative plots were



















































TLR2 signaling on T cells promotes GC responses 
within the systemic compartment 
Our data so far have suggested that T cells directly detect TLR2 ligands in 
order to alter TFH differentiation and function. In order to test this in vivo, we 
created a T cell specific knock out of TLR2 by crossing TLR2 fl/fl mice with mice 
containing the cre-recombinase driven by the CD4 promoter (Figure 4.9a). These 
mice have severe reductions in the presence of TLR2 on T cells, while 
maintaining it on non-T cell subsets (Figure 4.9b). At steady-state conditions, 
these mice exhibited no defects in TFH cell and GC B cell populations within the 
intestines (Figure 4.10a,). However, during OVA immunization, T-TLR2-/- mice 
experience significant defects in GC B cell responses, despite the fact that they 
have similar frequencies of TFH populations (Figure 4.10b). Importantly, this 
defect is not due to non-T cell specific defects within these mice. Naïve T-TLR2-/- 
T cells transferred to TCRb-/- mice also demonstrate a significant defect in their 
ability to induce germinal center responses during OVA immunization (Figure 
4.10c). While this does not completely recapitulate the TFH defects seen in T- 
MyD88-/- mice, it demonstrates that direct recognition of TLR2 ligands by T cells 
is required for the proper function of TFH cells. OVA immunization of WT B6 
mice containing WT or T-MyD88-/- OTII cells demonstrated that effects on GC 
responses are likely cell extrinsic. To determine whether this was the case for 
defects seen in T-TLR2-/- mice, we crossed these animals to OTII mice and 
injected CD4+ OTII cells in WT B6 mice before immunizing them with OVA. In 
agreement with our previous findings, OVA immunized B6 mice given T-TLR2-/-  
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Figure 4.9 Specific deletion of TLR2 within T cells was created by crossing a 
TLR2fl/fl mouse to a CD4-cre+ mouse. A) The TLR2 fl/fl mouse contains loxp 
sites surrounding Exon 3 of TLR2. This was crossed to mice containing cre-
recombinase driven by the CD4 promoter. Genotyping identified successful 
offspring that contain TLR2fl/fl allele and the presence of CD4-cre. B-C) TLR2 
expression was measured on T cells, defined as CD3+CD4+, and non-T cells, 
defined as CD3-, using flow cytometry. B) Representative plots were previously 
gated on CD3+CD4+ cells to measure MFI of TLR2. C) Representative plots 











































Figure 4.10 TLR2 signaling on T cells promotes GC responses within the 
systemic compartment. A) Flow cytometry was used to measure GC-TFH cells 
and GC B cells within PPs. B) Flow cytometry was used to measure TFH cells 
and GC B cells within spleens following OVA immunization. C)  Flow cytometry 
was used to measure TFH cells and GC B cells within spleens of TCRb-/- mice 
given WT or T-TLR2-/- T cells following OVA immunization. D) Flow cytometry 
was used to measure TFH cells and GC B cells within spleens of WT B6 mice 



















































































































































































































OTII had no defects in GC formation, indicating that TLR2 ligands and MyD88 
signaling promote GC responses through cell extrinsic signals (Figure 4.10d) 
 
TLR2 signaling promotes commensal specific immune  
responses in extra-intestinal sites 
In order to understand whether TLR2 signaling on T cells might influence 
TFH responses to commensal antigens, we created germfree WT and T-TLR2-/- 
mice by reconstituting germfree Rag-/- mice with bone marrow from WT or T-
TLR2-/- mice. During reconstitution, we monocolonized these mice with the 
commensal, Bacteroides fragilis, that has been designed to express OVA. WT 
and T-TLR2-/- mice were monocolonized to similar levels as measured by the 
detection of OVA reads within fecal DNA (Figure 4.11a). Colonization with this 
single species expressing OVA, however, revealed a defect in the ability of T 
cells lacking TLR2 to produce an antigen-specific immune response.  We did not 
detect any differences in activated T cells trafficking along the lamina propria 
between monocolonized WT or T-TLR2-/- mice (Figure 4.11b). In contrast to this, 
we detected dramatic defects within commensal antigen-specific responses  
within the spleen. Spleens of monocolonized T-TLR2-/- mice had significantly 
fewer activated T cells and TFH cells (Figure 4.11c,d). Furthermore, restimulation 
of splenocytes with OVA resulted in significantly less IFNg production from T- 
TLR2-/- spleens (Figure 4.11,e). While these data do not provide a mechanism 
by which TLR2 might be influencing antigen-specific immune responses, it 
provides consistent argument that direct detection of TLR2 ligands influences  
72	
Figure 4.11 TLR2 signaling promotes commensal specific immune responses in 
extra-intestinal sites. A) quantitative PCR (qPCR) measured total presence of the 
OVA gene within fecal DNA of monocolonized WT and T-TLR2-/- mice. B) 
Representative plots were previously gated on CD3+CD4+ cells to measure 
frequencies activated T cells, defined as CD3+CD4+CD69+CD44+, within the 
lamina propria of the gut. C) Representative plots were previously gated on 
CD3+CD4+ cells to measure frequencies and total numbers of activated T cells, 
defined as CD3+CD4+CD69+CD62L-, within spleens. D) Representative plots 
were previously gated on CD3+CD4+ cells to measure frequencies and total 
numbers of TFH cells defined as CD3+CD4+CXCR5+PD1+ within spleens. E) 
ELISA was used to measure IFNg produced from splenic cells that were cultured 














































































































































antigen-specific immune responses on T cells. Additionally, it reveals an 
interesting pathway by which antigen-specific responses of systemic T cells are 
influenced by commensal antigens within the gut. 
Discussion 
Collectively, these data demonstrate that T cells respond directly to 
microbial cues via TLR2 to promote TFH differentiation in an MyD88 dependent 
manner. MyD88 is a common signaling adaptor for both host cytokines and 
multiple TLRs that recognize microbial cues. MyD88 activation leads to 
downstream transcriptional and metabolic changes within the cell. T cells 
express TLR1, TLR2, and TLR6 as well as IL1b and IL18 receptors, however, 
only stimulation of TLR1/TLR2 or TLR6/2 is capable of inducing ICOS expression 
and TFH differentiation. T cells lacking MyD88 signaling maintain steady-state 
defects within PPs along the gut, resulting in reduced IgA targeting of the 
microbiota and a greater susceptibility to colitis. MyD88 is also required for 
antibody production via TFH differentiation and germinal center responses.  
Interestingly, while our findings within the gut suggest that ICOS 
expression is defective when MyD88 is not present within T cells, the results from 
our systemic immunizations imply that other factors are required for TFH 
differentiation. This could mean that ICOS is more strongly upregulated within 
TFH differentiation in PPs. Indeed, multiple subtypes of TFH cells have been 
identified that each maintain a unique ability to direct various antibody responses 
(9, 10). It is possible that the TFH cells within PPs depend more strongly on 
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ICOS than splenic TFH cells. Comparison of ICOS expression between splenic 
TFH cells and PP TFH cells supports such a possibility. It is also feasible that 
ICOS is acting concomitantly with another pathway during TFH differentiation. 
Recent studies have revealed that, due to the increased metabolic burden on 
TFH cells, ICOS signaling and the mTOR pathway cooperate to promote TFH 
differentiation and germinal center responses (11, 12). Mice lacking T cell 
intrinsic mTOR1 and mTOR2 signaling have fewer TFH cells within PPs, and are 
less able to promote BCL6 activation during ICOS ligation in vitro. During 
differentiation of other T cell subsets, MyD88 is required for proper mTOR 
activation, making this a suggestive candidate for an alternative mechanism 
necessary to maintain TFH populations in an MyD88 dependent manner (13). 
Indeed, in the absence of ICOS defects, we identified a cell intrinsic defect in 
TFH differentiation within the spleen. Furthermore, TFH cells within PPs are also 
defective in their proliferative capacity, suggesting that differentiation alone from 
ICOS signaling is not the only defective pathway in T-MyD88-/- germinal center 
responses. Future investigation into the metabolic capacity of T-MyD88-/- mice is 
necessary to characterize its contribution to antigen-specific germinal center 
responses.  
We have demonstrated that T cell recognition of TLR2 ligands are capable 
of promoting TFH differentiation and ICOS expression in vitro and in vivo. While 
mice specifically lacking TLR2 contain similar levels of TFH populations as WT 
within their PPs, OVA immunization experiments revealed an inability to promote 
GC B cell responses within the spleen. Additionally, TLR2 signaling on T cells 
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promotes commensal specific immune responses within the systemic 
compartment. Experiments such as these may reveal a pathway that is one part 
of a greater network. While no defects are revealed in steady-state conditions, 
the inundation of microbial signals might be enough to compensate for the loss of 
TLR2 on T cells. It is also possible that measurements of frequency and total 
numbers alone of germinal center populations might not be sensitive enough to 
identify defects within IgA targeting of microbes when T cells lack TLR2.  
Despite seeing no defects within PPs under steady-state conditions, we 
consistently observe fewer germinal center B cells in immunized T-TLR2-/- mice. 
These data, along with the identification that commensal antigens can drive 
systemic T cell responses in a TLR2 dependent manner reveal an intriguing 
method by which microbiota colonization can influence systemic immune 
responses to infections or vaccines. Recent studies have revealed antibody 
cross- reactivity between commensal antigens and the envelope protein gp41 
found on HIV (14, 15). These results lead to speculation that some individuals 
may be colonized with a microbiota that could provide greater protection by an 
HIV or other vaccine response. Additionally, introduction of specific commensals 
concomitant with immunizations may have the potential to boost vaccine efficacy. 
Whether or not commensal microbes are acting as an adjuvant through other T 
cell expressed microbial pattern receptors or just through TLR2 remains 
unknown, however, TLR2 signaling on T cells may be an ideal target as a means 
to enhance TFH responses during vaccines to promote stronger germinal center 
and antigen-specific antibody responses. Greater delineation of these signaling 
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pathways is required to fully understand and harness T cell responses to the 





MyD88 LoxP/LoxP mice were purchased from Jackson Laboratories and 
subsequently crossed to CD4-Cre animals (Taconic) to produce homozygote 
offspring. MyD88WT/WT CD4-Cre+ mice are designated as WT and 
MyD88LoxP/LoxPCD4-Cre+ are designated as T-MyD88-/-.  TLR2loxp/loxp were 
created using EUCOMM. Mice were crossed to CD4-cre+ mice to create 
TLR2loxp/loxp designated as WT and TLR2loxp/loxpCD4-Cre+ mice designated 
as T-TLR2-/- mice. Age matched animals were used to compare phenotypic 
differences between genotypes. TCRb-/- mice were purchased from Jackson 
and maintained as a colony within out mouse facility. MyD88LoxP/LoxPCD4-
Cre+ and TLR2loxp/loxpCD4-Cre+ were crossed to OT-II mice (Jackson) in order 
to obtain mice that were CD4-Cre+ OT-II mice designated as WT OTII mice, 
MyD88LoxP/LoxPCD4-Cre+ OT-II mice designated as T-MyD88-/- OTII mice, 
and TLR2loxp/loxpCD4-Cre+ OT-II mice designated as T-TLR2-/- OTII mice.  
Germ-free mice were maintained in sterile isolators and assayed monthly 
for germ-free status by plating and PCR. Age matched germfree Balb/c mice 
were compared to SPF Balb/c mice to compare phenotypic differences in TFH 
cells along gut associated lymphoid tissues. For the TLR-ligand experiment 
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Germ-free C57Bl/6 mice were born germ-free and then fed drinking water 
containing 10µg/mL of Pam3CSK4 (Invivogen) for two weeks. For the 
reconstituted mono-association and TLR ligand experiments, germfree Rag1-/- 
mice were reconstituted with bone marrow (~2.5x106 cells) from WT and T-
MyD88-/- mice. For the mono-association study, reconstituted germfree Rag1-/- 
mice were mono-associated with erythromycin/gentamicin resistant Bacteroides 
fragilis that was engineered to express OVA (B.fragilis-OVA: a gift from Sarkis 
Mazmanian (California Institute of Technology) via oral gavage. Animals were 
maintained for two months with 1milligram per milliliter of both erythromycin and 
gentamicin in drinking water in SPF animals housing conditions (not within 
germfree isolators) and were validated to be correctly colonized by fecal aerobic 
& anaerobic plating of feces as well as PCR analysis. The reconstituted Rag1-/- 
mice were analyzed two-months postcolonization.  For the TLR-ligand 
experiment, reconstituted Rag1-/- mice were maintained on 1milligram per 
milliliter of ampicillin (Fisher Scientific), neomycin (Fisher Scientific), erythromycin 
(Fisher Scientific), and gentamicin (GoldBio) for two months. During the last two 
weeks, 10µg/mL of Pam3CSK4 (Invivogen) was added to antibiotic cocktails. 
For ovalbumin immunization, mice were subcutaneously immunized 
with150µL of 100µg of OVA and 20µg of Pam3CSK mixed 1:1 in incomplete 
Freunds adjuvant (IFA). Animals were sacrificed 7-10 days later. For OTII and 
TCRb-/- experiments, one day before OVA immunization, 2.5X106 MACS CD4+ 
enriched cells or FACS purified Naïve T cells were retro-orbitally injected into WT 
B6 or TCRb-/- mice, respectively.  
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Enzyme-linked immunosorbant assay (ELISA) 
For quantification of serum IgG, blood was collected into 1.5mL eppendorf 
tubes and spun at 4°C for 15 min at 12,000g. Serum supernatant was then 
transferred to a new Eppendorf tube, flash frozen and stored at 70°C. 1:10 
dilutions of serum samples were used to detect IgG and OVA specific IgG using 
the Mouse IgG total Ready-set-go ELISA kit (eBioscience), performed as per kit 
instructions. Absorbance was read at 450nm, and concentrations of IgG were 
calculated using the provided standard. For quantification of OVA specific IgG, 
IgG quantification was performed using the same IgG specific ELISA kit, with 
slight modification. Instead of coating plates with capture antibody specific for 
IgG, plates were coated overnight at 4°C using 4µg/mL ovalbumin in PBS. For in 
vitro supernatant detection of IFNg and IL-17, 1X105 splenic cells were 
incubated with or without 1µg/mL of OVA for 3 days. Supernatent was diluted 
1:1000 for IFNg and 1:10 for IL17 and analyzed using Mouse IFNg ELISA MAX 
(Biolegend) and Mouse IL17A Ready-set-go (eBioscience), performed as per kit 
instructions. Absorbance was read at 450nm, and concentrations of were 
calculated using the provided standard. 
 
T cell isolation 
Lymphocytes were isolated from spleens as mentioned above and the 
resulting cells were sorted through MACS columns using negative selection 
(CD4+ T Cell Isolation Kit II (Miltenyi)). Sorts were performed as per kit 
instructions. Isolated T cells were further purified via FACS using a BD FACSAria 
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Cell Sorter For Naïve T cells, CD3+CD4+CD62L+CD25- cells were collected into 
RPMI media (Corning) supplemented with 10%FBS (v./v.) (Gibco BRL), 50 U/mL 
penicillin and 50 µg/mL streptomycin (Cellgro), 5µM 2-Mercaptoethanol 
(CalBiochem), 1µM sodium pyruvate (Cellgro), 1x MEM Nonessential Amino 
Acids (Cellgro) and 2.05mM L-glutamine (Cellgro). For TFH purified cells 
CD3+CD4+B220-CXCR5+PD1+ cells were collected into supplemented RPMI 
media. For TFH-depleted T cells, CD3+CD4+B220-CXCR5-PD1- cells were 
collected into supplemented RPMI media. 
Quantification of OVA gene within fecal DNA 
Fecal pellets were collected from monocolonized mice in 2mL screw cap 
tubes containing ~250 milligram of 0.15 mm garnet beads (MoBio) for DNA 
extraction. DNA was extracted using Power Fecal Kit (MoBio) per kit instructions. 
Concentrations of fecal DNA was quantified using Nanodrop, and 50ng of fecal 
dna was used to quantify the levels of OVA gene using LightCycler ® 480 SYBR 
Green I Master (Roche) and a Lightcycler 480.  OVA forward primer: 
AGAAATGTCCTTCAGCCAAGCTC. OVA reverse primer: 
GCCCATAGCCATTAAGACAGATGTG 
Retroviral overexpression 
Full length ICOS was inserted into the MIGR1 plasmid (Addgene) for 
overexpression of ICOS. ICOS was amplified and the ICOS PCR product and 
MIGR1 plasmid were digested using restriction enzymes EcoRI and Bgl2 (New 
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England Biolabs) and ligated using T4 DNA Ligase (New England Biolabs). 
Plasmid was introduced into Mix & Go Competent E. coli (Zymo Research) and 
plated on LB + Ampicillin overnight. 7μg of MIGR1-EICOS or 7 μg of control 
MIGR1 was mixed with 7 μg of pCL-Eco in 1.5 mL serum-free DMEM containing 
35 μL TransIT-293 Transfection Reagent (Mirus Bio). After 15 min of incubation, 
this mixture was added to 5 mL of DMEM in a tissue culture flask containing 
~5,000,000 293T cells. After 3 days of incubation, supernatant from cells was 
collected and passed through a .45 μm syringe tip. 150-200 μL of retroviral 
containing media was then added to 96 well plates containing 200 μL of RPMI 
containing CD4+ splenic cells isolated from mice using CD4+ T cell Isolation Kit 
(Miltenyi) with anti-CD3 (5 μg/mL) and anti-CD28 (1 μg/mL) (eBioscience) and 
spun at 2500 RPM from 90 min at 37°C. 100 μL of RPMI was removed and 
replaced with complete RPMI containing anti-CD28 and plates were incubated 
for 3 days at 37°C. After incubation, cells were sort purified for GFP+ CD3+ using 
FACSAria. Confirmation of ICOS over expression was verified in 293T cells and 
primary T cells through flow cytometry analysis of ICOS on the cell surface. 
 
In vitro activation experiments 
Purified Cells were plated in 250µL of supplemented RPMI containing 
20ng/mL IL-2 in 96 well plates (2X105 cells per plate) that had been previously 
coated with 5µg/mL purified α-CD3. For TFH skewing conditions, 1µg/mL of the 
co-stimulatory antibody α-CD28, 10µg/mL α-CD4, 10µg/mL α-IFNγ, 50ng/mL IL-
21, and 50ng/mL IL-6 were added. For TLR ligand stimulation, 1µg/mL of either 
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Pam2CSK (Invivogen), Pam3CSK (Invivogen), Flagellin from S. typhimurium 
(Invivogen) or LPS was added. For cytokine stimulation, 50ng/mL of IL1b or IL18 
were added. For NFKB inhibition, 100ng/mL of BAY 11-7082 dissolved in DMSO 
was added and equal volume of DMSO was added in control wells. Cell were 
cultured for 3 days at 37°C in these conditions before being analyzed by flow 
cytometry.  
Flow cytometry staining of isolated lymphocytes 
Lymphocytes were isolated from PPs, spleens, and inguinal lymphnodes 
by gently pushing tissue through a 40µM filter to obtain white blood cells. Splenic 
cells were additionally treated with 1x RBC Lysis Buffer (Biolegend) to remove 
red blood cells. Surface staining for lymphocytes was done in HBSS (Corning) 
supplemented with 10mM Hepes (Cellgro), 2mM EDTA (Cellgro), and 0.5% FBS 
(Gibco BRL) using α-CD4 (Biolegend), α-CD3 (Biolegend), α-B220 (Biolegend), 
α-CXCR5 (eBioscience), α-PD-1 (Biolegend), α-ICOS (eBioscience), α-GL-7 
(eBioscience), α-Fas (BD Biosciences), α-IgD (Biolegend), for 20 min at 4°C. 
Intra-Cellular Staining For α-ki-67 (eBioscience) intracellular staining, cells were 
first surface stained and then permeabilized and fixed in 100ml of Perm/Fix buffer 
(eBiosciences) at 4°C overnight. Cells were washed twice in Perm/Wash buffer 
(eBioscience). Gating and analysis of positive cell populations was done utilizing 
respective isotype controls for antibodies against ICOS, CXCR5, GL-7 and PD-1. 
Other cell populations were identified using single stain controls. Data were 
collected using a BD LSR Fortessa and analyzed using FLOWJO software.  
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CHAPTER 5 
GUT IMMUNITY REGULATES INTER-MICROBIOTA 






 Over the past century, obesity has developed into a U.S. epidemic. 
Currently, less than one-third of the U.S. population is considered to have a 
healthy normal weight. Obesity, as measured by a body-mass-index (BMI) of 30 
or greater, significantly increases mortality compared to a healthy BMI of less 
than 25 (1). Additionally, obesity is associated with a number of comorbidities 
such as type II diabetes, cardiovascular disease, and liver disease. Heart 
disease alone is the cause of 1 in 4 deaths within the US, highlighting the 
significant impact this disease has on the health and longevity of individuals (2).  
 While it has been previously established that both diet and genetics play a 
role in the development of obesity, it has become more apparent over the past 
decade that an additional factor, the microbiota, also contributes.  Obese 
individuals have a distinct microbiota composition as compared to lean 
individuals (3).  This has functional consequences, as obese microbiota is 
capable of transferring weight gain to germfree mice, demonstrating its ability to 
induce obesity in addition to diet and genetics (4). While researchers have 
gained insight into which microbes are associated with lean or obese body mass, 
it has been difficult to identify the mechanisms by which these shifts within the 
microbiota occur. Diet has been demonstrated to have a significant influence on 
microbiota composition, however, host genetics also shape the microbiota 
architecture (5). One major biological pathway responsible for sculpting 
commensals within the gut is the secretion of immunoglobulin A (IgA) (6-9). IgA 




mucosal surfaces to modulate community membership and antigen expression 
within the microbiota as well we maintain a healthy barrier between the 
commensals and host tissue (7, 10). 
 IgA production is driven by both T cell-dependent and T cell–independent 
mechanisms. We recently revealed a requirement for MyD88 signaling within T 
cells to direct proper IgA targeting of the microbiota via follicular T helper (Tfh) 
cells development and germinal center responses along the gut (7). Animals 
lacking MyD88 within T cells developed dysbiosis, or harmful shifts within the 
microbiota, that predisposed them to increased susceptibility to colitis. We have 
since uncovered a requirement for this pathway in the prevention of dysbiosis-
induced obesity. Disruptions to IgA targeting of commensals within mice lacking 
MyD88 signaling in T cells, lead to the development of obesity as mice age. 
Shifts within the microbiota prior to weight gain are capable of transferring the 
disease to otherwise healthy animals. These shifts include expansion of the 
pathobiont, Desulfovibrio, and widespread loss of species and functional diversity. 
Reintroduction of beneficial spore-forming microbes associated with a lean 
phenotype are able to rescue weight gain in predisposed animals. Finally, the 
initial defect in T cell-dependent IgA is responsible for initiating dysbiosis and 
weight gain, providing us with valuable insight into host dependent mechanisms 








Loss of MyD88 signaling within T cells results in the spontaneous  
development of obesity 
The microbiota is a rich and constant source of microbial ligands that can 
be recognized by Toll-like receptors (TLRs).  These microbial products are not 
only found within the gut, but have also been shown to be circulating within the 
blood. As T cells are known to express TLRs, this represents a mechanism by 
which microbial products can directly influence T cell responses. Most TLRs, with 
the exception of TLR3, signal through the adaptor molecule MyD88; therefore, 
we crossed an MyD88 floxed animal to a CD4-Cre driver to make T-MyD88-/- 
mice in order to study how T cells might be influenced by MyD88 dependent 
signals (7). Deletion of MyD88 in the T cell compartment leads to local reductions 
in TFH development within the gut, and we have subsequently demonstrated that 
this pathway functions to control the microbiota by directing IgA binding (7, 11). 
While conducting this previous study, we noted that as animals aged they gained 
significantly more weight when compared to age and sex matched wild-type 
animals (Figure 5.1A). Despite being fed a standard diet, T-MyD88-/- mice exhibit 
significantly increased weight gain by 6 months of age that is characterized by 
increased fat accumulation (Figure 5.1A-C and Figure S5.1A and S5.1B). By one 
year of age, male T-MyD88-/- mice weigh as much as sixty grams and are 
composed of, on average, fifty percent fat based on NMR analysis (Figure 5.1D 
and 5.1E).  In addition to weight gain, there are a number of comorbidities that 





Figure 5.1: Mice lacking MyD88 signaling within T cells develop obesity.  
A) Side by side image of 6-month WT and T-MyD88-/- mice. B) Percentage of 
weight gained as mice age, starting at 2 months of age (WT, N=8; T-MyD88-/-, 
N=7). C) Grams of fat accumulation as mice, age starting at 2 months of age (WT, 
N=8; T-MyD88-/-, N=7). D) Total weight in grams of one year old WT and T-
MyD88-/- mice (N=6). E) Total fat percentage as measured by NMR of one year 
old WT and T-MyD88-/- mice (N=6). F) Fasting serum insulin (ng/mL) 
concentrations within 1 year old WT and T-MyD88-/- mice (WT, N=9; T-MyD88-/-, 
N=10). G) Blood levels of glucose (milligram per decaliter) measured over time 
following i.p. insulin (0.75U/kg) injection during insulin resistance test. H) 
Representative image of H&E histology of the liver from one year old WT and T-
MyD88-/- mice.  
I) Representative image of H&E histology of adipose tissue from one year old WT 
and T-MyD88-/- mice. Statistics: P-value<0.05 (*); P-value<0.01 (**); P-
value<0.001 (***) using a two-tailed, unpaired t-test (B-F) and a repeated 
measures ANOVA (G). 






































































































While one-year-old T-MyD88-/- mice raised on a standard diet cleared glucose to 
similar levels as their WT counterparts (Figure S5.1C), these mice have 
significantly higher levels of circulating insulin (Figure 5.1F). Moreover, when 
animals are challenged with additional insulin, T-MyD88-/- fail to clear glucose 
with similar kinetics as WT animals, indicating that these animals also develop 
insulin resistance (Figure 5.1G).  Histological analysis of T-Myd88-/- liver tissue 
by hematoxylin and eosin (H&E) staining revealed the presence of steatosis, or 
fat deposition, that is not seen in WT animals (Figure 5.1H). Moreover, while 
visceral adipocytes are uniform in size and shape in WT mice, adipocytes within 
T-MyD88-/- animals are much larger and irregular in shape. In addition to this, we 
detected macrophage infiltration and prominent formation of “crown-like” 
structures, a hallmark of obesity, in the visceral adipose tissue (VAT) of T-
MyD88-/- animals but not in WT animals. (Figure 5.1I). Compared to WT animals, 
T-MyD88-/- mice have a number of metabolic shifts that contribute to their age-
dependent obesity. These include reductions in oxygen and carbon dioxide 
respiration that result in reduced energy expenditure by two months of age, as 
well as increases in food intake that occur at the onset of spontaneous weight 
gain (Figure S5.1D-G). Other factors such as heat and movement, however, are 
not altered in these mice (Figure S5.1H-S5.1I). Collectively, these data 
demonstrate the requirement for intact innate signaling within T cells to prevent 
the onset of metabolic syndrome Obesity takes months to develop on a standard 
mouse diet in this model, making it difficult to tease apart the mechanisms for 
increased weight gain. Therefore, we tested whether placing animals on a high-
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fat diet (HFD) would accelerate the phenotype. WT and T-MyD88-/- mice were fed 
a control diet containing 10% of the calories made from fat or a HFD containing 
45% of calories made from fat for 4 months. As has been reported, mice 
receiving HFD gained more weight than the control fed animals, however, T-
MyD88-/- mice fed HFD gained significantly more weight than WT animals (Figure 
S5.1J and S5.1K). Thus, similar trends were observed in HFD and aged animals, 
and obesity in T-MyD88-/- mice is independent of the type of diet. 
Host immune responses are dysregulated within adipose 
tissue of T-MyD88-/- mice 
Given that we have observed deficiencies in the immune response within 
the intestine of animals lacking T cell intrinsic MyD88 signaling, and inflammation 
is a known contributor to obesity and metabolic syndrome, we interrogated the 
immune cell populations within adipose tissue. Under lean conditions, regulatory 
T cells (Tregs) are maintained in high frequency within adipose tissue (12, 13). 
However, as obesity develops, the immune system shifts towards an 
inflammatory response that can exacerbate fat accumulation. Consistent with a 
shift in adipose specific immune responses, T-MyD88-/- mice have significantly 
fewer Tregs within adipose tissue on either diet (Figure 5.2A-C and Figure 
S5.2A-B). During obesity, increased adipocyte cell death leads to the recruitment 
of macrophage populations that surround dead adipocytes and promote 
inflammatory immune responses (14). We also observe an increase in 





Figure 5.2: Obese T-MyD88-/- mice have greater inflammation within adipose 
tissue. A) Representative flow cytometry plots were previously gated on 
CD3+CD4+ T cells within adipose tissue and measured for Tregs, defined as 
CD3+CD4+FoxP3+ cells. B) Percentage of Tregs within adipose tissue. C) Total 
number of Tregs within adipose tissue (WT, N=12; T-MyD88-/-, N=10). D) 
Representative flow cytometry plots were previously gated on CD45+ cells within 
adipose tissue and measured for macrophages, defined as 
CD45+CD11b+F4/80+ cells. E) Percentages of macrophages within adipose 
tissue. F) Total numbers of macrophages within adipose tissue (WT, N=12; T-
MyD88-/-, N=10). G) qPCR of mRNA expression of various T cell and myeloid 
cell immune parameters for 6-month and 12-month-old mice (6 month: WT, N=3; 
T-MyD88-/-, N=4; 12 months: WT, N=8; T-MyD88-/-, N=7). H) Percentage of 
weight gained by WT and T-MyD88-/- mice fed control diet or 5-ASA diet, starting 
at 2 months of age (WT CTRL, N=3; WT 5-ASA, N=4; T-MYD CTRL, N=3; TMYD 
5-ASA, N=4). Statistics: P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) 
using a two-tailed, unpaired t-test (A-G) and a repeated measures ANOVA (H). 




















































































































































WT animals in both frequency and total number of macrophages on normal chow 
but not HFD (Figure 5.2D-F, Figure S5.2C-D). As a number of MyD88 dependent 
cytokines, including IL-33, have been implicated in the development of metabolic 
syndrome, we isolated mRNA from VAT to analyze a number of T cell and 
myeloid cell markers.  T-MyD88-/- mice that were either aged or fed a HFD had 
significant shifts within a number of immune genes when compared to their 
respective controls. These included elevations in the TH1 genes, Tbet and IFN-g, 
and reductions in Foxp3 and Gata3 (Figure 5.2G and Figure S5.2E). Changes in 
gene expression within the adipose tissue were subtle in aged T-MyD88-/- 
animals when compared to WT animals, however HFD appeared to exacerbate 
some of these differences (Figure S5.2E).  
As many of the shifts observed within immune parameters revealed 
enhanced inflammation, and chronic low grade inflammation is thought to 
influence weight gain, we placed WT or T-MyD88-/- mice on a normal chow diet 
containing 5-ASA, an anti-inflammatory derivative of salicylic acid that has been 
demonstrated to reduce complications of obesity in mice fed HFD (15). We then 
monitored age-dependent weight gain over 8 months.  Treatment of T-MyD88-/- 
mice with 5-ASA did not significantly ameliorate enhanced weight gain, 
suggesting that chronic low grade inflammation is likely not involved in the 
development of spontaneous obesity within T-MyD88-/- mice (Figure 5.2H). 
Collectively, these data suggest that shifts within the host immune system alone 
were not the main cause of the metabolic syndrome and obesity that develops in 
these mice.  
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T cell intrinsic MyD88 signaling supports microbiota diversity and 
colonization of beneficial Clostridia 
We have previously reported that defective IgA targeting of the microbiota 
in T-MyD88-/- animals lead to shifts in microbial composition that exacerbated 
chemically induced models of intestinal colitis (7). Worsened disease is rescued 
by a microbial transplant from a healthy donor, indicating that the absence of the 
T cell intrinsic signaling lead to shifts in the microbiota that might be associated 
with disease.  To identify whether the composition of the microbiota in T-MyD88-/-
mice was driving obesity, we placed WT and T-MyD88-/- mice on a broad 
spectrum antibiotic cocktail while on HFD. While WT mice exhibit no difference in 
weight gain while on antibiotics, obesity is almost completely rescued by 
antibiotic treatment of T-MyD88-/- (Figure 5.3A). This was accompanied by a 
reduction in body fat percentage and VAT mass that was similar to the fat 
accumulation observed in WT animals (Figure 5.3B and Figure S5.3A). Notably, 
antibiotic treatment did not influence the Treg populations within T-MyD88-/-
adipose tissue (Figure S5.3B). Collectively these data demonstrate that 
alterations within the microbiota of T-MyD88-/- mice promote obesity independent 
of adipose Treg function.  
Sequencing of 16s rRNA from fecal samples isolated from one-year-old 
WT or T-MyD88-/- mice was performed to determine compositional differences in 
the microbiota between these two genotypes.  In agreement with our previous 
study with young mice, microbial communities between WT and T-MyD88-/- mice 
are significantly different between each other (Figure S5.3C). In addition to this,  
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Figure 5.3: Dysbiosis within T-MyD88-/- mice is associated with spontaneous 
weight gain. A) Grams of weight gained by WT and T-MyD88-/- mice fed HFD 
with or without antibiotics. B) Total fat percentage as measured by NMR of WT 
and T-MyD88-/- mice fed HFD with or without antibiotics (WT CTRL, N=5; TMYD 
CTRL, N=4; WT ABX, N=5, TMYD ABX, N=5). C)  a-diversity measured by 
observed species within ileal and fecal 16s sequencing samples from one year 
old WT and T-MyD88-/- mice (WT, N=8; T-MyD88-/-, N=7). D) Volcano plot of 
ratio of T-MyD88-/- bacterial transcripts to WT transcripts within Ileal samples 
from one year old WT and T-MyD88-/- mice. E) Volcano plot of ratio of T-MyD88-
/- bacterial transcripts to WT transcripts within fecal samples from one year old 
WT and T-MyD88-/- mice. F) Heat map of biological pathways within fecal 
bacterial between one year old WT and T-MyD88-/- mice (N=6 per genotype). G) 
Parts of whole pie chart of bacterial classes within fecal 16s sequencing samples 
of one year old WT and T-MyD88-/- mice. H) Genus level comparison of 
Turicibacter relative abundance within fecal 16s sequencing samples of one year 
old WT and T-MyD88-/- mice. I) Genus level comparison of SMB53 relative 
abundance within fecal 16s sequencing samples of one year old WT and T-
MyD88-/- mice. J) Genus level comparison of Dorea relative abundance within 
fecal 16s sequencing samples of one year old WT and T-MyD88-/- mice (WT, 
N=8; T-MyD88-/-, N=7). Statistics: P-value<0.05 (*); P-value<0.01 (**); P-
value<0.001 (***) using a repeated measures ANOVA (A), two-tailed, unpaired t-
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we identified significant reductions in observed species within fecal, but not ileal 
populations in T-MyD88-/- mice, demonstrating that microbial diversity is lost in T-
MyD88-/- animals (Figure 5.3C). Reduced diversity is correlated to a number of 
western-lifestyle associated diseases, including inflammatory bowel disease, 
asthma, and obesity (16-19). Indeed, individuals that contain a microbiota with 
lower gene richness are more likely to be obese and more likely to gain weight 
over time (18). One mechanism that genetic diversity influences host metabolism 
is by altering the network of microbial derived metabolites that are absorbed 
within the small and large intestine. Therefore, to understand how loss of T cell 
intrinsic signaling might functionally impact the microbiota, we compared the 
transcriptomes of ileal and fecal microbiota populations between WT and T-
MyD88-/- animals. The vast majority of transcripts were found to be reduced 
within both niches of T-MyD88-/- mice (Figure 5.3D and 5.3E). These included 
wide spread reductions within biological pathways such as glucose metabolism, 
amino acid synthesis, and fatty acid synthesis (Figure 5.3F and Figure S5.3D) 
Loss of functional diversity in the fecal metatranscriptome was consistent with 
reduced diversity identified by 16s sequencing (Figure 5.3C and 5.3E). However, 
the reduced diversity in T-MyD88-/- ileal transcripts were independent of any 
reductions in species diversity detected by 16s sequencing at this site, potentially 
highlighting a key difference between measuring the composition and metabolic 
landscape of the microbiota (Figure 5.3C and 5.3D).  
These data indicate that there is a loss of species and functional diversity 




explain the major differences between WT and T-MyD88-/- microbiota 
communities, we analyzed our 16s sequencing results using LEfSe, a method 
which factors both effect size and statistical significance (20). LEfSe revealed 
that this loss of diversity was mainly restricted to the Firmicutes phylum and, 
more specifically, reductions in Clostridia (Figure 5.3G and Figure S5.3E). In 
agreement with this, 16s sequencing detected significant reductions within the 
bacterial families, Turicibacteraceae, Clostridiaceae, Lachnospiraceae, and 
Peptostreptococcaceae within T-MyD88-/- fecal samples (Figure S5.3F-I). The 
reductions within the first three were driven primarily by the genera Turicibacter, 
SMB53, and Dorea, respectively (Figure 5.3H-J). When we correlated the 
abundance of these microbes with total weights of both WT and T-MyD88-/- mice, 
we found that each exhibited a highly significant negative correlation with weight 
gain, supporting that loss of these organisms might influence obesity.  In addition 
to 16s sequencing, Transcriptomic analysis provided additional resolution to 
identify a number of Clostridia species that were reduced within mice lacking 
MyD88 signaling in T cells (Figure S5.3J-K). When combined, these two 
analyses uncovered loss of both species and functional diversity as well as 
specific reductions within beneficial microbes associated with leanness.  
 
T cell-dependent reductions in Clostridiaceae are associated 
with metabolic syndrome 
Our data indicate that the microbiota formed within the absence of T cell 




whether the microbiota is sufficient to cause disease in WT animals we 
conducted fecal transplants by oral gavage from either WT or T-MyD88-/- animals 
into two different backgrounds (Swiss Webster and C57Bl/6) of germfree WT 
mice. Additionally, we performed a cross-fostering experiment in which either 
SPF WT or T-MyD88-/- pregnant dams were cohoused with germfree WT 
pregnant dams and the resulting colonized pups were separated at weaning and 
measured for weight gain. However, none of these methods were able to transfer 
the obesity phenotype of T-MyD88-/- to WT animals (Figure S5.4A). Due to the 
resistance of germfree animals to this dysbiosis-induced obesity, we considered 
that intact T cell-dependent IgA within WT animals was capable of reshaping the 
microbiota to a healthy state.  IgA sculpting of the microbiota is initiated by T cell-
dependent and T cell-independent pathways, and we previously discovered a 
defect within the former pathway when T cells lacked MyD88 signaling (7). We 
sought to quantify how MyD88-dependent T cell shaping of the microbiota 
influenced the development of spontaneous weight gain. To achieve this, we 
purchased TCRb-/- mice from Jackson laboratories and reduced the colonizing 
microbiota with broad spectrum antibiotic treatment. Animals were subsequently 
colonized with a 1:1 mixture of WT and T-MyD88-/- microbiota prior to adoptive 
transfer of either WT or T-MyD88-/- CD4+ T cells (Figure 5.4A). Mice were 
separated into individually housed cages and monitored weekly for weight gain 
and compositional changes to the microbiota. Despite the fact that these mice 
were initially colonized with the same microbiota, TCRb-/- - mice given T-MyD88-/- 
CD4+ T cells gained significantly more weight when compared to TCRb-/- mice  
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Figure 5.4: T cell shaping of the microbiota is associated with spontaneous 
weight gain. A) Schematic of T cell shaping of the microbiota experiment. B) 
Percent weight gained by TCRKO mice given WT or T-MyD88-/- cells and fed a 
normal chow for 8 weeks (N=6 per cohort). C) Representative flow cytometry plot 
was previously gaited on SyBRGreen+ cells in order to quantify the percentage 
of IgA bound bacteria within TCRKO mice given WT or T-MyD88-/- cells and fed 
a normal chow for 8 weeks. D) Representative flow cytometry plot was previously 
gaited on SyBRGreen+ cells in order to quantify the percentage of IgG1 bound 
bacteria within TCRKO mice given WT or T-MyD88-/- cells and fed a normal 
chow for 8 weeks. E) Box and whisker plot of Unweighted Unifrac Distance 
between TCRKO mice given WT and T-MYD88-/- over time. F) Box and whisker 
plot of Weighted Unifrac Distance between TCRKO mice given WT and T-
MYD88-/- over time. G) Relative abundance of Clostridiaceae within fecal 
samples from TCRKO mice given WT and T-MYD88 after 4 weeks. Statistics: P-
value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) using a two-tailed, 
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given WT CD4+ T cells (Figure 5.4B), demonstrating that defects in MyD88 
signaling within T cells drives the metabolic defects in animals. Additionally, 
consistent with our previous study, IgA targeting of the microbiota was defective 
when analyzed by flow cytometry. Only 10% of IgA coated bacteria are detected 
within TCRb-/- mice. However, one week post-T cell transfer, mice given WT T 
cells have a 3-fold increase in IgA bound microbes (Figure S5.4B). IgG1 or IgG3 
responses against the microbiota took a bit longer to develop but were detectable 
eight weeks post T cell transfer (Figure S5.4C-D).  While TCRb-/-  animals 
receiving WT or T-MyD88-/- T cells had similar levels of total IgA as measured by 
ELISA, TCRb-/- mice given T-MyD88-/- T cells bound significantly fewer bacteria 
with IgA (Figure 5.4C and Figure S5.4B and S5.4E). IgG1-bound bacteria was 
also significantly reduced, however, we did not detect differences of IgG3-bound 
bacteria between mice receiving WT or T-MyD88-/- T cells (Figure 5.4D and 
Figure S5.4D and S5.4F).   
We analyzed the contribution of T cell intrinsic MyD88 signaling during T 
cell-dependent shaping of the microbiota. Over time, the microbiota composition 
of TCRb-/- mice given WT or T-MyD88-/- T cells became significantly dissimilar, 
as measured by both weighted and unweighted unifrac analysis (Figure 5.4E-F), 
demonstrating the influence of T cell-directed antibody targeting on the 
microbiota. One of the most striking differences in microbial composition between 
one-year-old WT and T-MyD88-/- animals is loss of Clostridia species; and, 
despite the fact that the mice within this experiment started with the same 
microbiota composition, animals receiving T cells from T-MyD88-/-  had 
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significantly fewer Clostridaceae after 4 weeks when compared to animals 
receiving WT T cells (Figure 5.4G). While both sets of animals begin with 
relatively low levels of Clostridiaceae at Day 0, the Clostridiaceae were only able 
to expand in animals given WT T cells (Figure S5.4G). Collectively, these data 
demonstrate that metabolic disease is a result of a failure in the immune system 
to maintain appropriate microbial composition. These data support that metabolic 
syndrome and obesity is a combination of host genetics and environment.  
Obesity and metabolic syndrome in the absence of innate signaling 
within T cells is transmissible 
Our results argue that loss of critical organisms within the Clostridaceae 
might play a role during disease. Therefore, we sought to determine whether we 
could rescue metabolic syndrome in T-MyD88-/- animals with a microbiota 
transplant from a healthy donor. Our adoptive transfer experiments suggest that 
the microbiota might be inappropriately pruned if we transplanted mircrobiota 
only once by oral gavage. Since mice are copraphagic, we reasoned that a co-
housing experiment would allow efficient and frequent transfer of microbes 
between genotypes. To this end, WT or T-MyD88-/- animals were either housed 
together with animals of the same genotype or co-housed with animals of the 
opposite genotype upon weaning. After 1 week of cohousing animals were 
placed on a HFD and monitored for signs of fat accumulation (Figure 5.5A and  
Figure S5.5A). The results of these experiments were quite striking; however, 
they were opposite of what we hypothesized.  Indeed, compared to separated 
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Figure 5.5: Dysbiosis within T-MyD88-/- mice transfers obesity to WT animals. 
A) Schematic of timeline and samples collection for cohousing experiment. B)
Percent weight gained by separated or cohoused WT and T-MyD88-/- mice fed a
HFD (N=4 per cohort). C) Blood levels of glucose (milligram per decaliter)
measured over time following i.p. insulin (0.75U/kg) injection during insulin
resistance test. D) Total fat percentage as measured by NMR of separated or
cohoused WT and T-MyD88-/- mice fed a HFD. E) Grams of VAT from separated
or cohoused WT and T-MyD88-/- mice fed a HFD. F) b-diversity measured by
unweighted unifrac analysis of separated or cohoused WT and T-MyD88-/- mice
fed a normal chow both prior to cohousing and one week following cohousing. G)
b-diversity measured by unweighted unifrac analysis of separated or cohoused
WT and T-MyD88-/- mice at final timepoint following HFD (N=4 for each cohort).
Statistics: P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) using a
repeated measures ANOVA (B), two-tailed, unpaired t-test (C-E), and permanova
(F, G).
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WT mice, T-MyD88-/- mice and any animal cohoused with them gained 
significantly more weight and developed insulin resistance (Figure 5.5B-C). 
Following three months, T-MyD88-/- mice and their cohoused counterparts 
weighed significantly more, had greater body fat percentages, and contained 
significantly more VAT than separated WT animals (Figure 5.5D-E and Figure 
S5.5B). This was once again independent of Treg populations within adipose 
tissue, however, the transferred obesity phenotype was accompanied with an 
increase in a number of other inflammatory markers (Figure S5.5C-D).  
We also monitored the composition of the microbiota over the course of 
the cohousing experiment. Prior to cohousing, T-MyD88-/- mice had a distinct 
microbiota composition, which is consistent with our previous results (Figure 
5.5F). Cohousing for just one week, caused homogenous mixing of the two WT 
and T-MyD88-/- communities (Figure 5.5F). Following three months, however, the 
microbiota from cohoused animals became significantly distinct from separately 
housed WT mice and looked similar to separately housed T-MyD88-/- microbiota 
(Figure 5.5G). These data demonstrate that the microbiota formed in a T-MyD88-
/- animal can transfer metabolic syndrom to an otherwise healthy WT animal and 
suggest that the immune environment within a T-MyD88-/- animal is conducive to 
the growth of aggressive and potentially harmful organisms. 
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Expansion of Desulfovibrio within T-MyD88-/- mice leads to a loss of 
beneficial microbes that promote leanness 
To identify organisms that were transferred from T-MyD88-/- animals into 
WT hosts, we compared the microbiota composition between separately and 
cohoused analyzed WT and T-MyD88-/- mice.  Differences in weight gain of 
cohoused animals were detected within the first 3 weeks, therefore, we focused 
on candidates that were transferred at both the early and final time points (Figure 
5.5B). After three months of cohousing and HFD, Desulphovibrio, Lactobacillales, 
and Bifidobacterium pseudolongum, were all present at greater abundances 
within T-MyD88-/- and cohoused mice (Figure 5.6A and Figure S5.6A-B). 
However, only Desulfovibrio was significantly more abundant in separately 
housed T-MyD88-/- animals and cohoused animals after just one week of co-
housing (Figure 5.6B). Desulfovibrio are mucolytic d-proteobacteria that produces 
hydrogen sulfide as a byproduct of disulfide bond degradation within mucin (21-
24). Colonization of Desulfovibrio is increased within patients with IBD as well as 
animal models of obesity and diabetes (25-30). Interestingly, it is also elevated in 
human patients with type II diabetes, suggesting that Desulfovibrio is highly 
relevant to human metabolic disease (31). 
We previously demonstrated that defective IgA targeting of the microbiota 
within T-MyD88-/- mice was correlated with an increased abundance of a number 
of mucolytic microbes (7). Using a recently published IgA-index calculation, we 
reanalyzed our previously published IgA sequencing of bound and unbound 
microbes in WT and T-MyD88-/- animals using LEFsE (32). Consistent with our 
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Figure 5.6: Expansion of Desulfovibrio and reductions in beneficial spore-forming 
microbes are associated with obesity. A) Relative abundance of Desulfovibrio 
within fecal 16s sequencing samples from separated or cohoused WT and T-
MyD88-/- mice at the final timepoint. B) Relative abundance of Desulfovibrio 
within fecal 16s sequencing samples from separated or cohoused WT and T-
MyD88-/- mice following one week of cohousing (N=4 per cohort). C) LEFsE 
analysis of IgA-index reanalysis of IgA targeting between WT and T-MyD88-/- 
mice (WT, N=6; T-MyD88-/- N=7). D) Relative abundance of Dorea within fecal 
16s sequencing samples from separated or cohoused WT and T-MyD88-/- mice 
following one week of cohousing (N=4 per cohort). E) Relative abundance of 
Lachnospiraceae within fecal 16s sequencing samples from mice colonized with 
or without D. desulfuricans and fed a HFD (N=5 per cohort). F) Relative 
abundance of Dorea within fecal 16s sequencing samples from mice colonized 
with or without D. desulfuricans and fed a HFD. G) Relative abundance of 
SMB53 within fecal 16s sequencing samples from mice colonized with or without 
D. desulfuricans and fed a normal chow (N=7 per cohort). H) Representative
parts of whole pie chart of bacterial families within fecal 16s sequencing samples
from germfree mice colonized with 3% chloroform treated fecal microbiota. I)
Grams of weight gained by control (CTRL) or spore-forming (SF) microbe
gavaged T-MyD88-/- mice fed HFD (CTRL, N=4; SF, N=5). J) Total fat
percentage as measured by NMR control (CTRL) or spore-forming (SF) microbe
gavaged T-MyD88-/- mice fed HFD. K) Grams of VAT of control of spore-forming
microbe gavaged T-MyD88-/- mice fed HFD. Statistics: P-value<0.05 (*); P-
value<0.01 (**); P-value<0.001 (***) using a Mann-Whitney U test (A-G),
repeated measures ANOVA (I), two-tailed, unpaired t-test (J, K).
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earlier findings, WT and T-MyD88-/- IgA showed differential targeting of 
Mucispirillium schaedleri and Ruminococcus gnavus (Figure 5.6C).  However, 
Lefse analysis of IgA-coated microbes also identified members from the family 
Desulfovibrionaceae that exhibited significantly altered IgA targeting between WT 
and T-MyD88-/- mice, providing a potential mechanism for the expansion of this 
pathobiont (Figure 5.6C).  
Inappropriate expansion of organisms can have a negative impact on the 
niche of beneficial microbes. One of the most significant changes to the 
microbiota that we have identified throughout these experiments is a profound 
loss of abundance and function of organisms that are known to have beneficial 
consequences, including members of Clostridia (Figure 5.3G). Specifically, 
Lachnospiraceae such Dorea and SMB53, are significantly reduced in T-MyD88-/- 
mice, and cohousing of WT mice with T-MyD88-/- animals leads to reduced 
Dorea colonization (Figure 5.3I and 5.3J and Figure 5.6D). Therefore, we 
hypothesized that an increased abundance of Desulfovibrio might cause 
concurrent deficiencies in the colonization of other organisms. To directly test this, 
we colonized mice with an ATCC isolate of Desulfovibrio desulfuricans that 
contained greater than 97% 16s sequence similarity to our commensal. Mice 
were fed a normal chow or HFD for one week with or without the addition of D. 
desulfuricans within their drinking water. Consistent with our hypothesis, WT SPF 
animals fed a HFD had significant reductions in Lachnospiraceae, and 
specifically, Dorea, when they were colonized with D. desulfuricans (Figure 5.6E 
and 5.6F). Similarly, animals fed normal chow had significant decreases in 
111	
SMB53 in the presence of D. desulfuricans (Figure 5.6G). Collectively, these 
data demonstrate that an expansion in Desulfovibrio species, as seen in T-
MyD88-/- mice, can impact the colonization of microbes associated with leaness.   
Obese T-MyD88-/- mice have pronounced reductions in the colonization of 
Turicibacter, Dorea, and SMB53 that have strong negative correlations with fat 
accumulation. We sought to determine whether replacement of organisms 
associated with leaness could reduce fat accumulation.  Turicibacteraceae, 
Lachnospiraceae, Peptostreptococcaceae, and Clostrideaceae are known spore-
formers which can be enriched from the fecal microbiota by chloroform treatment. 
To ensure that this treatment selects for organisms that are specifically depleted 
in the T-MyD88-/- mice, we gavaged germfree animals with chloroform treated 
fecal slurries isolated from WT SPF mice in our colony. Indeed, this purification 
enriched for Clostridiaceae and Lachnospiraceae (Figure 5.6H).  Our cohousing 
and T cell transfer experiments suggest that continuous administration of 
organisms might be required to see an effect. Therefore, we performed twice-
weekly gavages of T-MyD88-/- mice with sporeforming microbes and 
subsequently fed them a HFD. Strikingly, treatment of obesity prone T-MyD88-/- 
animals with a cocktail of spore-forming bacteria significantly reduced weight 
gain and fat accumulation (Figure 5.6I).  At the end of three months, T-MyD88-/- 
mice treated with spore-forming microbes had a lower body fat percentage and a 
reduced VAT mass when compared to untreated T-MyD88-/- mice (Figure 5.6J 
and 5.6K). Together, these data argue that early expansion of Desulfovibrio 
within T-MyD88-/- mice reduces beneficial microbes required to maintain healthy 
112	
weight and prevent metabolic disease. 
Discussion 
Here we have demonstrated a mechanism by which dysbiosis within the 
microbiota, caused by defective T cell-dependent IgA targeting within the gut, 
causes obesity. T-Myd88-/- mice experience an expansion of Desulfovibrio early 
in life which results in reductions in beneficial microbes and widespread losses in 
both species and functional diversity. Weight gain and fat accumulation can be 
prevented in T-MyD88-/- mice through the reintroduction of spore-forming 
microbes. Over the last decade, investigators have identified shifts within the 
microbiota that are concomitant with the development of metabolic syndrome. 
Fecal transfers of obese microbiota to WT germfree mice induce increased 
weight gain when compared to germfree animals given lean microbiota (4). 
Seminal works such as these have demonstrated that the microbiota does 
indeed help to drive obesity, however, much has remained unknown regarding 
which microbes are responsible for this, as well as the mechanism by which the 
obesity-inducing microbiota develops. In recent studies, obesity and type 2 
diabetes have been correlated with decreased diversity, expansion of 
Desulfovibrio, and losses of beneficial spore-forming microbes (18, 31). While 
there is a clear role that connects the microbiota to obesity there is little known 
about the organisms that cause or protect against increased weight gain and 
associated pathologies. Additionally, the impetus of dysbiosis development has 




to define the contribution of host regulation of the microbiota and dysbiosis during 
early development that leads to metabolic syndrome later in life. Furthermore, it 
has highlighted subclinical shifts within the microbiota that may occur prior to 
obesity and can be used as therapeutic targets for the prevention of metabolic 
syndrome.  
The increase of many diseases, including obesity, has coincided with 
shifting social customs linked to the wester-lifestyle, including antibiotics use, 
increased ratio of simple to complex carbohydrate intake, and hyperhygienic 
practices (33). These alterations to our behavior and environment have lasting 
effects on our microbiota (34-36). Despite this rise, however, many individuals 
experience no clinical consequences to a westernized lifestyle. Given these 
discrepancies, it is accepted within the scientific community that environmental 
and genetic factors likely interact to promote or protect against these complex 
diseases. Directed IgA targeting of the microbiota may be one mechanism by 
which host immune responses predispose individuals to a greater susceptibility 
toward disease onset. In agreement with this notion, studies have revealed that 
roughly 1 in 600 people is IgA-deficient, making it the most common primary 
immunodeficiency (37). As many as 30-50% of these individuals experience 
recurrent mucosal infections or develop autoimmune diseases (38, 39). This is a 
dramatic increase in disease susceptibility over individuals with healthy levels of 
IgA. Despite these statistics, many individuals are never diagnosed with IgA-
deficiency, and, therefore, additional screening for this disorder might reveal new 
links between IgA deficiency and westernized lifestyle-linked diseases. Studies 
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such as this provide unique opportunities to understand intricacies of immune 
development while gaining insight into the impact of specific commensals on the 
metabolic and compositional landscape of the microbiota. While the microbiota 
as a whole has evolved a vast network of species and redundant metabolic 
functions, identifying the underlying mechanisms of disease associated 
perturbations reveals keystone interactions that are necessary to push the 
balances in favor of health. 
Experimental Procedures 
Mice 
C57Bl/6 MyD88LoxP/LoxP mice (Jackson Laboratories) were crossed to 
C57Bl/6 CD4-Cre animals (Taconic) to produce MyD88+/+ CD4-Cre+ mice (WT) 
and MyD88LoxP/LoxPCD4-Cre+ (T-MyD88-/-) animals. C57Bl/6 MyD88LoxP/LoxP mice 
(Jackson Laboratories) were crossed to C57Bl/6 FoxP3-EGFP-cre+ (Jackson 
Laboratories) animals to produce MyD88+/+-FoxP3-cre+ (FoxP3-cre+) mice, 
MyD88-LoxP/LoxP (MyD88fl/fl) mice, and MyD88loxp/loxp FoxP3-cre+ (Treg-
MyD88-/-) mice. Age-matched male mice were used to compare the 
spontaneous weight phenotype, including immune and microbiota response, on 
standard diet. Age-matched male and female mice were used to compare the 
weight phenotype, including immune and microbiota response, on high-fat diet 
(HFD).  To measure T cell-dependent shaping of the microbiota, 4-week old 
TCRb-/- mice (Jackson Laboratories) were purchased. Desulfovibrio 




(Jackson Laboratories) were purchased or age-matched CD4-Cre+ (WT) mice 
from our facility were used. GF mice were maintained in sterile isolators and 
verified monthly for GF status by plating and PCR of feces. GF C57Bl/6 animals 
were used in this study. The use of animals in all experiments was in strict 
adherence to federal regulations as well as the guidelines for animal use set forth 
by the University of Utah Institutional Animal Care and Use Committee. 
 
Colonization of mice with spore-forming microbes 
 Fecal pellets were taken from WT mice and incubated in reduced PBS 
containing 3% chloroform (v/v) for 1 hr at 37°C in an anaerobic chamber. A 
control tube containing just reduced PBS and 3% chloroform was also incubated 
for 1 hr at 37°C in an anaerobic chamber. After incubation, tubes were gently 
mixed and fecal material was allowed to settle for 10 sec. Supernatant was 
transferred to a fresh tube and chloroform was removed by forcing CO2 gas into 
the tube. Mice within the SF cohort were orally gavaged with 100µL of spore 
forming fecal fraction. Mice within the CTRL cohort were orally gavaged with 
100µL of PBS control that also had chloroform removed. 
 
Adipose immune cell isolation 
 Reproductive fat pads were dissected from animals and weighed prior to 
immune cell isolations. Fat tissue was placed in ice-cold, sterile 1X HBSS and 
mechanically homogenized by repeated suction through a 1 mL syringe. 
Homogenized fat tissue was incubated in a solution containing sterile 1X HBSS 
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containing 5% (v/v) fetal bovine serum (GIBCO BRL), 50 U/ml Dispase (Roche), 
0.5 milligram per milliliter Collagenase D (Roche), and 0.5 milligram per milliliter 
DNaseI (Sigma) for 30 min at 37°C on a shaker. The supernatant was filtered 
over a 40 mm cell strainer into ice-cold, sterile 1X HBSS. Cells were pelleted by 
spinning at 1000g at 4°C for 10 min. The pellet was treated with 1X RBC Lysis 
Buffer (Biolegend) to lyse and remove red blood cells. Remaining cells were 
washed and resuspended with HBSS (10 mM HEPES [Cellgro], 2 mM EDTA 
[Cellgro], and 0.5% [v/v] fetal bovine serum [GIBCO]) and prepared for flow 
cytometry analysis.  
Diet treatment 
Animals housed within the SPF facility were fed a standard chow of 
irradiated 2920x (Envigo). Mice were fed a high-fat diet of 45% kcal% fat DIO 
mouse feed (Research Diets) or a diet of 10% kcal% fat DIO mouse feed 
(Research Diets) as a control during HFD experiments. Mice were also fed a 
custom diet containing irradiated standard 2020 chow containing 1% 5-ASA 
(Envigo) or a control diet lacking the 5-ASA (Envigo) during 5-ASA inflammation 
experiments.  
Antibiotics treatment 
WT and T-MyD88-/- mice were maintained on 0.5 milligram per milliliter of 
ampicillin (Fisher Scientific), neomycin (Fisher Scientific), erythromycin (Fisher 




while being fed a HFD in order to determine the relative contribution of the 
microbiota to the weight gain phenotype. TCRb-/- mice were placed on 0.5 
milligram per milliliter of ampicillin (Fisher Scientific), neomycin (Fisher Scientific), 
erythromycin (Fisher Scientific), and gentamicin (GoldBio) within their drinking 
water for 1 week to reduce the endogenous microbiota before being recolonized 
by fecal transfers. 
 
T cell shaping of the microbiota within tcrb-/- mice 
 Three separate cages of 4 TCRb-/- mice were placed on an antibiotic 
cocktail within their drinking water for one week. Antibiotics was removed for 
twenty-four hr before any further treatment. One fecal pellet from a WT donor 
and 1 fecal pellet from a T-MyD88-/- donor was mashed in reduced PBS 
containing 0.1% cysteine and immediately orally gavaged into the TCRb-/- mice. 
This oral gavage was repeated every other day for one week. Forty-eight hr 
following the final gavage, mice were placed into individually housed cages and 
retro-orbitally injected with 5x106 CD4+ MACS-enriched WT or T-MyD88-/- cells. 
This was labeled as D0.  
 
Glucose tolerance test 
 Mice were fasted for 6 hr prior to being challenged with glucose. Fasting 
levels of glucose were detected using a Contour Glucose Meter (Bayer) and 
Contour Glucose Strips (Bayer). One milligram per gram of body weight of 
glucose was injected intraperitoneally (i.p.) into animals at timepoint zero. Blood 
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levels of glucose were measured at 5,15,30,60, and 120-min time points using 
the glucose meter.  
Insulin resistance test 
Mice were fasted for 6 hr prior to being challenged with glucose. Fasting 
levels of glucose were detected using a Contour Glucose Meter (Bayer) and 
Contour Glucose Strips (Bayer). 0.75U/kg of body weight of insulin was injected 
intraperitoneally into animals at timepoint zero. Blood levels of glucose were 
measured at 5, 10,15, 20, 25, 30, 40, and 60-min time points using the glucose 
meter and strips. Animals were removed from the experiment following an 150µL 
i.p. injection of 25% glucose if blood glucose levels dropped to 30milligram per
decaliter. 
Flow cytometry of isolated immune cells 
Surface staining for immune cells was done in sterile 1XHBSS (Corning) 
supplemented with 10mMHEPES (Cellgro), 2mMEDTA (Cellgro), and 0.5% (v/v) 
fetal bovine serum (GIBCO BRL) for 20 min at 4°C. Cells were then washed 
twice in supplemented 1X HBSS and enumerated via flow cytometry. The 
following antibodies were used: anti-CD4 (eBioscience clone RM4-5 PerCP-
Cy5.5), anti-CD3 (Tonbo bio: 145-2C11 Pacific Blue), anti-CD45 (eBioscience 
clone 30-F11 Fitc), anti-F4/80 (Biolegend clone BM8 PE-Cy7), anti-CD11b 
(Tonbo bio clone M1/70 PerCP-Cy5.5). For intracellular staining, permeabilized 




washed twice in Perm/Wash buffer (eBioscience) and then stained for 
intracellular cytokines with the following antibodies: anti-Foxp3 (eBioscience: 
clone FJK-16 s APC). Cells were again washed twice in Perm/Wash buffer and 
then placed with supplemented HBSS (10 mM HEPES [Cellgro], 2 mM EDTA 
[Cellgro], and 0.5% [v/v] fetal bovine serum [GIBCO BRL]) and enumerated via 
flow cytometry. These data were collected with a BD LSR Fortessa and analyzed 
with FlowJo software. 
 
RNA isolation and qPCR 
 Sections of tissue 0.5 cm in length or 1X105 cells were stored at -70°C in 
700µL of RiboZol  (VWR). RNA was isolated using the Direct-zol RNA MiniPrep 
Kit (Zymoresearch). cDNA was synthesized using qScript cDNA synthesis kit 
(Quanta Biosciences). qPCR was conducted using LightCycler 480 SYBR Green 
I Master (Roche). qPCR experiments were conducted on a Lightcycler LC480 
instrument (Roche).  
 
Quantification of immunoglobulins within feces 
 To quantify luminal IgA, fecal pellets were collected in 1.5mL Eppendorf 
tubes and weighed. Luminal contents were resuspended in 10µL of sterile 1X 
HBSS per milligram of fecal weight and spun at 100 x g for 5 min to remove 
course materials. Supernatants were then placed in a new 1.5mL Eppendorf tube 
and spun at 8000 x g for 5 min to pellet bacteria.  
 Supernatants (containing IgA) were then placed in a new 1.5mL 
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Eppendorf tube and used as samples (1/10 and 1/100 (v/v) dilutions) for an IgA 
specific ELISA kit (eBioscience; performed per kit instructions). Absorbance was 
read at 450nm and concentrations of IgA were calculated with a standard curve. 
Concentrations were normalized to fecal weight.  
Bacterial pellet was resuspended in 500µL of sterile PBS and washed 
twice by spinning at 8000g for 5 min. The washed bacterial pellet was then 
resuspended in 10µL of sterile PBS per milligram of feces. 5µL of each sample 
were plated on to a 96 well, round-bottom plate. Bacteria was blocked for 15 min 
at room temperature with 100µL of sterile HBSS containing 10% (v/v) FBS. 
Without washing cells, 100µL of anti-IgA (ebioscience clone mA-6E1 PE), anti-
IgG1(Santacruz CruzFluor555), or anti-IgG3 (Santacruz CruzFluor555) diluted at 
1:500 sterile HBSS containing 10% (v/v) FBS was added to the wells. Wells were 
incubated at 4°C for 30 min. The plate was washed twice by spinning at 2500g 
for 5 min before flicking off supernatanant and resuspending cells in sterile HBSS. 
After final wash, bacterial wells were resuspended in 250µL of HBSS containing 
5µL of 1x SYBRgreen stain (Invitrogen cat #S7563). Wells were incubated for 20 
min at 4°C before immediate enumeration on a flow cytometer. Rag1-/- fecal 
pellets were included in all experiments as negative controls. 
FACS purified Treg and non-Treg for validation of 
Treg-MyD88-/- mouse 
Lymphocytes were isolated from MyD88+/+ FoxP3-EGFP-cre+ or 
MyD88loxp/loxp FoxP3-EGFP-cre+ mouse spleens and the resulting cells were 
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sorted through MACS columns by negative selection (CD4+ T Cell Isolation Kit II 
(Miltenyi)). Lymphocyte enrichment was performed per kit instructions. Isolated T 
cells were further purified via FACS with a BD FACSAria Cell Sorter. For Tregs, 
CD3+CD4+ FoxP3-EGFP-cre+ cells were gated on and sorted. For non-Treg T 
cells, CD3+CD4+ FoxP3-EGFP-cre were gated on and sorted. Cells collected 
into RPMI media (Corning) supplemented with 10% fetal bovine serum (v/v) 
(Gibco BRL), 50 U/mLpenicillin, 50 μg/mL streptomycin (Cellgro), 5μM 2-
Mercaptoethanol (CalBiochem), 1μMsodium pyruvate (Cellgro), 1X MEM 
Nonessential Amino Acids (Cellgro), and 2.05mM L-glutamine (Cellgro). 1X105 
Tregs and non-Treg T cells were spun down and stored in Ribozol at 70°C. 
Growth of Desulfovibrio desulfuricans ATCC  27774 
The bacterial species Desulfovibrio desulfuricans was purchased from 
ATCC (#27774). Vial was handled and opened per ATCC instructions for 
anaerobic bacteria and cells were grown in Desulfovibrio media described in Rey 
et al., PNAS 2013. Media was composed of NH4Cl (1g/L) (Fisher Chemical), 
Na2SO4 (2g/L) (Fisher Chemical), Na2S2O35H2O (1g/L) (Sigma), MgSO47H2O 
(1g/L) (Fisher Chemical), CaCl22H2O (0.1g/L) (Fisher Chemical), KH2PO4 (0.5g/L) 
(Fisher Bioreagents), Yeast Extract (1g/L) (Amresco), Resazurin (0.5mL/L) 
(Sigma), Cysteine (0.6g/L) (Sigma), DTT (0.6g/L) (Sigma), NaHCO3 (1g/L) 
(Fisher Chemical), Pyruvic Acid (3g/L) (Acros Organics), Malic Acid (3g/L) (Acros 
Organics), ATCC Trace Mineral Mix (10mL/L), ATCC Vitamin Mix (10mL/L). 
Adjusted to pH of 7.2 bacteria was grown for 48hr in an anaerobic chamber (Coy 
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Labs) and stored in growth media containing 25% glycerol at 70°C. 2.5X108 
bacterial CFUs were added to 250µL of drinking water of mice for one week.  
Isolation and 16s sequencing of fecal and ileal DNA 
Animals were sacrificed and their entire lower digestive tract (from 
duodenum to rectum) was removed and longitudinally sectioned. One fecal pellet 
and luminal content from lower 10cm of small intestine were collected from each 
animal to characterize the fecal and ileal microbiota communities, respectively. 
Fecal and ileal samples were immediately frozen at -70°C in 2mL screw cap 
tubes containing ~250 milligram of 0.15 mm garnet beads (MoBio, cat# 13122-
500). DNA was extracted using the Power Fecal DNA Isolation Kit (MoBio), per 
kit instructions. 16s DNA amplification and sequencing was done as previously 
described in Kubinak, Petersen et al., Cell Host and Microbe 2015.  
Metabolic phenotyping 
Total body fat composition was measured on an NMR Bruker Minispec. 
CLAMS Metabolic Cages were used to measure indirect calorimetry. Both 
services were provided by the Metabolic Phenotyping Core, a part of the Health 
Sciences Cores at the University of Utah. 
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Figure 5.S1: Mice lacking MyD88 signaling within T cells develop obesity. 
A) Grams of weight gained as mice age, starting at 2 months of age (WT, N=8; T-
MyD88-/-, N=7). B) Percentage of fat gained as mice age, starting at 2 months of
age (WT, N=8; T-MyD88-/-, N=7).  C) Blood levels of glucose (milligram per
decaliter) measured over time following i.p. glucose (1milligram per gram)
injection during glucose tolerance test of 1 year old WT and T-MyD88-/- mice. D)
VO2 of 2 month and 12 month mice (2 month N=3 per group; 12 month N=5 per
group) E) VCO2 of 2 month and 12 month mice (2 month N=3 per group; 12
month N=5 per group) F) Energry Expenditure of of 2 month and 12 month mice
(2 month N=3 per group; 12 month N=5 per group) G)Grams of food intake per
mouse while being fed normal chow (2 month N=3 per group; 6 months N=4 per
group; 12 months N=5 per group) H)Heat of 2 month and 12 month mice (2
month N=3 per group; 12 month N=5 per group) I) Movement of 2 month and 12
month mice (2 month N=3 per group; 12 month N=5 per group) J)Grams of
weight gained of WT and T-MyD88-/- mice fed a control or HFD (WT CTRL, N=8;
WT HFD, N=15; T-MyD88-/- CTRL, N=9; T-MyD88-/- HFD, N=13). K) Percentage
of weight gained of WT and T-MyD88-/- mice fed a control or HFD (WT CTRL,
N=8; WT HFD, N=15; T-MyD88-/- CTRL, N=9; T-MyD88-/- HFD, N=13).
Statistics: P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) using a
repeated measures ANOVA (A, C, J, K), two-tailed, unpaired t-test (B,D-I).
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Figure 5.S2: Obese T-MyD88-/- mice have greater inflammation within adipose 
tissue.  A) Representative flow cytometry plots were previously gated on 
CD3+CD4+ T cells within adipose tissue and measured for Tregs, defined as 
CD3+CD4+FoxP3+ cells.  B) Percentage of Tregs within adipose tissue of WT 
and T-MyD88-/- mice fed a control or HFD (WT CTRL, N=8; WT HFD, N=15; T-
MyD88-/- CTRL, N=9; T-MyD88-/- HFD, N=13). C) Representative flow cytometry 
plots were previously gated on CD45+ cells within adipose tissue and measured 
for macrophages, defined as CD45+CD11b+F4/80+ cells. D) Percentages of 
macrophages within adipose tissue of WT and T-MyD88-/- mice fed a control or 
HFD (WT CTRL, N=8; WT HFD, N=15; T-MyD88-/- CTRL, N=9; T-MyD88-/- HFD, 
N=13). E) qPCR of mRNA expression of various T cell and myeloid cell immune 
parameters from WT and T-MyD88-/- mice fed a HFD (WT, N=6; T-MyD88-/-, 
N=6). Statistics: P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) two-
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Figure 5.S3: Dysbiosis within T-MyD88-/- mice is associated with spontaneous 
weight gain A) Grams of VAT within WT and T-MyD88-/- mice fed HFD with or 
without antibiotics (WT CTRL, N=5; TMYD CTRL, N=4; WT ABX, N=5, TMYD 
ABX, N=5). B) Representative flow cytometry plots were previously gated on 
CD3+CD4+ T cells within adipose tissue and measured for percentage of 
adipose Tregs, defined as CD3+CD4+FoxP3+ cells, within WT and T-MyD88-/- 
mice fed HFD with or without antibiotics. C) Beta-diversity of ileal and fecal 16s 
sequencing samples from 1 year old WT and T-MyD88-/- mice, measured by 
unweighted unifrac and weighted unifrac (WT, N=8; T-MyD88-/-, N=7). D) Heat 
Map of biological pathways within fecal bacterial between one year old WT and 
T-MyD88-/- mice (N=6 per genotype). E) Cladogram of LEFSe analysis
comparing one year old WT and T-MyD88-/- fecal 16s sequencing samples. F)
Family level comparison of Turicibacteraceae relative abundance within fecal 16s
sequencing samples of one year old WT and T-MyD88-/- mice G) Family level
comparison of Clostridiaceae relative abundance within fecal 16s sequencing
samples of one year old WT and T-MyD88-/- mice. H) Family level comparison of
Lachnospiraceae relative abundance within fecal 16s sequencing samples of one
year old WT and T-MyD88-/- mice. I) Family level comparison of
Peptostreptococcaceae relative abundance within fecal 16s sequencing samples
of one year old WT and T-MyD88-/- mice. J) Mapped reads per million of
significantly different species from WT and T-MyD88-/- fecal transcripts (N=6 per
genotype). K) Mapped reads per million of significantly different species from WT
and T-MyD88-/- ileal transcripts. Statistics: P-value<0.05 (*); P-value<0.01 (**);
P-value<0.001 (***) using a two-tailed, unpaired t-test (A,B,J,K), permanova (C),



































































































































































































































































































































































































































Figure 5.S4: T cell shaping of the microbiota is associated with spontaneous 
weight gain.  A) Weight gained in germfree mice given WT or T-MyD88-/- 
microbiota through multiple methods of transfer (CF=cross fostered). B) Flow 
cytometry was used to quantify the percentage of IgA bound bacteria within 
TCRKO mice given WT or T-MyD88-/- cells at Day 0, Week 1, and Week 8 (N=6 
per cohort).  
C) Flow cytometry was used to quantify the percentage of IgG1 bound bacteria 
within TCRKO mice given WT or T-MyD88-/- cells at Day 0, Week 1, and Week 8.  
D) Flow cytometry was used to quantify the percentage of IgG3 bound bacteria 
within TCRKO mice given WT or T-MyD88-/- cells at Day 0, Week 1, and Week 8. 
E) Concentration of luminal IgA (µg/mL) within was measured TCRKO mice 
given WT or T-MyD88-/- cells after 8 weeks using an ELISA.  F) Representative 
flow cytometry plot was previously gaited on SyBRGreen+ cells in order to 
quantify the percentage of IgG3 bound bacteria within TCRKO mice given WT or 
T-MyD88-/- cells after 8 weeks. G) Relative abundance of Clostridiaceae within 
fecal samples from TCRKO mice given WT and T-MYD88 Day 0 and after 4 
weeksStatistics: P-value<0.05 (*); P-value<0.01 (**); P-value<0.001 (***) two-














































































































































































Figure 5.S5: Dysbiosis within T-MyD88-/- mice transfers obesity to WT animals. 
A) Schematic of cohousing experiment. B) Total grams of weight gained by
separated or cohoused WT and T-MyD88-/- mice fed a HFD (N=4 per cohort). C)
Percentage of adipose Tregs within WT and T-MyD88-/- mice fed a HFD D)
qPCR of mRNA expression of various T cell and myeloid cell immune
parameters from separated or cohoused WT and T-MyD88-/- mice fed a HFD.






































































































Figure 5.S6: Expansion of Desulfovibrio and reductions in beneficial spore-
forming microbes are associated with obesity. A) Relative abundance of 
Bifidobacterium pseudolongum within fecal 16s sequencing samples from 
separated or cohoused WT and T-MyD88-/- mice at the final timepoint (N=4 per 
cohort). B) Relative abundance of Lactobacillales within fecal 16s sequencing 
samples from separated or cohoused WT and T-MyD88-/- mice at the final 
timepoint (N=4 per cohort). Statistics: P-value<0.05 (*); P-value<0.01 (**); P-





Here we have discovered a mechanism by which recognition of microbial 
products by T cells directs IgA targeting of commensals to maintain healthy 
microbiota composition. T cells lacking MyD88 are defective in their ability to 
differentiate into Tfh cells to promote GC responses during steady-state 
conditions within the gut as well as immunogenic challenge of the systemic 
compartment. The resulting loss of GC responses leads to defective T cell-
dependent IgA targeting, and animals containing a specific deletion of MyD88 
within T cells develop dysbiosis that enhances susceptibility to colitis and drives 
the onset of obesity and insulin resistance. These diseases are rescued by either 
providing an FMT from a healthy WT donor or specifically reintroducing beneficial 
microbes that are capable of protect against obesity. We have thus uncovered a 
novel mechanism by which dysbiosis and disease develop, providing a new 
avenue in which potential preventative and therapeutic methods can be 
developed.  
While this dissertation makes great strides in understanding T cell-
dependent MyD88 signaling with regards to its role in shaping healthy microbiota 
communities, much work needs to be done to appreciate the mechanism by 
which T cells use innate signals to promote TFH responses, as well as how 
dysbiotic communities arise in mice lacking MyD88 signaling in T cells. 
Additionally, indentifying the mechanism by which these communities promote 
both obesity and colitis will lead to novel therapeutic targets in order to treat 
these diseases.  
Future studies are required to identify the mechanism by which T cells 
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use MyD88 signaling to promote TFH differentiation preliminary evidence from 
this thesis has identified defects within proliferation, ICOS signaling, and 
maintenance of GC B cell responses; however, the extent by which these 
pathways are working in conjunction or independently of each other is unknown. 
Additionally, while much of the work within this thesis looked at shifts within gene 
and protein expression, MyD88 has been demonstrated to modulate metabolic 
pathways within T cells. It should therefore be considered whether or not TFH 
cells require MyD88 signaling to maintain proper metabolic function. Lastly, this 
thesis has demonstrated a common defect within both splenic and gut TFH 
development when T cells lack MyD88 signaling. The types of germinal center 
responses that occur within the splenic compartment and PPs within the gut 
differ within respects to antibody production as well as stimulus. PPs maintain a 
constant germinal center response that results in IgA, while spleens have very 
little TFH differentiation and germinal center responses in the absence of 
infection. Furthermore, during pathogen invasion, antibody production results 
primarily in an IgG response. Therefore, it is likely that the TFH stimuli and 
differentiation vary between these two sights. Future studies to characterize site 
specific immune responses using the model antigen, OVA, or other antigens may 
reveal alternate roles for MyD88 signaling that could explain some of the 
inconsistencies identified within the results of this thesis.  
Mice lacking MyD88 signaling in T cells develop dysbiosis that 
predisposes them to both colitis and obesity. We have identified a correlative loss 
of IgA and IgA targeting of specific microbes with expansion of the pathobiont, 
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Desulfovibrio, the loss of beneficial Clostridia, and the reduction of diversity. A 
large body of literature supports the requirement of secretory IgA within the gut, 
however, it is has remained difficult to definitively test whether defects within T 
cell-dependent IgA signaling within the gut are the sole impetus for the dysbiosis 
that we observe in T-MyD88-/- mice. Future experiments using IgA deficient mice 
as well as BCL6 deficient animals, will provide additional insight, however, 
compensation by other immune responses within these animals may provide 
additional confounders. Regardless of this, the dysbiosis observed within these 
animals resembles a number of microbiota communities found within obese 
patients and individuals with type II diabetes. The parallels between our mouse 
model and humans provides us with a unique opportunity to understand inter-
microbe interactions and microbe-derived metabolites that contribute to both 
dysbiosis and metabolic syndrome. This can be achieved through two 
independent lines of experiments: (1) Utilizing the germfree facility, we can 
understand how co-colonization of microbes alters both the abundance and 
genetic expression of both commensals and pathobionts. Microbial communities 
are filled with overlapping niches and lead to both antagonistic and supportive 
interactions between commensals. The identification that dysbiosis reduces the 
abundance of Clostridia members points to a potential therapeutic target. if we 
can elucidate how Desulfovibrio promotes the loss of Clostridia, we can design 
therapies to restore the beneficial microbe; (2) Through metabolomics analysis, 
we can identify shifts within gut metabolites that promote weight gain. 
Commensals influence weight gain through both microbial-derived metabolites 
139	
and the alteration of host-derived metabolites. It is likely that one of these 
pathways is leading to the dyslipidemia identified in the T-MyD88-/- mice. 
Considering the parallels that the dysbiosis in these mice draws with clinical 
studies, it is likely that identifying which metabolic shifts within the microbiota 
drive disease will lead to a therapeutic target in the treatment of both obesity and 
diabetes. Harnessing the tools within our germfree facility, the metabolomics core, 
and meta-transcriptomics will provide valuable knowledge on the development 
and perpetuation of metabolic syndrome.  
The increase of allergic, autoimmune, and metabolic disorders in western 
society has coincided with shifting social practices involving antibiotics use, 
dietary behaviors, and hygiene (1). These alterations to our behavior and 
environment have lasting effects on our microbiota (2-4). Because of this, it has 
been postulated that a combination of these effects has led to a broad extinction 
of beneficial microbes within our society, resulting in reduced microbiota diversity, 
and a greater susceptibility to disease pathology (5). Despite this rise in disorders, 
however, many individuals experience no clinical consequences to a westernized 
lifestyle. Given these discrepancies, it is accepted within the scientific community 
that environmental and genetic factors likely interact to promote or protect 
against these complex diseases. Directed IgA targeting of the microbiota may be 
one mechanism by which host immune responses predispose individuals to a 
greater susceptibility toward disease onset. In agreement with this notion, studies 
have revealed that roughly 1 in 600 people is IgA-deficient, making it the most 
common primary immunodeficiency (6). As many as 30-50% of these individuals 
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experience recurrent mucosal infections or develop autoimmune diseases (6, 7). 
This is a dramatic increase in disease susceptibility over individuals with healthy 
levels of IgA. While many individuals are never diagnosed with IgA deficiency, 
future studies that screen for this disorder and compare their susceptibility to 
other diseases might reveal additional links between IgA deficiency and a 
westernized lifestyle.   
This dissertation has identified a novel component of a pathway that has 
co-evolved to maintain symbiosis between mammals and the microbiota. Studies 
such as this provide unique opportunities to understand intricacies of immune 
development while gaining insight into the impact of specific commensals on the 
metabolic and compositional landscape of the microbiota. While the microbiota 
as a whole has evolved a vast network of species and redundant metabolic 
functions, identifying the underlying mechanisms of disease associated 
perturbations reveals keystone interactions that are necessary to push the 
balances in favor of health.  
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